Avis juridique important

|

31996L0054

Commission Directive 96/54/EC of 30 July 1996 adapting to technical progress for the twenty-second time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)

Official Journal L 248 , 30/09/1996 P. 0001 - 0230

COMMISSION DIRECTIVE 96/54/EC of 30 July 1996 adapting to technical progress for the twenty-second time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Community,Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (1), as last amended by Commission Directive 94/69/EC (2), and in particular Article 28 thereof,Whereas Annex I to Directive 67/548/EEC contains a list of dangerous substances, their classification, labelling and where appropriate, their characterization by concentration limits and other parameters enabling their risk to human health and the environment to be assessed; whereas the list of dangerous substances in Annex I needs to be adapted in the light of present scientific and technical knowledge; whereas in consequence it is necessary to amend the foreword to Annex I so as to include notes relating to the labelling of preparations and a new group of organic substances in table B; whereas the list of dangerous substances in Annex I contains substances for which specific temporary classification and labelling derogations have been granted to Austria and Sweden by the Act of Accession of Austria, Finland and Sweden; whereas the Act of Accession provides for the review of the classification and labelling requirements of those substances; whereas the classifications of some of those substances have been reviewed accordingly;Whereas Annex III to Directive 67/548/EEC contains a list of phrases indicating the nature of special risks attributed to dangerous substances and preparations; whereas a phrase indicating the danger to health of certain substances and preparations on aspiration needs to be introduced;Whereas Annex V to Directive 67/548/EEC lays down the methods for the determination of the physico-chemical properties, toxicity and ecotoxicity of substances and preparations; whereas the adaptation to technical progress of that Annex is necessary;Whereas Annex VI to Directive 67/548/EEC contains general criteria for the classification and labelling of dangerous substances and preparations; whereas criteria for substances and preparations dangerous to health if aspirated need to be introduced; whereas the criteria for sensitizing substances and preparations need to be amended; whereas criteria for the labelling of gas containers intended for propane, butane or liquefied petroleum gas (LPG) need to be introduced;Whereas the provisions of this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade in Dangerous Substances and Preparations,HAS ADOPTED THIS DIRECTIVE:Article 1 Directive 67/548/EEC is hereby amended as follows:1. Annex I is amended as follows:(a) nota 4 in the Foreword is replaced by the following text:'Nota 4Preparations containing these substances have to be classified as harmful with R65 if they meet the criteria in section 3.2.3 in Annex VI.`;(b) the following nota 5 is added:'Nota 5The concentration limits for gaseous preparations are expressed as volume per volume percentage.`;(c) the following special classification for organic substances is added to table B in the foreword to Annex I to Directive 67/548/EEC:'647 EnzimasEnzymerEnzyme¸íæõìáEnzymesEnzymesEnzimiEnzymenEnzimasEntsyymitEnzymer`;(d) the entries in Annex I to this Directive replace the corresponding entries;(e) the entries in Annex II to this Directive are added for the first time;(f) the entries with the following numbers are deleted:008-002-00-3612-045-00-9648-011-00-5648-025-00-1648-157-00-X648-158-00-5648-159-00-0649-192-00-3(g) the entries shown in Annex III to this Directive are amended by replacing all references to 'R 22` by 'R 65`.2. The following phrase is added to Annex III:'R 65ES: Nocivo: si se ingiere puede causar daño pulmonar.DA: Farlig: kan give lungeskade ved indtagelse.DE: Gesundheitsschädlich: kann beim Verschlucken Lungenschäden verursachen.EL: ÅðéâëáâÝò: ìðïñåß íá ðñïêáëÝóåé âëÜâç óôïõò ðíåýìïíåò óå ðåñßðôùóç êáôÜðïóçò.EN: Harmful: may cause lung damage if swallowed.FR: Nocif: peut provoquer une atteinte des poumons en cas d'ingestion.IT: Nocivo: può causare danni ai polmoni in caso di ingestione.NL: Schadelijk: kan longschade veroorzaken na verslikken.PT: Nocivo: pode causar danos nos pulmões se ingerido.FI: Haitallista: voi aiheuttaa keuhkovaurion nieltäessä.SV: Farligt: kan ge lungskador vid förtäring.`3. Part B of Annex V is amended as follows:(a) the text in Annex IV.A to this Directive replaces the heading and the general introduction to Part B: Methods for the Determination of Toxicity;(b) the text in Annex IV.B to this Directive is inserted after chapter B.1 bis;(c) the text in Annex IV.C to this Directive replaces chapter B.6;(d) the text in Annex IV.D to this Directive replaces chapter B.7;(e) the text in Annex IV.E to this Directive is added at the end.4. Annex VI is amended by the texts set out in Annex V to this Directive, as indicated therein.Article 2 1. Without prejudice to paragraph 2, not later than 31 May 1998, Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive. Member States shall immediately inform the Commission thereof.2. Not later than 31 October 1997 the Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with Annex V, points F, I and J of this Directive. Member States shall immediately inform the Commission thereof.3. When Member States adopt the provisions referred to in paragraphs 1 and 2, they shall contain a reference to this Directive or shall be accompanied by such reference at the time of their official publication. The procedure for such reference shall be adopted by Member States.Article 3 This Directive shall enter into force on the 20th day following its publication in the Official Journal of the European Communities.Article 4 This Directive is addressed to the Member States.Done at Brussels, 30 July 1996.For the CommissionRitt BJERREGAARDMember of the Commission(1) OJ No L 196, 16. 8. 1967, p. 1.(2) OJ No L 381, 31. 12. 1994, p. 1.ANEXO I - BILAG I - ANHANG I - ÐÁÑÁÑÔÇÌÁ É - ANNEX I - ANNEXE I - ALLEGATO I - BIJLAGE I - ANEXO I - LIITE I - BILAGA I  >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC>Cas No 630-08-0EEC No 211-128-3NOTA ECOES: monóxido de carbonoDA: carbonmonoxid; kulilteDE: KohlenstoffmonoxidEL: ìïíïîåßäéï ôïõ ÜíèñáêáEN: carbon monoxideFR: monoxyde de carboneIT: monossido di carbonio; carbonio ossidoNL: koolstofmonoxidePT: monóxido de carbonoFI: hiilimonoksidiSV: kolmonoxidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12Repr. Cat. 1; R 61T; R 23-48/23 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+ >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>R:61-12-23-48/23S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 75-44-5EEC No 200-870-3No 006-002-00-8COCl2ES: fosgenoDA: phosgenDE: Phosgen; CarbonylchloridEL: öùóãÝíéïEN: phosgene; carbonyl chlorideFR: phosgèneIT: fosgene; carbonile cloruroNL: fosgeenPT: fosgenoFI: fosgeeni; karbonyylikloridiSV: fosgen; karbonyldikloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>R:26-34S:(1/2-)9-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 5%T+; R 26-341% <= C < 5%T+; R 26-36/37/380,5% <= C < 1%T; R 23-36/37/380,2% <= C < 0,5%T; R 230,02% <= C < 0,2%Xn; R 20Cas No 7664-41-7EEC  No 231-635-3No 007-001-00-5NH3ES: amoniaco, anhidroDA: ammoniak, vandfriDE: Ammoniak, wasserfreiEL: áììùíßá, ÜíõäñïòEN: ammonia, anhydrousFR: ammoniac, anhydreIT: ammoniaca, anidraNL: ammoniak, watervrijPT: amoníaco, anidroFI: ammoniakki, vedetönSV: ammoniak, vattenfriClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 10T; R 23C; R 34N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:10-23-34-50S:(1/2-)9-16-26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 5%T; R 23-340,5% <= C < 5%Xn; R 20-36/37/38Cas No 1336-21-6EEC No 215-647-6No 007-001-01-2NOTA BNH3 ....%ES: amoniaco ....%DA: ammoniak ....%DE: Ammoniak ....%EL: áììùíßá ....%EN: ammonia ....%FR: ammoniac ....%IT: ammoniaca ....%NL: ammoniak ....%PT: amoníaco ....%FI: ammoniakki ....%SV: ammoniaklösning ....%Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringC; R 34N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:34-50S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; N; R 34-5010% <= C < 25%C; R 345% <= C < 10%Xi; R 36/37/38Cas No 10102-44-0 [1] 10544-72-6 [2]EEC No 233-272-6 [1] 234-126-4 [2]No 007-002-00-0NO2 [1] N2O4 [2]ES: dióxido de nitrógeno [1]; tetraóxido de dinitrogeno [2]DA: nitrogendioxid [1]; dinitrogentetraoxid [2]DE: Stickstoffdioxid [1]; Distickstofftetraoxid [2]EL: äéïîåßäéï ôïõ áæþôïõ [1] . ôåôñáïîåßäéï ôïõ äéáæþôïõ[2]EN: nitrogen dioxide [1]; dinitrogen tetraoxide [2]FR: dioxyde d`azote [1]; tétraoxyde de diazote [2]IT: diossido di azoto [1]; tetraossido di diazoto [2]NL: stikstofdioxide [1]; distikstoftetraoxide [2]PT: dióxido de azoto [1]; tetraóxido de diazoto [2]FI: typpidioksidi [1]; dityppitetraoksidi [2]SV: kvävedioxid [1]; dikvävetetraoxid [2]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>R:26-34S:(1/2-)9-26-28-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 10% T+; R 26-345% <= C < 10%T; R 23-341% <= C < 5%T; R 23-36/37/380,5% <= C < 1%Xn; R 20-36/37/380,1% <= C < 0,5%Xn; R 20Cas No 7782-44-7EEC No 231-956-9No 008-001-00-8O2ES: oxígenoDA: oxygen; iltDE: SauerstoffEL: ïîõãüíïEN: oxygenFR: oxygèneIT: ossigenoNL: zuurstofPT: oxigénioFI: happiSV: syre; flytandeClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringO; R 8 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningO >REFERENCE TO A GRAPHIC>R:8S:(2-)17Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7782-41-4EEC No 231-954-8No 009-001-00-0F2ES: flúorDA: fluorDE: FluorEL: öèüñéïEN: fluorineFR: fluorIT: fluoroNL: fluorPT: flúorFI: fluoriSV: fluorClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 7T+; R 26C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:7-26-35S:(1/2-)9-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 78-57-9EEC No 201-123-4No 015-053-00-5>REFERENCE TO A GRAPHIC>ES: menazonDA: menazonDE: MenazonEL: menazonEN: menazonFR: menazonIT: menazone; S-[(4,6-diamino-1,3,5-triazin-2-il)-metil] O,O-dimetilditiofosfatoNL: menazonPT: menazonFI: menatsoniSV: menazon (ISO); S-4,6-diamino-1,3,5-triazin-2-ylmetyl-O,O-dimetylfosforoditioatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:22-52/53S:(2-)61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7783-06-4EEC No 231-977-3No 016-001-00-4H2SES: sulfuro de hidrógenoDA: hydrogensulfidDE: Hydrogensulfid; SchwefelwasserstoffEL: óïõëößäéï ôïõ õäñïãüíïõEN: hydrogen sulphideFR: sulfure d`hydrogèneIT: solfuro di idrogeno; idrogeno solforatoNL: hydrogeensulfidePT: sulfureto de hidrogénioFI: rikkivety; vetysulfidiSV: vätesulfid; svavelväteClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12T+; R 26N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+ >REFERENCE TO A GRAPHIC>T+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:12-26-50S:(1/2-)9-16-28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 10%T+; R 265% <= C < 10%T; R 231% <= C < 5%Xn; R 20Cas No 7446-09-5EEC No 231-195-2No 016-011-00-9SO2ES: dióxido de azufreDA: svovldioxidDE: SchwefeldioxidEL: äéïîåßäéï ôïõ èåßïõEN: sulphur dioxideFR: dioxyde de soufreIT: diossido di zolfoNL: zwaveldioxidePT: dióxido de enxofreFI: rikkidioksidiSV: svaveldioxidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23 C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:23-34S:(1/2-)9-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 20%T; R 23-345% <= C < 20%Xn; R 20-340,5% <= C < 5%Xi; R 36/37/38Cas No 7782-50-5EEC No 231-959-5No 017-001-00-7Cl2ES: cloroDA: chlorDE: ChlorEL: ÷ëþñéïEN: chlorineFR: chloreIT: cloroNL: chloorPT: cloroFI: klooriSV: klorClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23Xi; R 36/37/38N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23-36/37/38-50S:(1/2-)9-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7647-01-0 EEC No 231-595-7 017-002-00-2HClES: cloruro de hidrógenoDA: hydrogenchloridDE: Hydrogenchlorid; ChlorwasserstoffEL: ÷ëùñßäéï ôïõ õäñïãüíïõEN: hydrogen chlorideFR: chlorure d`hydrogèneIT: cloruro di idrogeno; acido cloridricoNL: hydrogeenchloridePT: cloreto de hidrogénioFI: kloorivety, vedetönSV: väteklorid; vattenfriClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:23-35S:(1/2-)9-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 5%T; C; R 23-351% <= C < 5%C; R 20-350,5% <= C < 1%C; R 20-340,2% <= C < 0,5%C; R 340,02% <= C < 0,2%Xi; R 36/37/38Cas No 1333-82-0EEC No 215-607-8No 024-001-00-0NOTA ECrO3ES: trióxido de cromoDA: chromtrioxidDE: ChromtrioxidEL: ôñéïîåßäéï ôïõ ÷ñþìéïõ EN: chromium trioxideFR: trioxyde de chromeIT: triossido di cromoNL: chroomtrioxidePT: trióxido de crómioFI: kromitrioksidiSV: kromtrioxidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringO; R 8Carc. Cat. 1; R 49T; R 25C; R 35R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningO >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-8-25-35-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7778-50-9 EECNo 231-906-6No 024-002-00-6NOTA EK2 Cr2 O7ES: dicromato de potasioDA: kaliumdichromatDE: KaliumdichromatEL: äé÷ñùìéêü êÜëéïEN: potassium dichromateFR: dichromate de potassium IT: dicromato di potassioNL: kaliumdichromaatPT: dicromato de potássioFI: kaliumdikromaattiSV: kaliumdikromat Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 49Muta. Cat. 2; R 46T+; R 26T; R 25Xn; R 21Xi; R 37/38-41R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-46-21-25-26-37/38-41-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 3C >= 7%T+; R 49-46-21-25-26-37/38-41-430,5% <= C < 7%T; R 49-46-430,1% <= C < 0,5%T; R 49-46Cas No 7789-09-5EEC No 232-143-1No 024-003-00-1NOTA E(NH4)2 Cr2 O7ES: dicromato de amonioDA: ammoniumdichromatDE: AmmoniumdichromatEL: äé÷ñùìéêü áììþíéïEN: ammonium dichromateFR: dichromate d`ammoniumIT: dicromato di ammonioNL: ammoniumdichromaatPT: dicromato de amónioFI: ammoniumdikromaattiSV: ammoniumdikromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringER1O;R8Carc.Cat.2;R49Muta.Cat.2;R46T+;R26T;R25Xn;R21Xi;R37/38-41R43N;R50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningE >REFERENCE TO A GRAPHIC>T+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-46-1-8-21-25-26-37/38-41-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 3C >= 7%T+; R 49-46-21-25-26-37/38-41-430,5% <= C < 7%T; R 49-46-430,1% <= C < 0,5%T; R 49-46Cas No 14977-61-8EEC No 239-056-8No 024-005-00-2NOTA ECr O2 Cl2ES: dicloruro de cromiloDA: chromyldichloridDE: Chromyldichlorid; ChromoxychloridEL: äé÷ëùñßäéï ôïõ ÷ñùìýëïõEN: chromyl dichloride; chromic oxychlorideFR: dichlorure de chromyleIT: dicloruro di cromileNL: chromyldichloridePT: dicloreto de cromiloFI: kromioksikloridiSV: kromyldiklorid; kromdioxidkloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringO; R 8Carc. Cat. 2; R 49Muta. Cat. 2; R 46C; R 35R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningO >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-46-8-35-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 3C >= 10%T; C; R 49-46-35-435% <= C < 10%T; R 49-46-34-430,5% <= C < 5%T; R 49-46-36/37/38-430,1% <= C < 0,5%T; R 49-46Cas No 7789-00-6EEC No 232-140-5No 024-006-00-8NOTA EK2 Cr O4ES: cromato de potasioDA: kaliumchromatDE: KaliumchromatEL: ÷ñùìéêü êÜëéïEN: potassium chromateFR: chromate de potassium IT: cromato di potassioNL: kaliumchromaatPT: cromato de potássioFI: kaliumkromaattiSV: kaliumkromat Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc.Cat. 2; R49Muta.Cat.2;R46Xi;R36/37/38R43N;R50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-46-36/37/38-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 3C >= 20%T; R 49-46-36/37/38-430,5% <= C < 20%T; R 49-46-430,1% <= C < 0,5%T; R 49-46Cas No -EEC No -No 024-007-00-3NOTA ANOTA EES: cromatos de cinc, incluido el cromato de cinc y de potasioDA: zinkchromater, herunder zinkkaliumchromatDE: Zinkchromate, einschließlich ZinkkaliumchromatEL: ÷ñùìéêÜ øåõäáñãýñïõ, ðåñéëáìâáíïìÝíïõ ôïõ ÷ñùìéêïý ôïõ øåõäáñãýñïõ êáé êáëßïõEN: zinc chromates including zinc potassium chromateFR: chromates de zinc y compris le chromate de zinc et potassiumIT: cromato di zinco, compreso il cromato di zinco e potassioNL: zinkchromaat met inbegrip van zinkkaliumchromaatPT: cromatos de zinco, incluindo o cromato de zinco e potássioFI: sinkkikromaatit mukaan luettuna sinkkikaliumkromaattiSV: zinkkromater inklusive zinkkaliumkromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 1; R 45Xn; R 22R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 13765-19-0EEC No 237-366-8No 024-008-00-9NOTA ECaCrO4ES: cromato de calcioDA: calciumchromatDE: CalciumchromatEL: ÷ñùìéêü áóâÝóôéïEN: calcium chromateFR: chromate de calciumIT: cromato di calcioNL: calciumchromaatPT: cromato de cálcioFI: kalsiumkromaattiSV: kalciumkromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7789-06-2EEC No 232-142-6No 024-009-00-4NOTA ESrCrO4ES: cromato de estroncioDA: strontiumchromatDE: StrontiumchromatEL: ÷ñùìéêü óôñüíôéïEN: strontium chromateFR: chromate de strontiumIT: cromato di stronzioNL: strontiumchromaatPT: cromato de estrôncioFI: strontiumkromaattiSV: strontiumkromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 24613-89-6EEC No 246-356-2No 024-010-00-XCr2(CrO4)3ES: tris(cromato) de dicromoDA: dichromtris(chromat)DE: Dichromtris(chromat); Chrom(III)-chromatEL: ôñéò(÷ñùìéêü) ôïõ äé÷ñùìßïõEN: dichromium tris(chromate); chromium III chromate; chromic chromateFR: tris(chromate) de dichromeIT: tris(cromato) di dicromoNL: dichroomtris(chromaat)PT: tris(cromato) de dicrómioFI: kromi(III)kromaattiSV: krom(III)kromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringO; R 8Carc. Cat. 2; R 45C; R 35R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningO >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-8-35-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 10034-85-2EEC No 233-109-9No 053-002-00-9HIES: ioduro de hidrógenoDA: hydrogeniodidDE: Hydrogeniodid; JodwasserstoffEL: éùäßäéï ôïõ õäñïãüíïõEN: hydrogen iodideFR: iodure d`hydrogèneIT: ioduro di idrogeno; acido iodidricoNL: hydrogeenjodidePT: iodeto de hidrogénioFI: jodivety, vedetönSV: vätejodid; vattenfriClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringC; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:35S:(1/2-)9-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 10%C; R 350,2% <= C < 10%C; R 340,02% <= C < 0,2%Xi; R 36/37/38Cas No -EEC No -No 056-002-00-7NOTA AES: sales de bario, excepto el sulfato de bario, ácido 1-azo-2-hidroxinaftalenil aril sulfónico y aquellas específicamente expresadas en este anexoDA: bariumsalte, undtagen bariumsulfat, salte af 1-azo-2-hydroxynaphthalenylarylsulfonsyre, og bariumsalte nævnt andetsteds i dette bilagDE: Bariumsalze, mit Ausnahme des Bariumsulfats, der Salze von 1-Azo-2-hydroxynaphthalenylarylsulfonsäuren, und der namentlich in diesem Anhang bezeichneten SalzeEL: Üëáôá âáñßïõ, åêôüò áðü ôï èåééêü âÜñéï, Üëáôá ôïõ 1-áæù-2-õäñïîõíáöèáëéíï áñõëï óïõëöïíéêïý ïîÝïò, êáé Üëáôá ðïõ áíáöÝñïíôáé ó` Üëëï óçìåßï áõôïý ôïõ êáôáëüãïõEN: barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this AnnexFR: sels de baryum, à l`exclusion du sulfate de baryum, des sels de l`acide 1-azo-2-hydroxynaphthalénylarylsulfonique, et des sels nommément désignés dans cette annexeIT: sali di bario, esclusi il solfato di bario, i sali dell`acido 1-azo-2-idrossinaftalenil aril solfonico, e i sali espressamente indicati in questo allegatoNL: bariumzouten, met uitzondering van bariumsulfaat, zouten van 1-azo-2-hydroxynaphtyl aryl sulfoonzuur en in deze bijlage met name genoemde zoutenPT: sais de bário, com excepção do sulfato de bário, sais de ácido 1-azo-2-hidroxinaftalenil aril sulfónico, e dos sais expressamente referidos no presente anexoFI: bariumsuolat paitsi bariumsulfaatti, 1-atso-2-hydroksinaftenyyliaryylisulfonihapon suolat ja muualla tässä liiteessä mainitut suolatSV: bariumsalter utom bariumsulfat, salter av 1-azo-2-hydroxinaftalenylarylsulfonsyra och sådana som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 20/22 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:20/22S:(2-)28Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 1C >= 1%Xn; R 20/22Cas No -EEC No -No 082-002-00-1NOTA ANOTA EPb (CnH2n+1)xn=1-5ES: derivados de alquilplomoDA: blyalkylerDE: BleialkyleEL: áëêõëéêÝò åíþóåéò ìïëýâäïõEN: lead alkylsFR: dérivés alkylés du plombIT: piomboalchiliNL: loodalkylenPT: alquilos de chumboFI: lyijyalkyylitSV: blyalkylerClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringRepr. Cat. I; R 61Repr. Cat. 3; R 62T+; R 26/27/28R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:61-62-26/27/28-33-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 1C >= 5%T+; R 61-62-26/27/28-330,5% <= C < 5%T+; R 61-26/27/28-330,1% <= C < 0,5%T; R 61-23/24/25-330,05% <= C < 0,1%Xn; R 20/21/22-33Cas No 7758-97-6EEC No 231-846-0No 082-004-00-2PbCrO4ES: cromato de plomoDA: blychromatDE: BleichromatEL: ÷ñùìéêüò ìüëõâäïò EN: lead chromateFR: chromate de plombIT: cromato di piomboNL: loodchromaatPT: cromato de chumboFI: lyijykromaattiSV: blykromatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringRepr. Cat. 1; R 61Repr. Cat. 3; R 62Carc. Cat. 3; R 40R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:61-62-33-40-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 1Cas No 77-73-6EEC No 201-052-9No 601-044-00-9>REFERENCE TO A GRAPHIC>ES: 3a,4,7,7a-tetrahidro-4,7-metanoindenoDA: 3a,4,7,7a-tetrahydro-4,7-methanoindenDE: 3a,4,7,7a-Tetrahydro-4,7-methanoindenEL: 3a,4,7,7a-ôåôñáûäñï-4,7-ìåèáíïúíäÝíéïEN: 3a,4,7,7a-tetrahydro-4,7-methanoindeneFR: 3a,4,7,7a-tétrahydro-4,7-méthanoindèneIT: 3a,4,7,7a-tetraidro-4,7-metanoindene; diciclopentadieneNL: 3a,4,7,7a-tetrahydro-4,7-methanoindeenPT: 3a,4,7,7a-tetrahidro-4,7-metanoindenoFI: 3a,4,7,7a-tetrahydro-4,7-metaani-indeeniSV: 3a,4,7,7a-tetrahydro-4,7-metanoinden; dicyklopentadienClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/22Xi; R 36/37/38N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:11-20/22-36/37/38-51/53S:(2-)36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 74-95-3EEC No 200-824-2No 602-003-00-8CH2Br2ES: dibromometanoDA: dibrommethanDE: DibrommethanEL: äéâñùìïìåèÜíéïEN: dibromomethaneFR: dibromométhaneIT: dibromometanoNL: dibroommethaanPT: dibromometanoFI: dibromimetaani; metyleenidibromidiSV: dibrommetan; metylenbromidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 20R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:20-52/53S:(2-)24-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 12,5%Xn; R 20Cas No 75-25-2EEC No 200-854-6No 602-007-00-XCHBr3ES: bromoformoDA: bromoformDE: Bromoform; TribrommethanEL: âñùìïöüñìéïEN: bromoform; tribromomethaneFR: bromoformeIT: bromoformio; tribromometanoNL: bromoformPT: bromoformeFI: bromoformi; tribromimetaaniSV: bromoform; tribrommetanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23Xi; R 36/38N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23-36/38-51/53S:(1/2-)28-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 56-23-5 EECNo 200-262-8No 602-008-00-5CCl4ES: tetracloruro de carbonoDA: carbontetrachloridDE: Kohlenstofftetrachlorid; TetrachlormethanEL: ôåôñá÷ëùñßäéï ôïõ ÜíèñáêáEN: carbon tetrachloride; tetrachloromethaneFR: tétrachlorure de carboneIT: tetracloruro di carbonio; tetraclorometanoNL: koolstoftetrachloridePT: tetracloreto de carbonoFI: hiilitetrakloridiSV: koltetraklorid; tetraklormetanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40T; R 23/24/25-48/23R 52-53N; R 59 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-40-48/23-52/53-59S:(1/2-)23-36/37-45-59-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 1%T; R 23/24/25-40-48/230,2% <= C < 1%Xn; R 20/21/22-48/20Cas No 75-00-3EEC No 200-830-5No 602-009-00-0C2H5ClES: cloroetanoDA: chlorethanDE: Chlorethan; EthylchloridEL: ÷ëùñïáéèÜíéï EN: chloroethaneFR: chloroéthaneIT: cloroetanoNL: chloorethaanPT: cloroetanoFI: kloorietaani; etyylikloridiSV: kloretan; etylkloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12Carc. Cat. 3; R 40R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+ >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:12-40-52/53S:(2-)9-16-33-36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 106-93-4EEC No 203-444-5No 602-010-00-6NOTA EBrCH2CH2BrES: 1,2-dibromoetanoDA: 1,2-dibromethanDE: 1,2-Dibromethan; EthylendibromidEL: 1,2-äéâñùìïáéèÜíéïEN: 1,2-dibromoethaneFR: 1,2-dibromoéthaneIT: 1,2-dibromoetanoNL: 1,2-dibroomethaanPT: 1,2-dibromoetanoFI: 1,2-etyleenidibromidiSV: 1,2-dibrometan; 1,2-etylendibromidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T; R 23/24/25Xi; R 36/37/38N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-23/24/25-36/37/38-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 20%T; R 45-23/24/25-36/37/381% <= C < 20%T; R 45-23/24/250,1% <= C < 1%T; R 45-20/21/22Cas No 75-34-3EEC No 200-863-5No 602-011-00-1CH3CHCl2ES: 1,1-dicloroetanoDA: 1,1-dichlorethanDE: 1,1-DichlorethanEL: 1,1-äé÷ëùñïáéèÜíéïEN: 1,1-dichloroethaneFR: 1,1-dichloroéthaneIT: 1,1-dicloroetanoNL: 1,1-dichloorethaanPT: 1,1-dicloroetanoFI: 1,1-dikloorietaaniSV: 1,1-dikloretan; etylidendikloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 22Xi; R 36/37R 52-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:11-22-36/37-52/53S:(2-)16-23-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 20%Xn; R 22-36/3712,5% <= C < 20%Xn; R 22Cas No 79-27-6EEC No 201-191-5No 602-016-00-9CHBr2CHBr2ES: 1,1,2,2-tetrabromoetanoDA: 1,1,2,2-tetrabromethan DE: 1,1,2,2-TetrabromethanEL: 1,1,2,2-ôåôñáâñùìïáéèÜíéïEN: 1,1,2,2-tetrabromoethaneFR: 1,1,2,2-tétrabromoéthaneIT: 1,1,2,2-tetrabromoetanoNL: 1,1,2,2-tetrabroomethaan PT: 1,1,2,2-tetrabromoetano FI: 1,1,2,2-tetrabromietaaniSV: 1,1,2,2-tetrabrometanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26Xi; R 36R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>R:26-36-52/53S:(1/2-)24-27-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 20%T+; R 26-367% <= C < 20%T+; R 261% <= C < 7%T; R 230,1% <= C < 1%Xn; R 20Cas No 540-54-5 [1] 75-29-6 [2]EEC No 208-749-7 [1] 200-858-8 [2]No 602-018-00-XNOTA CC3H7ClES: 1-cloropropano [1]; 2-cloropropano [2]DA: 1-chlorpropan [1]; 2-chlorpropan [2]DE: 1-Chlorpropan [1]; 2-Chlorpropan [2]EL: 1-÷ëùñïðñïðÜíéï [1] . 2-÷ëùñïðñïðÜíéï [2] EN: 1-chloropropane [1]; 2-chloropropane [2]FR: 1-chloropropane [1]; 2-chloropropane [2]IT: 1-cloropropano [1]; 2-cloropropano [2]NL: 1-chloorpropaan [1]; 2-chloorpropaan [2]PT: 1-cloropropano [1]; 2-cloropropano [2]FI: 1-klooripropaani [1]; 2-klooripropaani [2]SV: 1-klorpropan [1]; 2-klorpropan [2]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:11-20/21/22S:(2-)9-29Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%Xn; R 20/21/22Cas No 96-12-8EEC No 202-479-3No 602-021-00-6NOTA ECH2Br - CHBr - CH2ClES: 1,2-dibromo-3-cloropropanoDA: 1,2-dibrom-3-chlorpropanDE: 1,2-Dibrom-3-chlorpropanEL: 1,2-äéâñùìï-2-÷ëùñïðñïðÜíéïEN: 1,2-dibromo-3-chloropropaneFR: 1,2-dibromo-3-chloropropaneIT: 1,2-dibromo-3-cloropropanoNL: 1,2-dibroom-3-chloorpropaanPT: 1,2-dibromo-3-cloropropanoFI: 1,2-dibromi-3-klooripropaaniSV: 1,2-dibrom-3-klorpropanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Muta. Cat 2; R 46Repr. Cat. 1; R 60T; R 25Xn; R 48/20/22R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-46-60-25-48/20/22-52/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 543-59-9 [1]  625-29-6 [2]  616-20-6 [3] EEC No 208-846-4 [1]  210-885-7 [2]  210-467-4 [3] No 602-022-00-1NOTA CC5H11ClES: 1-cloropentano [1]; 2-cloropentano [2]; 3-cloropentano [3]DA: 1-chlorpentan [1]; 2-chlorpentan [2]; 3-chlorpentan [3]DE: 1-Chlorpentan [1]; 2-Chlorpentan [2]; 3-Chlorpentan [3]EL: 1-÷ëùñïðåíôÜíéï [1] . 2-÷ëùñïðåíôÜíéï [2] . 3-÷ëùñïðåíôÜíéï [3]EN: 1-chloropentane [1]; 2-chloropentane [2]; 3-chloropentane [3]FR: 1-chloropentane [1]; 2-chloropentane [2]; 3-chloropentane [3]IT: 1-cloropentano [1]; 2-cloropentano [2]; 3-cloropentano [3]NL: 1-chloorpentaan [1]; 2-chloorpentaan [2]; 3-chloorpentaan [3]PT: 1-cloropentano [1]; 2-cloropentano [2]; 3-cloropentano [3]FI: 1-klooripentaani [1]; 2-klooripentaani [2]; 3-klooripentaani [3]SV: 1-klorpentan [1]; 2-klorpentan [2]; 3-klorpentan [3]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:11-20/21/22S:(2-)9-29Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%Xn; R 20/21/22Cas No 593-60-2EEC No 209-800-6No 602-024-00-2CH2CHBrES: bromoetilenoDA: bromethylen; vinyl bromideDE: Bromethylen; VinylbromidEL: âñùìïáéèõëÝíéïEN: bromoethyleneFR: bromoéthylèneIT: bromoetileneNL: broomethyleenPT: bromoetilenoFI: bromietyleeni; vinyylibromidiSV: brometen; vinylbromidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12Carc. Cat. 2; R 45 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+ >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>R:45-12S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 540-59-0 [1]  156-59-2 [2]  156-60-5 [3]EEC No 208-750-2 [1]  205-859-7 [2]  205-860-2 [3] No 602-026-00-3NOTA CCHClCHClES: 1,2-dicloroetileno [1]; cis-dicloroetileno [2]; trans-dicloroetileno [3]DA: 1,2-dichlorethylen [1]; cis-dichlorethylen [2]; trans-dichlorethylen [3]DE: 1,2-Dichlorethylen [1]; cis-Dichlorethylen [2]; trans-Dichlorethylen [3]; 1,2-Dichlorethen [1]; cis-Dichlorethen [2]; trans-Dichlorethen [3]EL: 1,2-äé÷ëùñïáéèõëÝíéï [1] . cis-äé÷ëùñïáéèõëÝíéï [2] . trans-äé÷ëùñïáéèõëÝíéï [3]EN: 1,2-dichloroethylene [1]; cis-dichloroethylene [2]; trans-dichloroethylene [3]FR: 1,2-dichloroéthylène [1]; cis-dichloroéthylène [2]; trans-dichloroéthylène [3]IT: 1,2-dicloroetilene [1]; cis-dicloroetilene [2]; trans-dicloroetilene [3]NL: 1,2-dichloorethyleen [1]; cis-dichloorethyleen [2]; trans-dichloorethyleen [3]PT: 1,2-dicloroetileno [1]; cis-dicloroetileno [2]; trans-dicloroetileno [3]FI: 1,2-dikloorietyleeni [1]; cis-dikloorietyleeni [2]; trans-dikloorietyleeni [3]SV: 1,2-dikloretylen [1]; cis-dikloretylen [2]; trans-dikloretylen [3]; 1,2-dikloreten [1]; cis-dikloreten [2]; trans-dikloreten [3]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:11-20-52/53S:(2-)7-16-29-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 12,5%Xn; R 20Cas No 79-01-6 EECNo 201-167-4No 602-027-00-9>REFERENCE TO A GRAPHIC>ES: tricloroetilenoDA: trichlorethylenDE: TrichlorethylenEL: ôñé÷ëùñïáéèõëÝíéïEN: trichloroethyleneFR: trichloroéthylèneIT: tricloroetileneNL: trichloorethyleenPT: tricloroetilenoFI: trikloorietyleeniSV: trikloretenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:40-52/53S:(2-)23-36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 1%Xn; R 40Cas No 127-18-4EEC No 204-825-9No 602-028-00-4>REFERENCE TO A GRAPHIC>ES: tetracloroetilenoDA: tetrachlorethylenDE: Tetrachlorethylen; PerchlorethylenEL: ôåôñá÷ëùñïáéèõëÝíéïEN: tetrachloroethyleneFR: tétrachloroéthylèneIT: tetracloroetilene; percloroetileneNL: tetrachloorethyleenPT: tetracloroetilenoFI: tetrakloorietyleeniSV: tetrakloretenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:40-51/53S:(2-)23-36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 1%Xn; R 40Cas No 542-75-6 [1]  10061-01-5 [2]EEC No 208-826-5 [1] 233-195-8 [2]No 602-030-00-5NOTA DNOTA CClCHCHCH2ClES: 1,3-dicloropropeno [1]; (Z)-1,3-dicloropropeno [2]DA: 1,3-dichlorpropen [1]; (Z)-1,3-dichlorpropen [2]DE: 1,3-Dichlorpropen [1]; (Z)-1,3-Dichlorpropen [2]EL: 1,3-äé÷ëùñïðñïðÝíéï [1] . (Æ)-1,3-äé÷ëùñïðñïðÝíéï [2]EN: 1,3-dichloropropene [1]; (Z)-1,3-dichloropropene [2]FR: 1,3-dichloropropène [1]; (Z)-1,3-dichloropropène [2]IT: 1,3-dicloropropene [1]; (Z)-1,3-dicloropropene [2]NL: 1,3-dichloorpropeen [1]; (Z)-1,3-dichloorpropeen [2]PT: 1,3-dicloropropeno [1]; (Z)-1,3-dicloropropeno [2]FI: 1,3-diklooripropeeni [1]; (Z)-1,3-diklooripropeeni [2]SV: 1,3-diklorpropen [1]; (Z)-1,3-diklorpropen [2]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 10T; R 25Xn; R 20/21Xi; R 36/37/38R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:10-20/21-25-36/37/38-43-50/53S:(1/2-)36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 563-58-6EEC No 209-253-3 6No 02-031-00-0CH3CHCCl2ES: 1,1-dicloropropenoDA: 1,1-dichlorpropenDE: 1,1-DichlorpropenEL: 1,1-äé÷ëùñïðñïðÝíéïEN: 1,1-dichloropropeneFR: 1,1-dichloropropèneIT: 1,1-dicloropropeneNL: 1,1-dichloorpropeenPT: 1,1-dicloropropenoFI: 1,1-diklooripropeeniSV: 1,1-diklorpropenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11T; R 25R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>R:11-25-52/53S:(1/2-)16-29-33-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 563-47-3EEC No 209-251-2No 602-032-00-6>REFERENCE TO A GRAPHIC>ES: 3-cloro-2-metilpropenoDA: 3-chlor-2-methylpropenDE: 3-Chlor-2-methylpropen; MethallylchloridEL: 3-÷ëùñï-2-ìåèõëïðñïðÝíéïEN: 3-chloro-2-methylpropeneFR: 3-chloro-2-méthylpropèneIT: 3-cloro-2-metilpropeneNL: 3-chloor-2-methylpropeenPT: 3-cloro-2-metilpropenoFI: 3-kloori-2-metyylipropeeni; metallyylikloridiSV: 3-klor-2-metylpropenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/22C; R 34R 43N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:11-20/22-34-43-51/53S:(2-)9-16-26-29-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 108-90-7EEC No 203-628-5No 602-033-00-1>REFERENCE TO A GRAPHIC>ES: clorobencenoDA: chlorbenzenDE: ChlorbenzolEL: ÷ëùñïâåíæüëéïEN: chlorobenzeneFR: chlorobenzèneIT: clorobenzeneNL: chloorbenzeenPT: clorobenzenoFI: klooribentseeniSV: klorbenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 10Xn; R 20N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:10-20-51/53S:(2-)24/25-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 5%Xn; R 20Cas No 95-49-8 [1]  108-41-8 [2]  106-43-4 [3]  25168-05-2 [4]EEC No 202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4]No 602-040-00-XNOTA C>REFERENCE TO A GRAPHIC>ES: 2-clorotolueno [1]; 3-clorotolueno [2]; 4-clorotolueno [3]; clorotolueno [4]DA: 2-chlortoluen [1]; 3-chlortoluen [2]; 4-chlortoluen [3]; chlortoluen [4]DE: 2-Chlortoluol [1]; 3-Chlortoluol [2]; 4-Chlortoluol [3]; Chlortoluol [4]EL: 2-÷ëùñïôïëïõüëç [1] . 3-÷ëùñïôïõëïõüëç [2] . 4-÷ëùñïôïëïõüëç [3] . ÷ëùñïôïëïõüëéï [4]EN: 2-chlorotoluene [1]; 3-chlorotoluene [2]; 4-chlorotoluene [3]; chlorotoluene [4]FR: 2-chlorotoluène [1]; 3-chlorotoluène [2]; 4-chlorotoluène [3]; chlorotoluène [4]IT: 2-clorotoluene [1]; 3-clorotoluene [2]; 4-clorotoluene [3]; clorotoluene [4]NL: 2-chloortolueen [1]; 3-chloortolueen [2]; 4-chloortolueen [3]; chloortolueen [4]PT: 2-clorotolueno [1]; 3-clorotolueno [2]; 4-clorotolueno [3]; clorotolueno [4]FI: 2-klooritolueeni [1]; 3-klooritolueeni [2]; 4-klooritolueeni [3]; klooritolueeni [4]SV: 2-klortoluen [1]; 3-klortoluen [2]; 4-klortoluen [3]; klortoluen [4]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 20N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20-51/53S:(2-)24/25-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 602-042-00-0NOTA C>REFERENCE TO A GRAPHIC>ES: 1,2,3,4,5,6-hexaclorociclohexanos excepto los especialmente indicados en este AnexoDA: 1,2,3,4,5,6-hexachlorcyclohexaner med undtagelse af sådanne angivet andetsteds i dette bilagDE: 1,2,3,4,5,6-Hexachlorcyclohexane mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: 1,2,3,4,5,6-åîá÷ëùñïêõêëïåîÜíéï, åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this AnnexFR: 1,2,3,4,5,6-hexachlorocyclohexanes à l`exception de ceux nommément désignés dans cette annexeIT: 1,2,3,4,5,6-esaclorocicloesani esclusi quelli espressamente indicati in questo allegatoNL: 1,2,3,4,5,6-hexachloorcyclohexanen met uitzondering van de in deze bijlage met name genoemdePT: 1,2,3,4,5,6-hexaclorocicloexanos com excepção dos expressamente referidos no presente anexoFI: 1,2,3,4,5,6-heksakloorisykloheksaani paitsi muualla tässä liitteessä mainitutSV: 1,2,3,4,5,6-hexaklorcyklohexaner med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40T; R 25Xn; R 21N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21-25-40-50/53S:(1/2-)22-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 8001-35-2EEC No 232-283-3No 602-044-00-1>REFERENCE TO A GRAPHIC>ES: toxafenoDA: toxaphenDE: Toxaphen; CamphechlorEL: ôïîïöáßíéïEN: Toxaphene; camphechlorFR: toxaphèneIT: toxafene; camfeclorNL: toxafeenPT: toxafenoFI: toksafeeni; kamfeklooriSV: toxafen; kamfeklor (ISO)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat 3; R 40T; R 25Xn; R 21Xi; R 37/38N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21-25-37/38-40-50/53S:(1/2-)36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 465-73-6EEC No 207-366-2No 602-050-00-4>REFERENCE TO A GRAPHIC>ES: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexacloro-1,4,4a,5,8,8a-hexahidro-1,4:5,8-dimetanonaftaleno; isodrinDA: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexachlor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphtalen; isodrinDE: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-Hexachlor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalin; IsodrinEL: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-åîá÷ëùñï-1,4,4a,5,8,8a-åîáûäñï-1,4:5,8-äéìåèáíïíáöèáëÝíéï . éóïôñßíEN: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene; isodrinFR: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-diméthanonaphtalène; isodrineIT: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-esacloro-1,4,4a,5,8,8a-esaidro-1,4:5,8-dimetanonaftalene; isodrinNL: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexachloor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaftaleen; isodrinPT: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexacloro-1,4,4a,5,8,8a-hexahidro-1,4:5,8-dimetanonaftaleno; isodrineFI: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-heksakloori-1,4,4a,5,8,8a-heksahydro-1,4:5,8-dimetanonaftaleeni; isodriiniSV: (1a,4a,4aß,5ß,8ß8aß)-1,2,3,4,10,10-hexaklor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimetanonaftalen; isodrinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26/27/28N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:26/27/28-50/53S:(1/2-)13-28-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 108-86-1EEC No 203-623-8No 602-060-00-9>REFERENCE TO A GRAPHIC>ES: bromobencenoDA: brombenzenDE: BrombenzolEL: âñùìïâåíæüëéïEN: bromobenzeneFR: bromobenzèneIT: bromobenzeneNL: broombenzeenPT: bromobenzenoFI: bromibentseeniSV: brombenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 10Xi; R 38N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:10-38-51/53S:(2-)61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 118-74-1EEC No 204-273-9No 602-065-00-6NOTA E>REFERENCE TO A GRAPHIC>ES: hexaclorobencenoDA: hexachlorbenzenDE: HexachlorbenzolEL: åîá÷ëùñïâåíæüëéïEN: hexachlorobenzeneFR: hexachlorobenzèneIT: esaclorobenzeneNL: hexachloorbenzeenPT: hexaclorobenzenoFI: heksaklooribentseeniSV: hexaklorbenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T; R 48/25N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-48/25-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 118-75-2EEC No 204-274-4No 602-066-00-1>REFERENCE TO A GRAPHIC>ES: tetracloro-p-benzoquinonaDA: tetrachlor-p-benzoquinonDE: Tetrachlor-p-benzochinon; ChloranilEL: ôåôñá÷ëùñï-ðáñá-âåíæïêéíüíçEN: tetrachloro-p-benzoquinoneFR: tétrachloro-p-benzoquinoneIT: tetracloro-p-benzochinone; cloranileNL: tetrachloor-p-benzochinonPT: tetracloro-p-benzoquinonaFI: tetrakloori-p-bentsokinoni; kloraniiliSV: tetraklor-p-benzokinonClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/38N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:36/38-50/53S:(2-)37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 541-73-1EEC No 208-792-1No 602-067-00-7 >REFERENCE TO A GRAPHIC>ES: 1,3-diclorobencenoDA: 1,3-dichlorbenzenDE: 1,3-DichlorbenzolEL: 1,3-äé÷ëùñïâåíæüëéïEN: 1,3-dichlorbenzeneFR: 1,3-dichlorobenzèneIT: 1,3-diclorobenzeneNL: 1,3-dichloorbenzeenPT: 1,3-diclorobenzenoFI: 1,3-diklooribentseeniSV: 1,3-diklorbenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-51/53S:(2-)61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 764-41-0EEC No 212-121-8No 602-073-00-XNOTA ECH2Cl-CH=CH-CH2ClES: 1,4-diclorobut-2-enoDA: 1,4-dichlorbut-2-enDE: 1,4-Dichlorbut-2-enEL: 1,4-äé÷ëùñïâïõô-2-ÝíéïEN: 1,4-dichlorobut-2-eneFR: 1,4-dichlorobut-2-èneIT: 1,4-diclorobut-2-eneNL: 1,4-dichloorbut-2-eenPT: 1,4-diclorobut-2-enoFI: 1,4-diklooribut-2-eeniSV: 1,4-diklorbut-2-enClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T+; R 26T; R 24/25C; R 34N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-24/25-26-34-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 608-93-5EEC No 210-172-0No 602-074-00-5>REFERENCE TO A GRAPHIC>ES: pentaclorobencenoDA: pentachlorbenzenDE: PentachlorbenzolEL: ðåíôá÷ëùñïâåíæüëéïEN: pentachlorobenzeneFR: pentachlorobenzèneIT: pentaclorobenzeneNL: pentachloorbenzeenPT: pentaclorobenzenoFI: pentaklooribentseeniSV: pentaklorbenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:11-22-50/53S:(2-)41-46-50-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2431-50-7EEC No 219-397-9No 602-076-00-6>REFERENCE TO A GRAPHIC>ES: 2,3,4-triclorobut-1-enoDA: 2,3,4-trichlorbut-1-enDE: 2,3,4-Trichlorbut-1-enEL: 2,3,4-ôñé÷ëùñïâïõô-1-ÝíéïEN: 2,3,4-trichlorobut-1-eneFR: 2,3,4-trichlorobut-1-èneIT: 2,3,4-triclorobut-1-eneNL: 2,3,4-trichloorbut-1-eenPT: 2,3,4-triclorobut-1-enoFI: 2,3,4-triklooribut-1-eeniSV: 2,3,4-triklorbut-1-enClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23Carc. Cat 3; R 40Xn; R 22Xi; R 36/37/38N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-23-36/37/38-40-50/53S:(1/2-)36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 120-83-2 EECNo 204-429-6No 604-011-00-7>REFERENCE TO A GRAPHIC>ES: 2,4-diclorofenolDA: 2,4-dichlorphenolDE: 2,4-DichlorphenolEL: 2,4-äé÷ëùñïöáéíüëçEN: 2,4-dichlorophenolFR: 2,4-dichlorophénolIT: 2,4-diclorofenoloNL: 2,4-dichloorfenolPT: 2,4-diclorofenolFI: 2,4-dikloorifenoliSV: 2,4-diklorfenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-34-51/53S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 59-50-7EEC No 200-431-6No 604-014-00-3>REFERENCE TO A GRAPHIC>ES: clorocresolDA: chlorocresolDE: Chlorkresol; 4-Chlor-3-methylphenolEL: ÷ëùñïêñåæüëçEN: chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenolFR: chlorocrésolIT: clorocresoloNL: chloorkresolPT: clorocresolFI: kloorikresoli; 4-kloori-3-metyylifenoliSV: klorkresol; 4-klor-3-metylfenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22Xi; R 41R 43N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-41-43-50S:(2-)26-36/37/39-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 10%Xn; R 21/22-41-435% <= C < 10%Xn; R 21/22-36-431% <= C < 5%Xi; R 43Cas No 50-00-0EEC No 200-001-8No 605-001-00-5NOTA BNOTA D>REFERENCE TO A GRAPHIC>ES: formaldehído ...%DA: formaldehyd ...%DE: Formaldehyd ...%EL: öïñìáëäåàäç ...%EN: formaldehyde ...%FR: formaldéhyde ...%IT: formaldeide ...%NL: formaldehyde ...%PT: formaldeído ...%FI: formaldehydi ...%SV: formaldehyd ...%Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40T; R 23/24/25C; R 34R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:23/24/25-34-40-43S:(1/2-)26-36/37/39-45-51Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%T; R 23/24/25-34-40-435% <= C < 25%Xn; R 20/21/22-36/37/38-40-431% <= C < 5%Xn; R 40-430,2% <= C < 1%Xi; R 43Cas No 541-41-3EEC No 208-778-5No 607-020-00-4>REFERENCE TO A GRAPHIC>ES: cloroformiato de etiloDA: ethylchlorformiatDE: Ethylchlorformiat; ChlorameisensäureethylesterEL: ÷ëùñïìõñìçêéêü áéèõëïEN: ethyl chloroformateFR: chloroformiate d`éthyleIT: cloroformiato di etileNL: ethylchloorformiaatPT: cloroformato de etiloFI: etyyliklooriformiaattiSV: etylklorformiatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11T+; R 26Xn; R 22C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>T + >REFERENCE TO A GRAPHIC>R:11-22-26-34S:(1/2-)9-16-26-28-33-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 98-95-3EEC No 202-716-0No 609-003-00-7>REFERENCE TO A GRAPHIC>ES: nitrobencenoDA: nitrobenzenDE: NitrobenzolEL: íéôñïâåíæüëéïEN: nitrobenzeneFR: nitrobenzèneIT: nitrobenzeneNL: nitrobenzeenPT: nitrobenzenoFI: nitrobentseeniSV: nitrobenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40Repr. Cat. 3; R 62T; R 23/24/25-48/23/24N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-40-48/23/24-51/53-62S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 610-003-00-4NOTA C>REFERENCE TO A GRAPHIC>ES: clorodinitrobencenoDA: chlordinitrobenzenDE: ChlordinitrobenzolEL: ÷ëùñïäéíéôñïâåíæüëéïEN: chlorodinitrobenzeneFR: chlorodinitrobenzèneIT: dinitroclorobenzeneNL: dinitrochloorbenzeenPT: clorodinitrobenzenoFI: klooridinitrobentseeniSV: klordinitrobenzen, alla isomererClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 610-006-00-0NOTA C>REFERENCE TO A GRAPHIC>ES: cloronitroanilinas excepto aquellos específicamente expresados en este AnexoDA: chlornitroaniliner undtagen sådanne nævnt andetsteds i dette bilagDE: Chlornitroanilin mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: ÷ëùñïíéôñïáíéëßíåò åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: chloronitroanilines with the exception of those specified elsewhere in this AnnexFR: chloronitroanilines à l`exception de ceux nommément désignés dans cette annexeIT: cloronitroaniline escluse quelle espressamente indicate in questo allegatoNL: chloornitroanilines met uitzondering van de in deze bijlage met name genoemdePT: cloronitroanilinas com excepção dos expressamente referidos no presente anexoFI: kloorinitroaniliinit paitsi muualla tässä liitteessä mainitutSV: klornitroaniliner med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26/27/28R 33N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:26/27/28-33-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 74-89-5 [1] 124-40-3 [2] 75-50-3 [3]EEC No 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] No 612-001-00-9CH3NH2 [1](CH3)2NH [2](CH3)3N [3]ES: metilamina (mono-[1], di-[2] y tri-[3])DA: methylamin (mono-[1], di-[2] y tri-[3])DE: Methylamin (mono-[1], di-[2] und tri-[3])EL: ìåèõëáìßíç (ìïíï-[1], äé-[2] êáé ôñé-[3])EN: methylamine (mono-[1], di-[2] and tri-[3])FR: méthylamine (mono-[1], di-[2] et tri-[3])IT: metilamina (mono-[1], di-[2] e tri-[3])NL: methylamine (mono-[1], di-[2] en tri-[3])PT: metilamina (mono-[1], di-[2] e tri-[3])FI: metyyliamiini (mono-[1], di-[2] ja tri-[3])SV: metylamin (mono-[1], di-[2] och tri-[3])Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12Xn; R 20Xi; R 37/38-41 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+ >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:12-20-37/38-41S:(2-)16-26-39Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 5C >= 5%Xn; R 20-37/38-410,5% <= C < 5%Xi; R 36Cas No 109-89-7EEC No 203-716-3No 612-003-00-X>REFERENCE TO A GRAPHIC>ES: dietilaminaDA: diethylaminDE: DiethylaminEL: äéáéèõëáìßíçEN: diethylamineFR: diéthylamineIT: dietilaminaNL: diethylaminePT: dietilaminaFI: dietyyliamiiniSV: dietylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:11-20/21/22-35S:(1/2-)3-16-26-29-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 20/21/22-3510% <= C < 25%C; R 355% <= C < 10%C; R 341% <= C < 5%Xi; R 36/37/38Cas No 121-44-8EEC No 204-469-4No 612-004-00-5>REFERENCE TO A GRAPHIC>ES: trietilaminaDA: triethylaminDE: TriethylaminEL: ôñéáéèõëáìßíçEN: triethylamineFR: triéthylamineIT: trietilaminaNL: triethylaminePT: trietilaminaFI: trietyyliamiiniSV: trietylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:11-20/21/22-35S:(1/2-)3-16-26-29-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 20/21/22-3510% <= C < 25%C; R 355% <= C < 10%C; R 341% <= C < 5%Xi; R 36/37/38Cas No 109-73-9EEC No 203-699-2No 612-005-00-0C4H9 - NH2ES: butilaminaDA: butylaminDE: Butylamin; 1-Amino-butanEL: âïõôõëáìßíçEN: butylamineFR: butylamineIT: butilaminaNL: butylaminePT: butilaminaFI: butyyliamiiniSV: butylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:11-20/21/22-35S:(1/2-)3-16-26-29-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 20/21/22-3510% <= C < 25%C; R 355% <= C < 10%C; R 341% <= C < 5%Xi; R 36/37/38Cas No 107-15-3EEC No 203-468-6No 612-006-00-6H2N - CH2 - CH2 - NH2ES: etilendiaminaDA: ethylendiaminDE: Ethylendiamin; 1,2-Diamino-ethanEL: áéèõëåíïäéáìßíçEN: ethylenediamine; 1,2-diaminoethaneFR: éthylénediamineIT: etilendiaminaNL: ethyleendiaminePT: etilenodiaminaFI: etyleenidiamiini; 1,2 diaminoetaaniSV: etylendiamin; 1,2-diaminoetanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, Klassificering R 10Xn; R 21/22C; R 34R 42/43Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:10-21/22-34-42/43S:(1/2-)23-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 21/22-34-42/4310% <= C < 25%C; R 34-42/432% <= C < 10%Xn; R 36/38-42/431% <= C < 2%Xn; R 42/43Cas No -EEC No -No 612-009-00-2NOTA A>REFERENCE TO A GRAPHIC>ES: sales de anilinaDA: salte af anilinDE: Salze von AnilinEL: Üëáôá áíéëßíçòEN: salts of anilineFR: sels d`anilineIT: sali di anilinaNL: zouten van anilinePT: sais de anilinaFI: aniliinin suolatSV: anilin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40T; R 48/23/24/25Xn; R 20/21/22 N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20/21/22-40-48/23/24/25-50S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 1%T; R 20/21/22-40-48/23/24/250,2% <= C < 1%Xn; R 48/20/21/22Cas No -EEC No -No 612-010-00-8NOTA C>REFERENCE TO A GRAPHIC>ES: cloroanilina (mono-, di-, tri-)DA: chloranilin (mono-, di- og tri-)DE: Chloranilin (mono-, di- und tri-)EL: ÷ëùñïáíéëßíç (ìïíï-, äé- êáé ôñé-)EN: chloroaniline (mono-, di- and tri-)FR: chloroaniline (mono-, di- et tri-)IT: cloroanilina (mono-, di- e tri-)NL: chlooraniline (mono-, di- en tri-)PT: cloroanilina (mono-, di- e tri-)FI: kloorianiliini (mono-, di- ja tri-)SV: kloranilin (mono-, di- och tri-); klorbenzenamin (mono-, di- och tri-)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 121-57-3EEC No 204-482-5No 612-014-00-X>REFERENCE TO A GRAPHIC>ES: ácido sulfanílicoDA: sulfanilsyreDE: Sulfanilsäure; 4-Amino-benzolsulfonsäureEL: óïõëöáíéëéêü ïîýEN: sulphanilic acid; 4-aminobenzenesulphonic acidFR: acide sulfaniliqueIT: acido solfanilico; 4-aminobenzensolfonicoNL: sulfanilzuurPT: ácido sulfanílicoFI: sulfaniilihappo; 4-aminobentseenisulfonihappoSV: sulfanilinsyra; 4-aminobenzensulfonsyraClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/38R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>R:36/38-43S:(2-)24-37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 100-61-8EEC No 202-870-9No 612-015-00-5>REFERENCE TO A GRAPHIC>ES: N-metilanilinaDA: N-methylanilinDE: N-MethylanilinEL: Í-ìåèõëáíéëßíçEN: N-methylanilineFR: N-méthylanilineIT: N-metilanilinaNL: N-methylanilinePT: N-metilanilinaFI: N-metyylianiliiniSV: N-metylanilin; N-metylbenzenaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 121-69-7EEC No 204-493-5No 612-016-00-0>REFERENCE TO A GRAPHIC>ES: N,N-dimetilanilinaDA: N,N-dimethylanilinDE: N,N-DimethylanilinEL: Í,Í-äéìåèõëáíéëßíçEN: N,N-dimethylanilineFR: N,N-diméthylanilineIT: N,N-dimetilanilinaNL: N,N-dimethylanilinePT: N,N-dimetilanilinaFI: N,N-dimetyylianiliiniSV: N,N-dimetylanilin; N,N-dimetylbenzenaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40T; R 23/24/25N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-40-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2844-92-0EEC No 220-639-0No 612-019-00-7>REFERENCE TO A GRAPHIC>ES: dipicrilamina, sal amónicaDA: dipicrylamin, ammoniumsaltDE: Dipikrylamin, Ammoniumsalz; Ammonium-bis(2,4,6-trinitrophenyl)aminEL: äéðéêñõëáìßíç, ôï Üëáò ìå áììþíéïEN: dipicrylamine, ammonium saltFR: dipicrylamine, sel d`ammoniumIT: dipicrilamina, sale di ammonioNL: dipicrylamine, ammoniumzoutPT: dipicrilamina, sal de amónioFI: dipikryyliamiini, ammonium suolaSV: ammoniumbis(2,4,6-trinitrofenyl)aminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringER 1T+; R 26/27/28R 33N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningE >REFERENCE TO A GRAPHIC>T+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:1-26/27/28-33-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 134-32-7EEC No 205-138-7No 612-020-00-2>REFERENCE TO A GRAPHIC>ES: 1-naftilaminaDA: 1-naphthylaminDE: 1-NaphthylaminEL: 1-íáöèõëáìßíçEN: 1-naphthylamineFR: 1-naphtylamineIT: 1-naftilaminaNL: 1-naftylaminePT: 1-naftilaminaFI: 1-naftyyliamiiniSV: 1-naftylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-51/53S:(2-)24-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 91-59-8EEC No 202-080-4No 612-022-00-3NOTA E>REFERENCE TO A GRAPHIC>ES: 2-naftilaminaDA: 2-naphthylaminDE: 2-NaphthylaminEL: 2-íáöèõëáìßíçEN: 2-naphthylamineFR: 2-naphtylamineIT: 2-naftilaminaNL: 2-naftylaminePT: 2-naftilaminaFI: 2-naftyyliamiiniSV: 2-naftylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 1; R 45Xn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%T; R 45-220,01% <= C < 25%T; R 45Cas No -EEC No -No 612-025-00-XNOTA C>REFERENCE TO A GRAPHIC>ES: nitrotoluidinaDA: nitrotoluidinDE: NitrotoluidinEL: íéôñïôïëïõéäßíçEN: nitrotoluidineFR: nitrotoluidineIT: nitrotoluidinaNL: nitrotoluidinePT: nitrotoluídinaFI: nitrotoluidiiniSV: nitrotoluidin; aminometylnitrobenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 122-39-4EEC No 204-539-4No 612-026-00-5>REFERENCE TO A GRAPHIC>ES: difenilaminaDA: diphenylaminDE: DiphenylaminEL: äéöáéíõëáìßíçEN: diphenylamineFR: diphénylamineIT: difenilaminaNL: difenylaminePT: difenilaminaFI: difenyyliamiiniSV: difenylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 612-027-00-0NOTA C>REFERENCE TO A GRAPHIC>ES: xilidinaDA: xylidinDE: XylidinEL: îõëéäßíçEN: xylidineFR: xylidineIT: xilidinaNL: xylidinePT: xilidinaFI: ksylidiiniSV: xylidin; aminodimetylbenzenClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-33-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 95-54-5 [1] 108-45-2 [2] 106-50-3 [3]EEC No 202-430-6 [1] 203-584-7 [2] 203-404-7 [3] No 612-028-00-6NOTA C>REFERENCE TO A GRAPHIC>ES: o-fenilendiamina [1]; m-fenilendiamina [2]; p-fenilendiamina [3]DA: o-phenylendiamin [1]; m-phenylendiamin [2]; p-phenylendiamin [3]DE: o-Phenylendiamin [1]; m-Phenylendiamin [2]; p-Phenylendiamine [3]EL: o-öáéíõëåíïäéáìßíç [1] . ì-öáéíõëåíïäéáìßíç [2] . ð -öáéíõëåíïäéáìßíç [3]EN: o-phenylenediamine [1]; m-phenylenediamine [2]; p-phenylenediamine [3]FR: o-phénylènediamine [1]; m-phénylènediamine [2]; p-phénylènediamine [3]IT: o-fenilendiamina [1]; m-fenilendiamina [2]; p-fenilendiamina [3]NL: o-fenyleendiamine [1]; m-fenyleendiamine [2]; p-fenyleendiamine [3]PT: o-fenilenodiamina [1]; m-fenilenodiamina [2]; p-fenilenodiamina [3]FI: o-fenyleenidiamiini [1]; m-fenyleenidiamiini [2]; p-fenyleenidiamiini [3]SV: o-fenylendiamin [1]; m-fenylendiamin [2]; p-fenylendiamin [3]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-43-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 5%T; R 23/24/25-431% <= C < 5%Xn; R 20/21/22-43Cas No 541-69-5 [1] 624-18-0 [2]EEC No 208-790-0 [1] 210-834-9 [2]No 612-029-00-1NOTA C>REFERENCE TO A GRAPHIC>ES: m-fenilenodiamina, diclorhidrato [1]; benceno-1,4-diamina, diclorhidrato [2]DA: m-phenylendiamindihydrochlorid [1]; benzen-1,4-diamindihydrochlorid [2]DE: m-Phenylendiamindihydrochlorid [1]; Benzol-1,4-diamindihydrochlorid [2]; 1,3-Phenylendiamindihydrochloride [1]; 1,4-Phenylendiamin-dihydrochloride [2]EL: ì-öáéíõëåíïäéáìßíç, äéõäñï÷ëùñéêÞ [1] . âåíæïëï-1,4-äéáìßíç äéõäñï÷ëùñéêÞ [2] EN: m-phenylenediamine dihydrochloride [1], benzene-1,4-diamine dihydrochloride [2]; benzene-1,3-diamine hydrochloride [1]; p-phenylenediamine, dihydrochloride [2]FR: m-phénylènediamine, dichlorhydrate [1]; benzène-1,4-diamine, dichlorhydrate [2]IT: m-fenilendiamina, dicloridrato [1]; benzen-1,4-diamina, dicloridrato [2]NL: m-fenyleendiaminedihydrochloride [1]; benzeen-1,4-diaminedihydrochloride [2]PT: m-fenilenodiamina, dicloridrato [1]; benzeno-1,4-diamina, dicloridrato [2]FI: m-fenyleenidiamiinidihydrokloridi [1]; p-fenyleenidiamiinidihydrokloridi [2]SV: m-fenylendiamindihydroklorid [1]; p-fenylendiamindihydroklorid [2]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/24/25-43-50/53S:(1/2-)28-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 615-50-9 6369-59-1EEC No 210-431-8 228-871-4No 612-030-00-7 >REFERENCE TO A GRAPHIC>ES: sulfato de 2-metil- p-fenilendiaminaDA: 2-methyl- p-phenylendiaminsulfatDE: 2-Methyl- p-phenylendiaminsulfat; Toluylen-2,5-diaminsulfatEL: èåééêÞ 2-ìåèõëï-ð-öáéíõëåíïäéáìßíçEN: 2-methyl- p-phenylenediamine sulphateFR: sulfate de 2-méthyl- p-phénylènediamine; sulfate de 2,5-diaminotoluèneIT: solfato di 2-metil- p-fenilendiamina; 2,5-diaminotoluene solfatoNL: 2-methyl- p-fenyleendiaminesulfaatPT: sulfato de 2-metil- p-fenilenodiaminaFI: 2-metyyli- p-fenyleenidiamiinisulfaattiSV: 2-metyl- p-fenylendiaminsulfat; 2-metyl-1,4-benzendiaminsulfatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 25Xn; R 20/21R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20/21-25-43-50/53S:(1/2-)24-37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2836-04-6 [1] 99-98-9 [2]EEC No 220-623-3 [1] 202-807-5 [2]No 612-031-00-2NOTA C>REFERENCE TO A GRAPHIC>ES: N,N-dimetilbenceno-1,3-diamina [1]; 4-amino-N,N-dimetilanilina [2]DA: N,N-dimethylbenzen-1,3-diamin [1]; 4-amino-N,N-dimethylanilin [2]DE: N,N-Dimethylbenzol-1,3-diamin [1]; 4-Amino-N,N-dimethylanilin [2]; N,N-Dimethylphenylendiamin (m,p)EL: N,N-äéìåèõëïâåíæïëï-1,3-äéáìßíç [1] . 4-áìéíï-N,N-äéìåèõëáíéëßíç [2]EN: N,N-dimethylbenzene-1,3-diamine [1]; 4-amino-N,N-dimethylaniline [2]; 3-amino- N,N`-dimethylaniline [1]; N,N`-dimethylbenzene-1,4-diamineFR: N,N-diméthylbenzène-1,3-diamine [1]; 4-amino-N,N-diméthylaniline [2]IT: N,N-dimetilbenzen-1,3-diamina [1]; 4-amino-N,N-dimetilanilina [2]NL: N,N-dimethylbenzeen-1,3-diamine [1]; 4-amino-N,N-dimethylaniline [2]PT: N,N-dimetilbenzeno-1,3-diamina [1]; 4-amino-N,N-dimetilanilina [2]FI: N,N-dimetyylibentseeni-1,3-diamiini [1]; 4-amino-N,N-dimetyylianiliini [2]SV: N,N-dimetyl-1,3-benzendiamin [1]; N,N-dimetyl-1,4-benzendiamin [2]; N,N-dimetylfenylendiamin ( m, p)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:23/24/25S:(1/2-)28-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 95-55-6EEC No 202-431-1No 612-033-00-3>REFERENCE TO A GRAPHIC>ES: 2-aminofenolDA: 2-aminophenolDE: 2-AminophenolEL: 2-áìéíïöáéíüëçEN: 2-aminophenolFR: 2-aminophénolIT: 2-aminofenoloNL: 2-aminofenolPT: 2-aminofenolFI: 2-aminofenoliSV: 2-aminofenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 20/22Muta. Cat. 3; R 40 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:20/22-40S:(2-)28-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 96-96-8EEC No 202-547-2No 612-038-00-0>REFERENCE TO A GRAPHIC>ES: 2-nitro- p-anisidinaDA: 2-nitro- p-anisidinDE: 2-Nitro- p-anisidin; 4-Methoxy-2-nitro-anilinEL: 2-íéôñï-ð-áíéóéäßíçEN: 2-nitro- p-anisidine; 4-methoxy-2-nitroanilineFR: 2-nitro- p-anisidineIT: 2-nitro p-anisidina; 2-nitro-4-metossianilinaNL: 2-nitro- p-anisidinePT: 2-nitro- p-anisidinaFI: 2-nitro- p-anisidiini; 4-metoksi-2-nitroaniliiniSV: 2-nitro- p-anisidin; 4-metoxi-2-nitro-anilinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26/27/28R 33R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>R:26/27/28-33-52/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 97-02-9EEC No 202-553-5No 612-040-00-1>REFERENCE TO A GRAPHIC>ES: 2,4-dinitroanilinaDA: 2,4-dinitroanilinDE: 2,4-DinitroanilinEL: 2,4-äéíéôñïáíéëßíçEN: 2,4-dinitroanilineFR: 2,4-dinitroanilineIT: 2,4-dinitroanilinaNL: 2,4-dinitroanilinePT: 2,4-dinitroanilinaFI: 2,4-dinitroaniliiniSV: 2,4-dinitroanilin; 2,4-dinitrobenzaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26/27/28R 33N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:26/27/28-33-51/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 119-93-7EEC No 204-358-0No 612-041-00-7NOTA E>REFERENCE TO A GRAPHIC>ES: 4,4`-bi- o-toluidinaDA: 4,4`-bi- o-toluidinDE: 4,4`-Bi- o-toluidin; 3,3`-DimethylbenzidinEL: 4,4`-äé- o-ôïëïõäßíçEN: 4,4`-bi- o-toluidineFR: 4,4`-bi- o-toluidineIT: 4,4`-bi- o-toluidina; 3,3`-dimetilbenzidinaNL: 4,4`-bi- o-toluidinePT: 4,4`-bi- o-toluídinaFI: 4,4`-bi- o-toluidiiniSV: 4,4`-bi- o-toluidin; 3,3`-dimetylbenzidinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 92-87-5EEC No 202-199-1No 612-042-00-2NOTA E>REFERENCE TO A GRAPHIC>ES: bencidinaDA: benzidinDE: BenzidinEL: âåíæéäßíçEN: benzidineFR: benzidineIT: benzidina; 1,1`-bifenil-4,4` diaminaNL: benzidinePT: benzidinaFI: bentsidiiniSV: benzidin; 1,1`-bifenyl-4,4`-diaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 1; R 45Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 107-11-9EEC No 203-463-9No 612-046-00-4CH2=CH-CH2-NH2ES: alilaminaDA: allylaminDE: AllylaminEL: áëëõëáìßíçEN: allylamineFR: allylamineIT: allilaminaNL: allylaminePT: alilaminaFI: allyyliamiiniSV: allylamin; 2-propen-1-aminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11T; R 23/24/25N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>T >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:11-23/24/25-51/53S:(1/2-)9-16-24/25-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 100-46-9EEC No 202-854-1No 612-047-00-X>REFERENCE TO A GRAPHIC>ES: bencilaminaDA: benzylaminDE: BenzylaminEL: âåíæõëáìßíçEN: benzylamineFR: benzylamineIT: benzilaminaNL: benzylaminePT: benzilaminaFI: bentsyyliamiiniSV: benzylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:21/22-34S:(1/2-)26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 142-84-7EEC No 205-565-9No 612-048-00-5>REFERENCE TO A GRAPHIC>ES: dipropilaminaDA: dipropylaminDE: DipropylaminEL: äéðñïðõëáìßíçEN: dipropylamineFR: dipropylamineIT: dipropilaminaNL: dipropylaminePT: dipropilaminaFI: dipropyyliamiiniSV: dipropylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/21/22C; R 35 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:11-20/21/22-35S:(1/2-)16-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 20/21/22-3510% <= C <  25%C; R 355% <= C < 10% C; R 341% <= C < 5%Xi; R 36/37/38Cas No 611-21-2 [1] 696-44-6 [2] 623-08-5 [3]EEC No 210-260-9 [1] 211-795-0 [2] 210-769-6 [3] No 612-055-00-3NOTA C>REFERENCE TO A GRAPHIC>ES: N-metil-o-toluidina [1]; N-metil- m-toluidina [2]; N-metil- p-toluidina [3]DA: N-methyl-o-toluidin [1]; N-methyl- m-toluidin [2]; N-methyl- p-toluidin [3]DE: N-Methyl-o-toluidin [1]; N-Methyl- m-toluidin [2]; N-Methyl- p-toluidin [3]EL: N-ìåèõëï-o-ôïëïõéäßíç [1] . N-ìåèõëï- ì-ôïëïõéäßíç [2] . N-ìåèõëï- ð-ôïëïõéäßíç [3]EN: N-methyl-o-toluidine [1]; N-methyl- m-toluidine [2]; N-methyl- p-toluidine [3]FR: N-méthyl-o-toluidine [1]; N-méthyl- m-toluidine [2]; N-méthyl- p-toluidine [3]IT: N-metil-o-toluidina [1]; N-metil- m-toluidina [2]; N-metil- p-toluidina [3]NL: N-methyl-o-toluïdine [1]; N-methyl- m-toluïdine [2]; N-methyl- p-toluïdine [3]PT: N-metil-o-toluídina [1]; N-metil- m-toluídina [2]; N-metil- p-toluídina [3]FI: N-metyyli-o-toluidiini [1]; N-metyyli- m-toluidiini [2]; N-metyyli- p-toluidiini [3]SV: N-metyl-o-toluidin [1]; N-metyl- m-toluidin [2]; N-metyl- p-toluidin [3]; N,2-dimetylbenzenamin [1]; N,3-dimetylbenzenamin [2]; N,4-dimetylbenzenamin [3]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24/25R 33R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:23/24/25-33-52/53S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 110-85-0EEC No 203-808-3No 612-057-00-4>REFERENCE TO A GRAPHIC>ES: piperazinaDA: piperazinDE: PiperazinEL: ðéðåñáæßíçEN: piperazineFR: pipérazineIT: piperazinaNL: piperazinePT: piperazinaFI: piperatsiiniSV: piperazinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringC; R 34R 42/43R 52/53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:34-42/43-52/53S:(1/2-)22-26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 56-18-8EEC No 200-261-2No 612-063-00-7>REFERENCE TO A GRAPHIC>ES: 3,3`-iminodi(propilamina)DA: 3,3`-iminodi(propylamin)DE: 3,3`-Iminodi(propylamin); DipropylentriaminEL: 3,3`-éìéíïäé(ðñïðõëáìßíç) EN: 3,3`-iminodi(propylamine); dipropylenetriamineFR: 3,3`-iminodi(propylamine); dipropylènetriamineIT: 3,3`-iminodi(propilamina); dipropilenetriaminaNL: 3,3`-iminodi(propylamine)PT: 3,3`-iminodi(propilamina)FI: 3,3`-iminodi(propyyliamiini); dipropyleenitriamiiniSV: 4-azaheptan-1,7-diamin; dipropylentriaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26T; R 24Xn; R 22C; R 35R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:22-24-26-35-43S:(1/2-)26-28-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 612-065-00-8>REFERENCE TO A GRAPHIC>ES: polietilenpolyaminas excepto aquellos específicamente expresados en este AnexoDA: polyethylenpolyaminer undtagen sådanne nævnt andetsteds i dette bilagDE: Polyethylenpolyamine mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: ðïëõáéèõëåíïðïëõáìßíåò, åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: polyethlyenepolyamines with the exception of those specified elsewhere in this AnnexFR: polyéthylènepolyamines, à l`exception de ceux nommément désignés dans cette annexeIT: polietilenpoliamine escluse quelle espressamente indicate in questo allegatoNL: polyethyleenpolyamine met uitzondering van de in deze bijlage met name genoemdePT: polietilenopoliaminas com excepção dos expressamente referidos no presente anexoFI: polyetyleenipolyamiinit paitsi muualla tässä liitteessä mainitutSV: polyetylenpolyaminer med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-34-43-50/53S:(1/2-)26-36/37/39-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 21/22-34-4310% <= C < 25%C; R 34-435% <= C < 10%Xi; R 36/38-431% <= C < 5%Xi; R 43Cas No 101-83-7EEC No 202-980-7612-066-00-3>REFERENCE TO A GRAPHIC>ES: diciclohexilaminaDA: dicyclohexylaminDE: DicyclohexylaminEL: äéêõêëïåîõëáìßíçEN: dicyclohexylamineFR: dicyclohexylamineIT: dicicloesilaminaNL: dicyclohexylaminePT: diciclohexilaminaFI: disykloheksyyliamiiniSV: dicyklohexylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22C; R 34N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-34-50/53S:(1/2-)26-36/37/39-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 22-3410% <= C < 25%C; R 342 % <= C < 10% Xi;R 36/38Cas No 2855-13-2EEC No 220-666-8No 612-067-00-9>REFERENCE TO A GRAPHIC>ES: 3-aminometil-3,5,5-trimetilciclohexilaminaDA: 3-aminomethyl-3,5,5-trimethylcyclohexylaminDE: 3-Aminomethyl-3,5,5-trimethylcyclohexylaminEL: 3-áìéíïìåèõëï-3,5,5-ôñéìåèõëïêõêëïåîõëáìßíçEN: 3-aminomethyl-3,5,5-trimethylcyclohexylamineFR: 3-aminométhyl-3,5,5-triméthylcyclohexylamine; isophoronediamineIT: 3-aminometil-3,5,5-trimetilcicloesilaminaNL: 3-aminomethyl-3,5,5-trimethylcyclohexylaminePT: 3-aminometil-3,5,5-trimetilciclohexilaminaFI: 3-aminometyyli-3,5,5-trimetyylisykloheksyyliamiini; isoforonidiamiiniSV: 3-aminometyl-3,5,5-trimetylcycklohexylamino; isoforondiaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34R 43R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:21/22-34-43-52/53S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 21/22-34-4310% <= C < 25%C; R 34-435% <= C < 10%Xi; R 36/38-431% <= C < 5%Xi; R 43Cas No 612-83-9 64969-34-2 74332-73-3EEC No 210-323-0 265-293-1 277-822-3 No 612-069-00-XNOTA ANOTA EES: sales de 3,3'-diclorobencidinaDA: salte af 3,3'-dichlorbenzidinDE: Salze von 3,3'-DichlorbenzidinEL: Üëáôá ôçò 3,3'-äé÷ëùñïâåíæéäßíçòEN: salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamineFR: sels de 3,3'-dichlorobenzidineIT: 3,3'-diclorobenzidina saliNL: zouten van 3,3'-dichloorbenzidinePT: sais de 3,3'-diclorobenzidinaFI: 3,3'-diklooribentsidiinin suolatSV: 3,3'-diklorbenzidin salter 3,3'-diklor[1,1'-bifenyl]-4,4'-diamin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 21R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-21-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 531-85-1 531-86-2 21136-70-9 36341-27-2EEC No 208-519-6 208-520-1 244-236-4 252-984-8No 612-070-00-5NOTA ANOTA EES: sales de bencidinaDA: salte af benzidinDE: Salze von BenzidinEL: Üëáôá ôçò âåíæéäßíçòEN: salts of benzidineFR: sels de benzidineIT: benzidina saliNL: zouten van benzidinePT: sais de benzidinaFI: bentsidiinin suolatSV: benzidin salter; [1,1'-bifenyl]-4,4'-diamin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 1; R 45Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 553-00-4 612-52-2EEC No 209-030-0 210-313-6 No 612-071-00-0NOTA ANOTA EES: sales de 2-naftilaminaDA: salte af 2-nafthylaminDE: Salze von 2-NaphthylaminEL: Üëáôá ôçò 2-íáöèõëáìßíçòEN: salts of 2-naphthylamineFR: sels de 2-naphtylamineIT: 2-naftilamina saliNL: zouten van 2-naftylaminePT: sais de 2-naftilaminaFI: 2-naftyyliamiinin suolatSV: 2-naftylamin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 1; R 45Xn; R 22 N;R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 103-83-3EEC No 203-149-1No 612-074-00-7>REFERENCE TO A GRAPHIC>ES: bencildimetilaminaDA: benzyldimethylaminDE: Benzyldimethylamin; N,N-DimethylbenzylaminEL: âåíæõëïäéìåèõëáìßíçEN: benzyldimethylamineFR: benzyldiméthylamineIT: benzildimetilamina; N,N-dimetilbenzilaminaNL: benzyldimethylaminePT: benzildimetilaminaFI: bentsyylidimetyyliamiiniSV: benzyldimetylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 10Xn; R 20/21/22C; R 34R 52-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:10-20/21/22-34-52/53S:(1/2-)26-36-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 62-75-9EEC No 200-549-8No 612-077-00-3NOTA E>REFERENCE TO A GRAPHIC>ES: dimetilnitrosoaminaDA: dimethylnitrosoaminDE: DimethylnitrosoaminEL: äéìåèõëïíéôñïäïáìßíçEN: dimethylnitrosoamineFR: diméthylnitrosoamineIT: dimetilnitrosoamina; N-nitrosodimetilaminaNL: dimethylnitrosoaminePT: dimetilnitrosoaminaFI: dimetyylinitrosamiiniSV: dimetylnitrosaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T+; R 26T; R 25-48/25N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-25-26-48/25-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 612-079-00-4NOTA ANOTA EES: sales de 2,2'-dicloro-4,4'-metilendianilina; sales de 4,4'-metilenbis(2-cloroanilina)DA: salte af 2,2'-dichlor-4,4'-methylendianilin; salte af 4,4'-methylenbis(2-chloranilin)DE: Salze von 2,2'-Dichlor-4,4'-methylendianilin; Salze von 4,4'-Methylen-bis(2-chloranilin)EL: Üëáôá ôçò 2,2'-äé÷ëùñï-4,4'-ìåèõëåíïäéáíéëßíçò . Üëáôá ôçò 4,4'-ìåèõëåíïäéó(2-÷ëùñïáíéëßíçò)EN: salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline)FR: sels de 2,2'-dichloro-4,4'-méthylènedianiline; sels de 4,4'-méthylènebis(2-chloraniline)IT: 2,2'-dicloro-4,4'-metilendianilina sali; 4,4'-metilenbis(2-cloroanilina) saliNL: zouten van 2,2'-dichloor-4,4'-methyleendianiline; zouten van 4,4'-methyleenbis(2-chlooraniline)PT: sais de 2,2'-dicloro-4,4'-metilenodianilina; sais de 4,4'-metileno-bis(2-cloroanilina)FI: 2,2'-dikloori-4,4'-metyleenidianiliniin suolat; 4,4'-metyleenibis(2-kloorianiliini):n suolatSV: 2,2'-diklor-4,4'-metylendianilin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 612-82-8 64969-36-4 74753-18-7EEC No 210-322-5 265-294-7 277-985-0 No 612-081-00-5NOTA ANOTA EES: sales de 3,3'-dimetilbencidina; sales de o-tolidinaDA: salte af 3,3'-dimethylbenzidin; salte af o-tolidinDE: Salze von 3,3'-Dimethyl-benzidin; Salze von o-TolidinEL: Üëáôá ôçò 3,3`-äéìåôõëïâåíæéäßíçò . Üëáôá ôçò ï-ôïëéäßíçòEN: salts of 3,3'-dimethylbenzidine; salts of o-tolidineFR: sels de 3,3'-diméthylbenzidine; sels de o-tolidineIT: 3,3'-dimetilbenzidina sali; o-tolidina saliNL: zouten van 3,3'-dimethylbenzidine; zouten van o-tolidinePT: sais de 3,3'-dimetilbenzidina; sais de o-tolidinaFI: 4,4'-bi- o-toluidiinin suolatSV: 4,4'-bi- o-toluidin, salter; 3,3'-dimetylbenzidin, salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 838-88-0EEC No 212-658-8No 612-085-00-7NOTA E>REFERENCE TO A GRAPHIC>ES: 4,4`-metilendi- o-toluidinaDA: 4,4`-methylendi- o-toluidinDE: 4,4`-Methylendi- o-toluidinEL: 4,4`-ìåèõëåíïäé- o-ôïëïõéäßíçEN: 4,4`-methylenedi- o-toluidineFR: 4,4`-méthylènedi- o-toluidineIT: 4,4`-metilendi- o-toluidinaNL: 4,4`-methyleendi- o-toluïdinePT: 4,4`-metilenodi- o-toluídinaFI: 4,4`-metyleenidi- o-toluídiiniSV: 4,4`-metylendi- o-toluidinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 13516-27-3EEC No 236-855-3No 612-087-00-8>REFERENCE TO A GRAPHIC>ES: guazatinaDA: guazatinDE: GuazatinEL: guazatineEN: guazatineFR: guazatineIT: guazatina; 1,1`-iminobis(ottametilen)diguanidinaNL: guazatinePT: guazatinaFI: guatsatiiniSV: guazatin; N,N```-(iminodi-8,1-oktandiyl)bisguanidinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22Xi; R 36/38N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-36/38-50/53S:(2-)36/37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2243-62-1EEC No 218-817-8No 612-089-00-9>REFERENCE TO A GRAPHIC>ES: 1,5-naftilenodiaminaDA: 1,5-naphthylendiaminDE: 1,5-NaphthylendiaminEL: 1,5-íáöèõëÝíéïäéáìßíçEN: 1,5-naphthylenediamineFR: 1,5-naphtylènediamineIT: 1,5-naftilenediaminaNL: 1,5-naftyleendiaminePT: 1,5-naftilenodiaminaFI: 1,5-naftyleenidiamiiniSV: 1,5-naftalendiaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:40-50/53S:(2-)36/37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 95-53-4EEC No 202-429-0No 612-091-00-XNOTA E>REFERENCE TO A GRAPHIC>ES: o-toluidinaDA: o-toluidinDE: o-ToluidinEL: o-ôïëïõéäßíçEN: o-toluidine; 2-aminotolueneFR: o-toluidineIT: o-toluidinaNL: o-toluïdinPT: o-toluídinaFI: o-toluidiini; 2-aminotolueeniSV: o-toluidin; 2-metylbenzenaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T; R 23/25Xi; R 36N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-23/25-36-50S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 492-80-8EEC No 207-762-5No 612-096-00-7>REFERENCE TO A GRAPHIC>ES: 4,4`-carbonimidoilbis[ N,N-dimetilanilina];DA: 4,4`-carbonimidoylbis[ N,N-dimethylanilin];DE: 4,4`-Carbonimidoylbis[ N,N-dimethylanilin]EL: 4,4`-êáñâïíéìéäïûëïäéò[ N,N-äéìåèõëáíéëßíç]EN: 4,4`-carbonimidoylbis[ N,N-dimethylaniline]FR: 4,4`-carbonimidoylbis[ N,N-diméthylaniline]; auramineIT: 4,4`-carbonimidoilbis[ N,N-dimetilanilina]; auraminaNL: 4,4`-carbonimidoylbis[ N,N-dimethylaniline]PT: 4,4`-carbonimidoílbis[ N,N-dimetilanilina]FI: 4,4`-karbonimidoyylibis[ N,N-dimetyylianiliini]; auramiiniSV: 4,4`-karbonimidoylbis[ N,N-dimetylanilin]; C.I. Solvent Yellow 34Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40Xn; R 22Xi; R 36N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-36-40-51/53S:(2-)36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 612-097-00-2NOTA AES: sales de 4,4'-carbonimididoibis[ N,N-dimetilanilina]DA: salte af 4,4'-carbonimidoylbis[ N,N-dimethylanilin]DE: Salze von 4,4'-Carbonimidoylbis[ N,N-dimethylanilin]EL: Üëáôá ôçò 4,4`-êáñâïíéìéäïûëïäéò[ Í,Í-äéìåèõëáíéëßíç]EN: salts of 4,4'-carbonimidoylbis[ N,N-dimethylaniline]FR: sels de 4,4'-carbonimidoylbis[ N,N-diméthylaniline]; sels d`auramineIT: sali di 4,4'-carbomidoibis[ N,N-dimetilanilina]; auramina saliNL: zouten van 4,4'-carbonimidoylbis[ N,N-dimethylaniline]PT: sais de 4,4'-carbonimidoylbis[ N,N-dimetilanilina]FI: 4,4'-karbonimidoyylibis[ N,N-dimetyylianiliini] suolatSV: 4,4'-karbonimidoylbis[ N,N-dimetylanilin], salterClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40Xn; R 22Xi; R 36N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-36-40-51/53S:(2-)36/37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 621-64-7EEC No 210-698-0No 612-098-00-8NOTA E>REFERENCE TO A GRAPHIC>ES: nitrosodipropilaminaDA: nitrosodipropylaminDE: NitrosodipropylaminEL: íéôñïäïäéðñïðõëáìßíçEN: nitrosodipropylamineFR: nitrosodipropylamineIT: nitrosodipropilaminaNL: nitrosodipropylaminePT: nitrosodipropilaminaFI: nitrosodipropyyliamiiniSV: nitrosodipropylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-22-51/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 95-80-7EEC No 202-453-1No 612-099-00-3NOTA E>REFERENCE TO A GRAPHIC>ES: 4-metil- m-fenilendiaminaDA: 4-methyl- m-phenylendiaminDE: 4-Methyl- m-phenylendiamin; Toluylen-2,4-diaminEL: 4-ìåèõëï- ì-öáéíïëåíïäéáìßíçEN: 4-methyl- m-phenlyenediamineFR: 4-méthyl- m-phénylènediamine; toluène-2,4-diamineIT: 4-metil- m-fenilendiaminaNL: 4-methyl- m-fenyleendiaminePT: 4-metil- m-fenilenodiaminaFI: 4-metyyli- m-fenyleenidiamiiniSV: 4-metyl- m-fenylendiamin; 4-metyl-1,3-benzendiaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T; R 25Xn; R 21Xi; R 36R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-21-25-36-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 100-97-0EEC No 202-905-8No 612-101-00-2>REFERENCE TO A GRAPHIC>ES: metenaminaDA: methenaminDE: Methenamin; HexamethylentetraminEL: ìåèåíáìßíçEN: methenamine; hexamethylenetetramineFR: méthenamine; hexaméthylènetétramineIT: metenamina; esametilentetraminaNL: methenaminePT: metenaminaFI: meteeniamiini; heksametyleenitetramiiniSV: metenamin; hexametylentetraminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11R 42/43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>Xn >REFERENCE TO A GRAPHIC>R:11-42/43S:(2-)16-22-24-37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 140-31-4EEC No 205-411-0No 612-105-00-4>REFERENCE TO A GRAPHIC>ES: 2-piperazin-1-iletilaminaDA: 2-piperazin-1-ylethylaminDE: 2-Piperazin-1-ylethylaminEL: 2-(ðéðåñáæéí-1-õë)áéèõëáìßíçEN: 2-piperazin-1-ylethylamineFR: 2-pipérazine-1-yléthylamineIT: 2-piperazin-1-iletilaminaNL: 2-piperazine-1-ylethylaminePT: 2-(1-piperazinil)etilaminaFI: 2-piperatsiini-1-yylietyyliamiiniSV: 2-piperazin-1-yletylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34R 43R 52-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:21/22-34-43-52/53S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 98-84-0 [1] 618-36-0 [2]EEC No 202-706-6 [1] 210-545-8 [2]No 612-107-00-5>REFERENCE TO A GRAPHIC>ES: 1-feniletilamina [1]; DL-á-metilbencilamina [2]DA: 1-phenylethylamin [1]; DL-á-methylbenzylamin [2]DE: 1-Phenylethylamin [1]; DL-á-Methylbenzylamin [2]EL: 1-öáéíïëáéèõëáìßíçá-ìåèõëïâåíæõëáìßíç [1] . DL-á-ìåèõëïâåíæõëáìßíç [2]EN: 1-phenylethylamine [1]; DL-á-methylbenzylamine [2]FR: 1-phényléthylamine [1]; DL-á-méthylbenzylamine [2]IT: 1-feniletilamina [1]; DL-á-metilbenzilamina [2]NL: 1-fenylethylamine [1]; DL-á-methylbenzylamine [2]PT: 1-feniletilamina [1]; DL-á-metilbenzilamina [2]FI: 1-fenyylietyyliamiini [1]; DL-á-metyylibentsyyliamiini [2]SV: 1-fenyletylamin [1]; DL-á-metylbenzylamin [2]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>R:21/22-34S:(1/2-)26-28-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 6864-37-5EEC No 229-962-1No 612-110-00-1>REFERENCE TO A GRAPHIC>ES: 2,2`-dimetil-4,4`-metilenbis(ciclonexilamina)DA: 2,2`-dimethyl-4,4`-methylenbis(cyclohexylamin)DE: 2,2`-Dimethyl-4,4`-methylenbis(cyclohexylamin)EL: 2,2`-äéìåèõëï-4,4`-ìåèõëåíïäéò(êõêëïåîõëáìßíç)EN: 2,2`-dimethyl-4,4`-methylenebis(cyclohexylamine)FR: 2,2`-diméthyl-4,4`-méthylènebis(cyclohexylamine)IT: 2,2`-dimetil-4,4`-metilenbis(cicloesilamina)NL: 2,2`-dimethyl-4,4`-methyleenbis(cyclohexylamine)PT: 2,2`-dimetil-4,4`-metilenobis(ciclohexilamina)FI: 2,2`-dimetyyli-4,4`-metyleenibis(sykloheksyyliamiini)SV: 2,2`-dimetyl-4,4`-metylenbis(cyklohexylamin)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/24Xn; R 22C; R 35N; R 51-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-23/24-35-51/53S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 823-40-5EEC No 212-513-9No 612-111-00-7>REFERENCE TO A GRAPHIC>ES: 2-metil- m-fenilenodiaminaDA: 2-methyl- m-phenylendiaminDE: 2-Methyl- m-phenylendiamin; Toluylen-2,6-diaminEL: 2-:ìåèõëï- ì-öáéíõëåíïäéáìßíçEN: 2-methyl- m-phenylenediamineFR: 2-méthyl- m-phénylènediamine; toluène-2,6-diamineIT: 2-metil- m-fenilendiamina; toluene-2,6-diaminaNL: 2-methyl- m-fenyleendiaminePT: 2-metil- m-fenilenodiaminaFI: 2-metyyli- m-fenyleenidiamiiniSV: 2-metyl- m-fenylendiamin; 2-metyl-1,3-benzendiaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringMuta. Cat. 3; R 40Xn; R 21/22R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-40-43-50/53S:(2-)24-36/37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 104-94-9EEC No 203-254-2No 612-112-00-2>REFERENCE TO A GRAPHIC>ES: p-anisidinaDA: p-anisidinDE: p-Anisidin; 4-MethoxyanilinEL: ð-áíéóéäßíçEN: p-anisidine; 4-methoxyanilineFR: p-anisidineIT: p-anisidina; 4-metossianilinaNL: p-anisidinePT: p-anisidinaFI: p-anisidiini; 4-metoksianiliiniSV: p-anisidin; 4-metoxianilinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26/27/28R 33N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:26/27/28-33-50S:(1/2-)28-36/37-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 28434-00-6EEC No 249-013-5No 613-055-00-6>REFERENCE TO A GRAPHIC>ES: [1 R-[1á(S*),3ß]]-2,2-dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de 3-alil-2-metil-4-oxociclopent-2-en-1-ilo; S-bioaletrinaDA: 3-allyl-2-methyl-4-oxocyclopent-2-en-1-yl-[1 R-[1á(S*),3ß]]-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropan- carboxylat; S-bioallethrinDE: 3-Allyl-2-methyl-4-oxocyclopent-2-en-1-yl-[1 R-[1á(S*),3ß]]-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropan- carboxylat; S-BioallethrinEL: [1 R-[1á(S*),3ß]]-2,2-äéìåèõëï-3-(2-ìåèõëïðñïð-1-åíõëï)êõêëïðñïðáíïêáñâïîõëéêü 3-áëëõëï-2-ìåèõë-4-ïîïêõêëïðåíô-2-åí-1-ýëéï . S-bioallethrinEN: 3-allyl-2-methyl-4-oxocyclopent-2-en-1-yl-[1 R-[1á(S*),3ß]]-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropano- carboxylate; S-bioallethrinFR: [1 R-[1á(S*),3ß]]-2,2-diméthyl-3-(2-méthylprop-1-enyl)cyclopropanecarboxylate de 3-allyl-2-méthyl-4-oxocyclopent-2-ène-1-yle; esdépalléthrineIT: [1 R-[1á(S*),3ß]]-2,2-dimetil-3-(2-metilprop-1-enil)ciclopropanocarbossilato di 3-allil-2-metil-4-ossociclopent-2-en-1-ile; S-bioalletrinaNL: 3-allyl-2-methyl-4-oxocyclopent-2-een-1-yl-[1 R-[1á(S*),3ß]]-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaan- carboxylaat; S-bioalletrinePT: [1 R-[1á(S*),3ß]]-2,2-dimetil-3-(2-metilprop-1-enil)ciclopropanocarboxilato de 3-alil-2-metil-4-oxociclopent-2-eno-1-ilo; S-bioaletrinaFI: 3-allyyli-2-metyyli-4-oksysklopent-2-en-1-yyli-[1 R-[1á(S*),3ß]]-2,2-dimetyyli-3-(2-metyyliprop-1-enyyli)syklopro- paanikarboksylaatti; S-bioalletriiniSV: 3-allyl-2-metyl-4-oxocyklopent-2-en-1-yl[1 R-[1á(S*),3ß]]-2,2-dimetyl-3-(2-metylprop-1-enyl)cyklopropankarboxylat; S-bioalletrinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-50/53S:(2-)60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 90989-39-2EEC No 292-695-4No 649-403-00-9NOTA HNOTA PES: hidrocarburos aromáticos, C8-10; Nafta de baja temperatura de inflamación, sin especificarDA: aromatiske carbonhydrider, C8-10; Lavtkogende uspecificeret naftaDE: Aromatische Kohlenwasserstoffe, C8-10; Naptha, niedrig siedend, nicht spezifiziertEL: áñùìáôéêïß õäñïãïíÜíèñáêåò, C8-10 . ÅëáöñÜ íÜöèá - íç ðñïäéáãåãñáììÝíç EN: Aromatic hydrocarbons, C8-10; Low boiling point naphtha - unspecifiedFR: hydrocarbures aromatiques en C8-10; Naphta à point d`ébullition bas - non spécifiéIT: idrocarburi aromatici C8-10; Nafta con basso punto di ebollizione - non specificataNL: aromatische koolwaterstoffen, C8-10; Nafta met laag kookpunt - niet gespecifieerdPT: hidrocarbonetos aromáticos, C8-10; Nafta de baixo ponto de ebulição - não especificadaFI: aromaattiset hiilivedyt, C8-10; matalan kiehumispisteen teollisuusbensiini (nafta)-määrittelemälönSV: aromatiska kolväten, C8-10; ospecificerad nafta med låg kokpunktClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Xn; R 65 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-65S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 4C >= 10%T; R 45-650,1% <= C < 10%T; R 45ANEXO II - BILAG II - ANHANG II - ÐÁÑÁÑÔÇÌÁ ÉÉ - ANNEX II - ANNEXE II - ALLEGATO II - BIJLAGE II - ANEXO II - LIITE II - BILAGA II  >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC> >REFERENCE TO A GRAPHIC>Cas No 7789-12-0EEC No 234-190-3No 024-004-01-4NOTA ENa2Cr2O7 . 2H2OES: dicromato de sodio, dihidratoDA: natriumdichromat, dihydratDE: Natriumdichromat, dihydratEL: äéîñùìéêü íÜôñéï, äéÝííäñïEN: sodium dichromate, dihydrateFR: dichromate de sodium, dihydrateIT: dicromato di sodio, diidratoNL: natriumdichromaat, dihydraatPT: dicromato de sódio, dihidratoFI: natriumdikromaatti, dihydraattiSV: natriumdikromat, dihydratClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 49Muta. Cat. 2; R 46T+; R 26T; R 25Xn; R 21Xi; R 37/38-41R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-46-21-25-26-37/38-41-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserNOTA 3C >= 7%T+; R 49-46-21-25-26-37/38-41-430,5% <= C < 7%T; R 49-46-430,1% <= C < 0,5%T; R 49-46Cas No -EEC No -No 024-017-00-8NOTA ANOTA EES: Compuestos de cromo(VI), excepto el cromato de bario y de los especialmente citados en este anexoDA: Krom(VI)forbindelser, med undtagelse af bariumkromat samt sådanne nævnt andetsteds i dette bilagDE: Chrom(VI)verbindungen, mit Ausnahme von Bariumchromat und Verbindungen die in diesem Anhang gesondert aufgeführt sindEL: åíþóåéò ÷ñùìßïõ (VI), åêôüò ôïõ ÷ñùìéêïý âáñßïõ êáé ôùí åíþóåùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this AnnexFR: Composés de chrome(VI), à l`exception du chromate de baryum et de ceux nommément désignés dans cette annexeIT: Composti di cromo(VI), esclusi bario cromato e quelli espressamente indicati in questo allegatoNL: Chroom(VI)verbindingen, met uitzondering van bariumchromaat alsmede van in deze bijlage met name genoemde zoutenPT: Compostos de crómio(VI), com excepção do cromato de bário e dos expressamente referidos no presente anexoFI: kromi(VI)-yhdisteet paitsi bariumkromaatti sekä muualla tässä liitteessä mainitut yhdisteetSV: krom(VI)föreningar med undantag för bariumkromat och föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 49R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:49-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 7784-42-1EEC No 232-066-3No 033-006-00-7AsH3ES: arsinaDA: arsinDE: Arsin; ArsenwasserstoffEL: áñóßíçEN: arsineFR: arsineIT: arsinaNL: arsinePT: arsinaFI: arsiiniSV: arsin; arsenikväteClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12 T+; R 26 Xn; R 48/20 N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, Märkning >REFERENCE TO A GRAPHIC>+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:12-26-48/20-50/53S:(1/2-)9-16-28-33-36/37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 10361-39-4EEC No 233-788-1No 056-004-00-8BaCl2ES: cloruro de barioDA: bariumchlorid; bariumdichloridDE: BariumchloridEL: ÷ëùñéïý÷ï âÜñéïEN: barium chlorideFR: chlorure de baryumIT: cloruro di bario; bario cloruroNL: bariumchloridePT: cloreto de bárioFI: bariumkloridiSV: bariumkloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 25Xn; R 20 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:20-25S:(1/2-)45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 77-47-4EEC No 201-029-3No 602-078-00-7>REFERENCE TO A GRAPHIC>ES: hexaclorociclopentadienoDA: hexachlorcyclopentadienDE: HexachlorcyclopentadienEL: åîá÷ëùñïêõêëïðåíôáäéÝíéïEN: hexachlorocyclopentadieneFR: hexachlorocyclopentadièneIT: esaclorociclopentadieneNL: hexachloorcyclopentadieenPT: hexaclorociclopentadienoFI: heksakloorisyklopentadieeniSV: hexaklorcyklopentadienClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT+; R 26T; R 24Xn; R 22C; R 34N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT+ >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-24-26-34-50/53S:(1/2-)25-39-45-53-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 94-59-7EEC No 202-345-4No 605-020-00-9NOTA E>REFERENCE TO A GRAPHIC>ES: 5-alil-1,3-benzodioxolDA: 5-allyl-1,3-benzodioxolDE: 5-Allyl-1,3-benzodioxol; SafrolEL: 5-áëëõëï-1,3-âåíæïäéïîüëçEN: 5-allyl-1,3-benzodioxole; safroleFR: 5-allyl-1,3-benzodioxole; safroleIT: 5-allil-1,3-benzodiossolo; safroloNL: 5-allyl-1,3-benzodioxool; safroolPT: 5-alil-1,3-benzodioxoleFI: 5-allyyli-1,3-bentsodioksoli; safroliSV: 5-allyl-1,3-benzodioxol; 5-(2-propenyl)-1,3-benzodioxolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Muta. Cat. 3; R 40Xn; R 22 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-22-40S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 91673-30-2EEC No 294-145-9No 605-021-00-4ES: formaldehído, productos de reacción con butilfenolDA: formaldehyd, reaktionsprodukter med butylphenolDE: Formaldehyd, Reaktionsprodukte mit ButylphenolEL: öïñìáëäåàäçò, ðñïúüíôá áíôßäñáóçò ìå âïõôõëïöáéíüëçEN: Formaldehyde, reaction products with butylphenolFR: formaldéhyde, produits de réaction avec le butylphénolIT: formaldeide, prodotti di reazione con butilfenoloNL: formaldehyd, reactieprodukten met butylfenolPT: formaldeído, produtos da reacção com butilfenolFI: formaldehydi, reaktiotuotteet butyylifenolin kanssaSV: formaldehyd, reaktionsprodukt med butylfenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>R:43S:(2-)24-37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 111-30-8EEC No 203-856-5No 605-022-00-X>REFERENCE TO A GRAPHIC>ES: glutaralDA: glutaral; glutaraldehydDE: Glutaral; GlutaraldehydEL: ãëïõôáñáëäåàäç;EN: glutaral; glutaraldehyde; 1,5-pentanedialFR: glutaralIT: glutarale; gluraraldeide; 1,5-pentandialeNL: glutaaraldehydPT: glutaralFI: glutaraldehydiSV: glutaraldehyd; pentandialClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 23/25C; R 34R 42/43N; R 50Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:23/25-34-42/43-50S:(1/2-)26-36/37/39-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 50%T; R 23/25-34-42/4325% <= C < 50%T; R 22-23-34-42/4310% <= C < 25%C; R 20/22-34-42/432% <= C < 10%Xn; R 20/22-37/38-41-42/431% <= C < 2%Xn; R 36/37/38-42/430,5% <= C < 1%Xi; R 36/37/38-43Cas No 19666-30-9EEC No 243-215-7No 606-045-00-8>REFERENCE TO A GRAPHIC>ES: 5-(1,1-dimetiletil)-3-[2,4-dicloro-5-(1-metiletoxi)fenil]-5-1,3,4-oxadiazol-2(3 H)-onaDA: 3-[2,4-dichlor-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxdiazol-2(3 H)-onDE: 3-[2,4-Dichlor-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3 H)-on; OxadiazonEL: 3-[2,4-äé÷ëùñï-5-(1-ìåèõëáéèïîõ)öáéíõëï]-5-(1,1-äéìåèõëáéèë)-1,3,4-ïîáäéáæïë-2(3 H)-üíçEN: 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3 H)-one; oxadiazonFR: 3-[2,4-dichloro-5-(1-méthylethoxy)phényl]-5-(1,1-diméthyléthyl)-1,3,4-oxadiazole-2(3 H)-one; oxadiazonIT: 5-(1,1-dimetiletil)-3-[2,4-dicloro-5-(1-metiletossi)fenil]-5-1,3,4-ossadiazol-2(3 H)-oneNL: 3-[2,4-dichloor-5-(1-methylethoxy)fenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazool-2(3 H)-onPT: 5-(1,1-dimetiletil)-3-[2,4-dicloro-5-(1-metiletoxi)fenil]-5-1,3,4-oxadiazole-2(3 H)-onaFI: 3-[2,4-dikloori-5-(1-metyylietoksi)fenyyli]-5-(1,1-dimetyylietyyli)-1,3,4-oksadiatsoli-2(3 H)-oni; oksadiatsoniSV: 3-[2,4-dikloro-5-(1-metyletoxi)fenyl]-5-(1,1-dimetyletyl)-1,3,4-oxadiazol-2(3 H)-on; oxadiazon (ISO)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringN; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningN >REFERENCE TO A GRAPHIC>R:50/53S:60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 117-82-8EEC No 204-212-6No 607-228-00-5>REFERENCE TO A GRAPHIC>ES: ftalato de bis(2-metoxietilo)DA: bis(2-methoxyethyl)phthalatDE: Bis(2-methoxyethyl)phthalatEL: öèáëéêü äéò(2-ìåèïîõáßèõëï)EN: bis(2-methoxyethyl) phthalateFR: phtalate de bis(2-méthoxyéthyle)IT: ftalato di bis(2-metossietile)NL: bis(2-methoxyethyl)ftalaatPT: ftalato de bis(2-metoxietilo)FI: bis(2-metoksietyyli)ftalaattiSV: di(2-metoxietyl)ftalatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringRepr. Cat. 2; R 61Repr. Cat. 3; R 62 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:61-62S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 88-10-8EEC No 201-798-5No 607-229-00-0>REFERENCE TO A GRAPHIC>ES: cloruro de dietilcarbomoiloDA: diethylcarbamoylchloridDE: DiethylcarbamoylchloridEL: ÷ëùñßäéï ôïõ äéáéèõëïêáñâáìïàëïõEN: diethylcarbamoyl chlorideFR: chlorure de diéthylcarbamoyleIT: cloruro di dietilcarbamoileNL: diethylcarbamoylchloridePT: cloreto de dietilcarbamoiloFI: dietyylikarbamyylikloridiSV: dietylkarbamoylkloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 3; R 40Xn; R 20/22Xi; R 36/37/38 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:20/22-36/37/38-40S:(2-)26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 149-57-5EEC No 205-743-6No 607-230-00-6>REFERENCE TO A GRAPHIC>ES: ácido 2-etilhexanoicoDA: 2-ethylhexansyreDE: 2-EthylhexansäureEL: 2-áéèõëåîáíïúêü ïîýEN: 2-ethylhexanoic acidFR: acide 2-éthylhexanoiqueIT: acido 2-etilesanoicoNL: 2-ethylhexaanzuurPT: ácido 2-etilhexanóicoFI: 2-etyyliheksaanihappoSV: 2-etylhexansyraClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringRepr. Cat. 3; R 63 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:63S:(2-)36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 1702-17-6EEC No 216-935-4No 607-231-00-1>REFERENCE TO A GRAPHIC>ES: ácido 3,6-dicloropiridina-2-carboxilicoDA: 3,6-dichlorpyridin-2-carboxylsyreDE: 3,6-Dichlorpyridin-2-carbonsäureEL: 3,6-äé÷ëùñïðõñéäéíï-2-êáñâïîõëéêü ïîýEN: 3,6-dichloropyridine-2-carboxylic acid; clopyralidFR: acide 3,6-dichloropyridine-2-carboxylique; clopyralidIT: acido 3,6-dicloropiridin-2-carbossilico; clopiralidNL: 3,6-dichloorpyridine-2-carbonzuurPT: ácido 3,6-dicloropiridina-2-carboxilicoFI: 3,6-diklooripyridiini-2-karboksyylikhappo; klopyralidiSV: 3,6-diklorpyridin-2-karboxylsyra; klopyralid (ISO)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 41N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:41-51/53S:(2-)26-39-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 127-68-4EEC No 204-857-3No 609-048-00-2>REFERENCE TO A GRAPHIC>ES: 3-nitrobencenosulfonato de sodioDA: natrium-3-nitrobenzensulfonatDE: Natrium-3-nitrobenzolsulfonatEL: 3-íéôñïâåíæïëïóïõëöïíéêü íÜôñéïEN: sodium 3-nitrobenzenesulphonateFR: 3-nitrobenzènesulfonate de sodiumIT: 3-nitrobenzensolfonato di sodioNL: natrium-3-nitrobenzeensulfonaatPT: 3-nitrobenzenossulfonato de sódioFI: natrium-3-nitrobentseenisulfonaattiSV: natrium-3-nitrobenzensulfonatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>R:36-43S:(2-)24-26-37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 121-87-9EEC No 204-502-2No 610-009-00-7>REFERENCE TO A GRAPHIC>ES: 2-cloro-4-nitroanilinaDA: 2-chlor-4-nitroanilinDE: 2-Chlor-4-nitroanilinEL: 2-÷ëùñï-4-íéôñïáíéëßíçEN: 2-chloro-4-nitroanilineFR: 2-chloro-4-nitroanilineIT: 2-cloro-4-nitroanilinaNL: 2-chloor-4-nitroanilinePT: 2-cloro-4-nitroanilinaFI: 2-kloori-4-nitroaniliiniSV: 2-klor-4-nitroanilinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-51/53S:(2-)22-24-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 611-024-00-1NOTA A>REFERENCE TO A GRAPHIC>ES: Colorantes azoicos derivados de la bencidina; colorantes 4,4-diarilazobifenilos, excepto aquellos específicamente expresados en este AnexoDA: Benzidinbaserede azofarvestoffer; 4,4'-diarylazobiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilagDE: Azofarbstoffe auf Benzidinbasis; 4,4'-Diarylazobiphenyl-Farbstoffe, mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: áæùôïý÷åò ÷ñùóôéêÝò ìå âÜóç âåõæéäßíç, 4,4'-äéáñõëáæùäéöáéíõëï-÷ñùóôéêÝò åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this AnnexFR: Colorants azoïques dérivant de la benzidine; colorants de 4,4'-diarylazobiphényle à l`exception de ceux nommément désignés dans cette annexeIT: Azocoloranti della benzidina; coloranti del 4,4'-diarilazobifenile, esclusi quelli espressamente indicati in questo allegatoNL: Azo kleurstoffen op basis van benzidine; 4,4-diarylazobifenylkleurstoffen, met uitzondering van de in deze bijlage met name genoemdePT: Corantes azoicos derivados da benzidina; corantes 4,4'-diarilazobifenil, com excepção dos expressamente referidos no presente anexoFI: bentsidiinipohjaiset atsoväriaineet, 4,4'-diaryyliatsobifenyyli väriaineet, paitsi muualla tässä liitteessä mainitutSV: benzidinbaserade azofärger, 4,4'-diarylazobifenylfärger med undantag för föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 1937-37-7EEC No 217-710-3No 611-025-00-7>REFERENCE TO A GRAPHIC>ES: 4-amino-3-[[4`-[(2,4-diaminofenil)azo][1,1`-bifenil]-4-il]azo]-6-(fenilazo)-5-hidroxinaftaleno-2,7-disulfonato de disodioDA: dinatrium-4-amino-3-[[4`-[(2,4-diaminophenyl)azo][1,1`-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalen-2,7-disulfonatDE: Dinatrium-4-amino-3-[[4`-[(2,4-diaminophenyl)azo][1,1`-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalin-2,7-disulfonat; C.I. Direct Black 38EL: 4-áìéíï-3[[4`-[(2,4-äéáìéíïöáéíõë)áæù][1,1`-äéöáéíõë]-4-õë]áæù]-5-õäñïîõ-6-(öáéíõëáæù)íáöèáëåíï-2,7-äéóïõëöïíéêü äéíÜôñéïEN: disodium 4-amino-3-[[4`-[(2,4-diaminophenyl)azo][1,1`-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38FR: 4-amino-3-[[4`-[(2,4-diaminophényl)azo][1,1`-biphényl]-4-yl]azo]-5-hydroxy-6-(phénylazo)naphtalène-2,7-disulfonate de disodium; C.I. Direct Black 38IT: 4-amino-3-[[4`-[(2,4-diaminofenil)azo][1,1`-bifenil]-4-il]azo]-6-(fenilazo)-5-idrossinaftalen-2,7-disolfonato di disodio; C.I. Direct Black 38NL: dinatrium-4-amino-3-[[4`-[(2,4-diaminofenyl)azo][1,1`-bifenyl]-4-yl]azo]-6-(fenylazo)-5-hydroxynaftaleen-2,7-disulfonaatPT: 4-amino-3-[[4`-[(2,4-diaminofenil)azo][1,1`-bifenil]-4-il]azo]-6-(fenilazo)-5-hidroxinaftaleno-2,7-dissulfonato de dissódioFI: dinatrium-4-amino-3-[[4`-[(2,4-diaminofenyyli)atso][1,1`-bifenyyli]-4-yyli]atso]-5-hydroksi-6-(fenyyliatso)naftaleeni-2,7-disulfonaatti; C.I. Direct Black 38SV: dinatrium-4-amino-3-[[4`-(2,4-diaminofenyl)azo][1,1`-bifenyl]-4-yl]azo]-5-hydroxy-6-(fenylazo)naftalen-2,7-disulfonat; C.I. Direct Black 38Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45 Repr. Cat. 3; R 63 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-63S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2602-46-2EEC No 220-012-1No 611-026-00-2>REFERENCE TO A GRAPHIC>ES: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis[5-amino-4-hidroxinaftaleno-2,7-disulfonato] de tetrasodioDA: tetranatrium-3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaphthalen-2,7-disulfonat] DE: Tetranatrium-3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaphthalin-2,7-disulfonat]; C.I. Direct Blue 6EL: 3,3`-[[1,1`-äéöáéíõëï]-4,4`-äéõëïäéò(áæù)]äéò[5-áìéíï-4-õäñïîõíáöèáëåíï-2,7-äéóïõëöïíéêü] ôåôñáíÜôñéïEN: tetrasodium 3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6FR: 3,3`-[[1,1`-biphényl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaphtalène-2,7-disulfonate] de tétrasodium; C.I. Direct Blue 6IT: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis[5-amino-4-idrossinaftalen-2,7-disolfonato] di tetrasodio; C.I. Direct Blue 6NL: tetranatrium-3,3`-[[1,1`-bifenyl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaftaleen-2,7-disulfonaat] PT: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis[5-amino-4-hidroxinaftaleno-2,7-dissulfonato] de tetrassódioFI: tetranatrium-3,3`-[[1,1`-bifenyyli]-4,4`-diyylibis(atso)]bis[5-amino-4-hydroksinaftaleeni-2,7-disulfonaatti]; C.I. Direct Blue 6SV: tetranatrium-3,3`-[[1,1`-bifenyl]-4,4`-diylbis(azo)]bis[5-amino-4-hydroxynaftalen-2,7-disulfonat]; C.I. Direct Blue 6Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Repr. Cat. 3; R 63 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-63S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 573-58-0EEC No 209-358-4No 611-027-00-8>REFERENCE TO A GRAPHIC>ES: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis(4-aminonaftaleno-1-sulfonato) de disodioDA: dinatrium-3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis(4-aminonaphthalen-1-sulfonat)DE: Dinatrium-3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis(4-aminonaphthalin-1-sulfonat); C.I. Direct Red 28 EL: 3,3`-[[1,1`-äéöáéíõëï]-4,4`-äéõëïäéò(áæù)]äéò(4-áìéíïíáöèáëåíï-1-óïõëöïíéêü) äéíÜôñéïEN: disodium 3,3`-[[1,1`-biphenyl]-4,4`-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28FR: 3,3`-[[1,1`-biphényl]-4,4`-diylbis(azo)]bis(4-aminonaphtalène-1-sulfonate) de disodium; C.I. Direct Red 28IT: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis(4-aminonaftalen-1-solfonato) di disodio; C.I. Direct Red 28NL: dinatrium-3,3`-[[1,1`-bifenyl]-4,4`-diylbis(azo)]bis(4-aminonaftaleen-1-sulfonaat)PT: 3,3`-[[1,1`-bifenil]-4,4`-diilbis(azo)]bis(4-aminonaftaleno-1-sulfonato) de dissódioFI: dinatrium-3,3`-[[1,1`-bifenyyli]-4,4`-diyylibis(atso)]bis(4-aminonaftaleeni-1-sulfonaatti); C.I. Direct Red 28SV: dinatrium-3,3`-[[1,1`-bifenyl]-4,4`-diylbis(azo)]bis(4-aminonaftalen-1-sulfonat); C.I. Direct Red 28Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45Repr. Cat. 3; R 63 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:45-63S:53-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 74-89-5 [1] 124-40-3 [2] 75-50-3 [3]EEC No 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] No 612-001-01-6NOTA BCH3NH2....% [1](CH3)2NH....% [2](CH3)3N....% [3]ES: metilamina (mono-[1], di-[2] y tri-[3])....%DA: methylamin (mono-[1], di-[2] og tri-[3])....%DE: Methylamin (mono-[1], di-[2] und tri-[3])....%EL: ìåèõëáìßíç (ìïíï-[1], äé-[2] êáé ôñé-[3])....%EN: methylamine (mono-[1], di-[2] and tri-[3])....%FR: méthylamine (mono-[1], di-[2] et tri-[3])....%IT: metilamina (mono-[1], di-[2] e tri-[3])....%NL: methylamine (mono-[1], di-[2] en tri-[3])....%PT: metilamina (mono-[1], di-[2] e tri-[3])....%FI: metyyliamiini (mono-[1], di-[2] ja tri-[3])....%SV: metylamin (mono-[1], di-[2] och tri-[3])....%Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF+; R 12Xn; R 20/22C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF+>REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:12-20/22-34S:(1/2-)3-16-26-29-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 15%C; R 20/22-3410% <= C < 15%C; R 345% <= C < 10%Xi; R 36/37/38Cas No 74070-46-5EEC No 277-704-1No 612-120-00-6>REFERENCE TO A GRAPHIC>ES: 2-cloro-3-fenoxi-6-nitro-anilinaDA: 2-chlor-6-nitro-3-phenoxyanilinDE: 2-Chlor-6-nitro-3-phenoxyanilinEL: 2-÷ëùñï-6-íéôñï-3-öáéíïîõáíéëßíçEN: 2-chloro-6-nitro-3-phenoxyanilineFR: 2-chloro-6-nitro-3-phénoxyaniline; aclonifène (ISO)IT: 2-cloro-3-fenossi-6-nitro-anilinaNL: 2-chloor-3-fenoxy-6-nitro-anilinePT: 2-cloro-3-fenoxi-6-nitro-anilinaFI: 2-kloori-6-nitro-fenoksianiliini; aklonifeeniSV: 2-klor-6-nitro-3-fenoxianilin; aklonifen (ISO)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringN; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningN >REFERENCE TO A GRAPHIC>R:50/53S:60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 68131-73-7EEC No 268-626-9No 612-121-00-1ES: aminas, polietilenpoli-; HEPADA: aminer, polyethylenpoly-; HEPADE: Amine, Polyethylenpoly-; HEPAEL: áìßíåò, ðïëõáéèõëåíïðïëõ- . HEPAEN: Amines, polyethylenepoly-; HEPAFR: amines, polyéthylènepoly-; HEPAIT: amine, polietilenpoli-; HEPANL: aminen, polyethyleenpoly-; HEPAPT: aminas, polietilenopoli-; HEPAFI: amiinit, polyetyleenipoly-: HEPASV: aminer, polyetylenpoly-: HEPAClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 21/22C; R 34R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningC >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:21/22-34-43-50/53S:(1/2-)26-36/37/39-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 21/22-34-4310% <= C < 25%C; R 34-435% <= C < 10%Xi; R 36/38-431% <= C < 5%Xi;R 43Cas No 7803-49-8EEC No 232-259-2No 612-122-00-7NH2OHES: hidroxilaminaDA: hydroxylaminDE: HydroxylaminEL: õäñïîõëáìßíçEN: hydroxylamineFR: hydroxylamineIT: idrossilaminaNL: hydroxylaminePT: hidroxilaminaFI: hydroksyyliamiiniSV: hydroxylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 5Xn; R 22-48/22Xi; R 37/38-41R 43N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:5-22-37/38-41-43-48/22-50S:(2-)22-26-36/37/39-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 5470-11-1 [1]  10039-54-0 [2]  10046-00-1 [3] EEC No 226-798-2 [1]  233-118-8 [2]  233-154-4 [3] No 612-123-00-2[NH2OH] . HCl [1][NH2OH]2 . H2SO4 [2][NH2OH] . H2SO4 [3]ES: cloruro de hidroxilamonio [1]; sulfato de bis(hidroxilamonio)[2]; hidrogenosulfato de hidroxilamonio [3]DA: hydroxylammoniumchlorid [1]; bis(hydroxylammonium)sulfat [2]; hydroxylammoniumhydrogen-sulfat [3]DE: Hydroxylammoniumchlorid [1]; Bis(hydroxylammonium)sulfat [2]; Hydroxylammoniumhydrogensulfat [3]EL: ÷ëùñßäéï ôïõ õäñïîõëáììùíßïõ [1] . èåééêü äéò(õäñïîõëáììþíéï) [2] . õäñïãïíïèåééêü õäñïîõëáììþíéï [3]EN: hydroxylammonium chloride [1]; bis(hydroxylammonium) sulphate [2]; hydroxylammonium hydrogensulphate [3]; hydroxylamine hydrochloride [1]; hydroxylamine sulphate (2:1)[2]; hydroxylamine sulphate (1:1)[3]FR: chlorure d`hydroxylammonium [1]; sulfate de bis(hydroxylammonium)[2]; hydrogénosulfate d`hydroxylammonium [3]IT: cloruro di idrossilammonio [1]; solfato di bis(idrossilammonio)[2]; idrogenosolfato di idrossilammonio [3]NL: hydroxylammoniumchloride [1]; bis(hydroxylammonium)sulfaat [2]; hydroxylammoniumhydrogeensulfaat [3]PT: cloreto de hidroxilamónio [1]; sulfato de bis(hidroxilamónio)[2]; hidrogénossulfato de hidroxilamónio [3]FI: hydroksyyliammoniumkloridi [1]; bishydroksyyliammoniumsulfaatti [2]; hydroksyyliammoniumvetysulfaatti [3]SV: hydroxylammoniumklorid [1]; hydroxylammoniumsulfat [2]; hydroxylammonium vätesulfat [3]Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22-48/22Xi; R 36/38R 43N; R 50Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-36/38-43-48/22-50S:(2-)22-24-37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 138-24-9EEC No 205-319-0No 612-124-00-8>REFERENCE TO A GRAPHIC>ES: cloruro de N,N,N-trimetilanilinioDA: N,N,N-trimethylaniliniumchloridDE: N,N,N-TrimethylaniliniumchloridEL: ÷ëùñßäéï ôïõ N,N,N-ôñéìåèõëáíéëéíßïõEN: N,N,N-trimethylanilinium chlorideFR: chlorure de N,N,N-triméthylaniliniumIT: cloruro di N,N,N-trimetilanilinioNL: N,N,N-trimethylaniliniumchloridePT: cloreto de N,N,N-trimetilanilínioFI: N,N,N-trimetyylianiliniumkloridiSV: N,N,N-trimetylfenylammoniumkloridClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 24/25 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:24/25S:(1/2-)25-39-45-53Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 95-70-5EEC No 202-442-1No 612-125-00-3>REFERENCE TO A GRAPHIC>ES: 2-metil- p-fenilendiaminaDA: 2-methyl- p-phenylendiaminDE: 2-Methyl- p-phenylendiamin; Toluylen-2,5-diaminEL: 2-ìåèõëï-ð-öáéíõëåíïäéáìßíçEN: 2-methyl- p-phenylenediamineFR: 2-méthyl- p-phénylènediamine; toluène-2,5-diamineIT: 2-metil- p-fenilendiamina; 2,5-diaminotolueneNL: 2-methyl- p-fenyleendiaminePT: 2-metil- p-fenilenodiaminaFI: 2-metyyli- p-fenyleenidiamiiniSV: 2-metyl- p-fenylendiamin; 2-metyl-1,4-benzendiaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 25Xn; R 20/21R 43N; R 50-53Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20/21-25-43-50/53S:(1/2-)24-37-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 65321-67-7EEC No 265-697-8No 612-126-00-9NOTA E>REFERENCE TO A GRAPHIC>ES: sulfato de tolueno-2,4-diamonioDA: toluen-2,4-diammoniumsulfatDE: Toluol-2,4-diammoniumsulfat; Toluylen-2,4-diaminsulfatEL: èåééêü ôïëïõåíï-2-4-äéáììþíéïEN: toluene-2,4-diammonium sulphate; 4-methyl- m-phenylenediamine sulfateFR: sulfate de toluène-2,4-diammoniumIT: solfato di toluen-2,4-diammonio; 4-metil- m-fenilendiamina solfatoNL: tolueen-2,4-diammoniumsulfaatPT: sulfato de tolueno-2,4-diamónioFI: tolueeni-2,4-diammoniumsulfaatti; 4-metyyli-m-fenyleenidiamiinisulfaattiSV: toluen-2,2-diammoniumsulfatClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringCarc. Cat. 2; R 45T; R 25Xn; R 21Xi; R 36R 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:45-21-25-36-43-50/53S:53-45-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 591-27-5EEC No 209-711-2No 612-127-00-4>REFERENCE TO A GRAPHIC>ES: 3-aminofenolDA: 3-aminophenolDE: 3-AminophenolEL: 3-áìéíïöáéíüëçEN: 3-aminophenolFR: 3-aminophénolIT: 3-aminofenoloNL: 3-aminofenolPT: 3-aminofenolFI: 3-aminofenoliSV: 3-aminofenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 20/22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20/22-51/53S:(2-)28-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 123-30-8EEC No 204-616-2No 612-128-00-X>REFERENCE TO A GRAPHIC>ES: 4-aminofenolDA: 4-aminophenolDE: 4-AminophenolEL: 4-áìéíïöáéíüëçEN: 4-aminophenolFR: 4-aminophénolIT: 4-aminofenoloNL: 4-aminofenolPT: 4-aminofenolFI: 4-aminofenoliSV: 4-aminofenolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringMuta. Cat. 3; R 40Xn; R 20/22N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:20/22-40-50/53S:(2-)28-36/37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 108-18-9EEC No 203-558-5No 612-129-00-5>REFERENCE TO A GRAPHIC>ES: diisopropilaminaDA: diisopropylaminDE: DiisopropylaminEL: äééóïðñïðõëáìßíçEN: diisopropylamineFR: diisopropylamineIT: diisopropilaminaNL: diisopropylaminePT: diisopropilaminaFI: diisopropyyliamiiniSV: diisopropylaminClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringF; R 11Xn; R 20/22C; R 34 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningF >REFERENCE TO A GRAPHIC>C >REFERENCE TO A GRAPHIC>R:11-20/22-34S:(1/2-)16-26-36/37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserC >= 25%C; R 20/22-3410% <= C < 25%C; R 345% <= C < 10%Xi; R 36/37/38Cas No 149-30-4EEC No 205-736-8No 613-108-00-3>REFERENCE TO A GRAPHIC>ES: benzotiazol-2-tiolDA: benzothiazol-2-thiolDE: Benzothiazol-2-thiol; 2-MercaptobenzothiazolEL: âåíæïèåéáæïë-2-èåéüëçEN: benzothiazole-2-thiolFR: benzothiazole-2-thiol; mercaptobenzothiazoleIT: benzotiazol-2-tiolo; mercaptobenzotiazoloNL: benzothiazool-2-thiolPT: benzotiazole-2-tiolFI: bentsotiatsoli-2-tioliSV: benzotiazol-2-tiolClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 43N; R 50-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:43-50/53S:(2-)24-37-60-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 94-37-1EEC No 202-328-1No 613-109-00-9>REFERENCE TO A GRAPHIC>ES: disulfuro de bis(piperidinotiocarbonilo)DA: bis(piperidinothiocarbonyl)disulfidDE: Bis(piperidinothiocarbonyl)disulfidEL: äéóïõëößäéï ôïõ äéò(ðéðåñéäéíïèåéïêáñâïíõëßïõ)EN: bis(piperidinothiocarbonyl) disulphideFR: disulfure de bis(pipéridinothiocarbonyle)IT: disolfuro di bis(piperidinotiocarbonile)NL: bis(piperidinothiocarbonyl)disulfidePT: dissulfureto de bis(piperidinotiocarbonilo)FI: bis(piperidiinotiokarbonyyli)disulfidiSV: bis(piperidintiokarbonyl)disulfidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>R:36/37/38-43S:(2-)24-26-37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 61432-55-1EEC No 262-784-2No 613-110-00-4>REFERENCE TO A GRAPHIC>ES: piperidina-1-carbotioato de S-(1-fenil-1-metiletilo)DA: S-(1-methyl-1-phenylethyl)piperidin-1-carbothioatDE: S-(1-Methyl-1-phenylethyl)piperidin-1-carbothioatEL: ðéðåñéäéíï-1-êáñâïèåéïúêü S-(1-ìåèõëï-1-öáéíõëáéèýëéï)EN: S-(1-methyl-1-phenylethyl) piperidine-1-carbothioateFR: pipéridine-1-carbothioate de S-(1-méthyl-1-phényléthyle); dimépipérateIT: piperidin-1-carbotioato di S-(1-fenil-1-metiletile)NL: S-(1-fenyl-1-methylethyl)piperidine-1-carbothioaatPT: piperidina-1-carbotioato de S-(1-fenil-1-metiletilo)FI: S-(1-metyyli-1-fenyylietyyli)piperidiini-1-karbotioaatti; dimepiperaattiSV: S-(1-metyl-1-fenyletyl)piperidin-1-karbotioat; dimepiperat (ISO)Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXn; R 22N; R 51-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:22-51/53S:(2-)61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 538-75-0EEC No 208-704-1No 615-019-00-5>REFERENCE TO A GRAPHIC>ES: diciclohexilcarbodiimidaDA: dicyclohexylcarbodiimidDE: DicyclohexylcarbodiimidEL: äéêõêëïåîõëïêáñâïäééìßäéïEN: dicyclohexylcarbodiimideFR: dicyclohexylcarbodiimideIT: dicicloesilcarbodiimideNL: dicyclohexylcarbodiimidePT: diciclohexilcarbodiimidaFI: disykloheksyylikarbodi-imidiSV: dicyklohexylkarbodiimidClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringT; R 24Xn; R 22Xi; R 41R 43 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:22-24-41-43S:(1/2-)24-26-37/39-45Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 6317-18-6EEC No 228-652-3No 615-020-00-0NC-S-CH2-S-CNES: ditiocianato de metilenoDA: methylendithiocyanatDE: MethylendithiocyanatEL: äéèåéïêõáíéêü ìåèõëÝíéïEN: methylene dithiocyanateFR: dithiocyanate de méthylèneIT: ditiocianato di metilene; metilene ditiociantoNL: methyleendithiocyanaatPT: ditiocianato de metilenoFI: metyleeniditiosyanaattiSV: metylenditiocyanat; ditiocyanatometanClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 43N; R 50 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXi >REFERENCE TO A GRAPHIC>N >REFERENCE TO A GRAPHIC>R:43-50S:(2-)24-37-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 2451-62-9EEC No 219-514-3No 615-021-00-6NOTA E>REFERENCE TO A GRAPHIC>ES: 1,3,5-tris(oxiranilmetil)-1,3,5-triazina-2,4,6(1 H,3 H,5 H)-triona; TGICDA: 1,3,5-tris(oxiranylmethyl)-1,3,5-triazin-2,4,6(1 H,3 H,5 H)-trion; TGICDE: 1,3,5-Tris(oxiranylmethyl)-1,3,5-triazin-2,4,6(1 H,3 H,5 H)-trion; TGICEL: 1,3,5-ôñéò(ïæéñáíõëïìåèõëï)-1,3,5-ôñéáæéíï-2,4,6(1 H,3 H,5 H)-ôñéüíç . TGICEN: 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1 H,3 H,5 H)-trione; TGICFR: 1,3,5-tris(oxirannylméthyl)-1,3,5-triazine-2,4,6(1 H,3 H,5 H)-trione; TGICIT: 1,3,5-tris(ossiranilmetil)-1,3,5-triazin-2,4,6(1 H,3 H,5 H)-trione; TGICNL: 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1 H,3 H,5 H)-trion; TGICPT: 1,3,5-tris(oxiranilmetil)-1,3,5-triazina-2,4,6(1 H,3 H,5 H)-triona; TGICFI: 1,3,5-tris(oksiranyylimetyyli)-1,3,5-triatsiini-2,4,6(1 H,3 H,5 H)-trioni; TGICSV: triglycidylisocyanurat; TGICClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringMuta. Cat. 2; R 46T; R 23/25Xn; R 48/22Xi; R 41R 43R 52-53 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningT >REFERENCE TO A GRAPHIC>R:46-23/25-41-43-48/22-52/53S:53-45-61Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-22-3EEC No 232-589-7No 647-001-00-8ES: glucosidasa, â-DA: glucosidase, â-DE: Glucosidase, â-EL: ãëõêïæéäÜóç, â-EN: Glucosidase, â-FR: glucosidase, â-IT: glucosidasi, â-NL: glucosidase, â-PT: glucosidase, â-FI: glukosidaasi, â-SV: glukosidas, â-Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9012-54-8EEC No 232-734-4No 647-002-00-3ES: celulasaDA: cellulaseDE: CellulaseEL: êõôôáñéíÜóçEN: CellulaseFR: cellulaseIT: cellulasiNL: cellulasePT: celulaseFI: sellulaasiSV: cellulasClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 37329-65-0EEC No 253-465-9No 647-003-00-9ES: celobiohidrolasa, exo-DA: cellobiohydrolase, exo-DE: Cellobiohydrolase, Exo-EL: êåëëïâéïûäñïëÜóç, åîù-EN: Cellobiohydrolase, exo-FR: cellobiohydrolase, exo-IT: cellobioidrolasi, eso-NL: cellobiohydrolase, exo-PT: celobiohidrolase, exo-FI: sellobiohydrolaasi, ekso-SV: cellobiohydralas, exo-Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, Klassificering R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 647-004-00-4ES: celulasa excepto aquellos específicamente expresados en este AnexoDA: cellulaser undtagen sådanne nævnt andetsteds i dette bilagDE: Cellulasen mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: êõôôáñéíÜóåò åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: cellulases with the exception of those specified elsewhere in this AnnexFR: cellulases à l`exception de celles nommément désignées dans cette annexeIT: cellulasi escluse quelle espressamente indicate in questo allegatoNL: cellulase met uitzondering van de in deze bijlage met name genoemdePT: celulase com excepção dos expressamente referidos no presente anexoFI: sellulaasit paitsi muualla tässä liitteessä mainitutSV: cellulaser med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, Klassificering R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-00-7EEC No 232-572-4No 647-005-00-XES: bromelaína, jugoDA: bromelain, saftDE: Bromelain, Fruchtsaft-EL: âñïìåëáÀíçò, ÷õìüòEN: Bromelain, juiceFR: broméline, jusIT: bromelina, succoNL: bromelia, sapPT: bromelaína, sucoFI: bromelaiini, mehuSV: bromelain, saftClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-33-6EEC No 232-599-1No 647-006-00-5ES: ficinaDA: ficinDE: FicinEL: öéóßíçEN: FicinFR: ficineIT: ficinaNL: ficinePT: ficinaFI: fisiiniSV: ficinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-73-4EEC No 232-627-2No 647-007-00-0ES: papaínaDA: papainDE: PapainEL: ðáðáÀíçEN: PapainFR: papaïneIT: papainaNL: papaïnePT: papaínaFI: papaiiniSV: papainClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-75-6EEC No 232-629-3No 647-008-00-6ES: pepsina ADA: pepsin ADE: Pepsin AEL: ðåøßíç ÁEN: Pepsin AFR: pepsine AIT: pepsina ANL: pepsine APT: pepsina AFI: pepsiini ASV: pepsin AClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9001-98-3EEC No 232-645-0No 647-009-00-1ES: reninaDA: renninDE: RenninEL: ñåííßíçEN: RenninFR: rennineIT: renninaNL: renninePT: reninaFI: renniiniSV: renninClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9002-07-7EEC No 232-650-8No 647-010-00-7ES: tripsinaDA: trypsinDE: TrypsinEL: èñõøßíçEN: TrypsinFR: trypsineIT: tripsinaNL: trypsinePT: tripsinaFI: trypsiiniSV: trypsinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9004-07-3EEC No 232-671-2No 647-011-00-2ES: quimotripsinaDA: chymotrypsinDE: ChymotrypsinEL: ÷õìïèñõøßíçEN: ChymotrypsinFR: chymotrypsineIT: chimotripsinaNL: chymotrypsinePT: quimotripsinaFI: kymotrypsiiniSV: chymotrypsinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9014-01-1EEC No 232-752-2No 647-012-00-8ES: subtilisinaDA: subtilisinDE: SubtilisinEL: óïõðôéëéóßíçEN: SubtilisinFR: subtilisineIT: subtilisinaNL: subtilisinePT: subtilisinaFI: subtilisiiniSV: subtilisinClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 37/38-41R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:37/38-41-42S:(2-)22-24-26-36/37/39Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9068-59-1EEC No 232-966-6No 647-013-00-3ES: proteinasa, microbiana neutraDA: proteinase, mikrobiel neutral-DE: Proteinase, mikrobenneutralEL: ðñùôåúíÜóç, ìéêñïâéáêÞ ïõäÝôåñçEN: Proteinase, microbial neutralFR: protéinase neutre microbienneIT: proteinasi, microbica neutraNL: proteïnase, microbieel neutraalPT: proteinase, neutra microbianaFI: proteinaasi, neutraali mikrobiperäinenSV: proteas, neutralt mikrobielltClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 647-014-00-9ES: protease excepto aquellos específicamente expresados en este AnexoDA: proteaser undtagen sådanne nævnt andetsteds i dette bilagDE: Proteasen mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: ðñùôåÜóåò åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: proteases with the exception of those specified elsewhere in this AnnexFR: protéases à l`exception de celles nommément désignées dans cette annexeIT: proteasi escluse quelle espressamente indicate in questo allegatoNL: protease met uitzondering van de in deze bijlage met name genoemdePT: protease com excepção dos expressamente referidos no presente anexoFI: proteaasit paitsi muualla tässä liitteessä mainitutSV: proteaser med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringXi; R 36/37/38R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:36/37/38-42S:(2-)22-24-26-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No 9000-90-2EEC No 232-565-6No 647-015-00-4ES: amilasa, á-DA: amylase, á-DE: Amylase, á-EL: áìõëÜóç, á-EN: Amylase, á-FR: amylase, á-IT: amilasi, á-NL: amylase, á-PT: amilase, á-FI: amylaasi, á-SV: amylas, á-Clasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, KlassificeringR 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserCas No -EEC No -No 647-016-00-XES: amilasa excepto aquellos específicamente expresados en este AnexoDA: amylaser undtagen sådanne nævnt andetsteds i dette bilagDE: Amylasen mit Ausnahme der namentlich in diesem Anhang bezeichnetenEL: áìõëÜóåò åêôüò åêåßíùí ðïõ êáôïíïìÜæïíôáé óå Üëëï óçìåßï áõôïý ôïõ ðáñáñôÞìáôïòEN: amylases with the exception of those specified elsewhere in this AnnexFR: amylases à l`exception de celles nommément désignées dans cette annexeIT: amilasi escluse quelle espressamente indicate in questo allegatoNL: amylase met uitzondering van de in deze bijlage met name genoemdePT: amilase com excepção dos expressamente referidos no presente anexoFI: amylaasit paitsi muualla tässä liitteessä mainitutSV: amylaser med undantag för de föreningar som är upptagna på annat ställe i bilaganClasificación, Klassificering, Einstufung, Ôáîéíüìçóç, Classification, Classification, Classificazione, Indeling, Classificação, Luokitus, Klassificering R 42 Etiquetado, Etikettering, Kennzeichnung, ÅðéóÞìáíóç, Labelling, Étiquetage, Etichettatura, Kenmerken, Rotulagem, Merkinnät, MärkningXn >REFERENCE TO A GRAPHIC>R:42S:(2-)22-24-36/37Límites de concentración, Koncentrationsgrænser, Konzentrationsgrenzwerte, ¼ñéá óõãêÝíôñùóçò, Concentration limits, Limites de concentration, Limiti di concentrazione, Concentratiegrenzen, Limites de concentração, Pitoisuusrajat, KoncentrationsgränserANEXO III - BILAG III - ANHANG III - ÐÁÑÁÑÔÇÌÁ ÉÉÉ - ANNEX III - ANNEXE III - ALLEGATO III - BIJLAGE III - ANEXO III - LIITE III - BILAGA III Index No 649-261-00-8649-262-00-3649-263-00-9649-264-00-4649-265-00-X649-266-00-5649-267-00-0649-268-00-6649-269-00-1649-270-00-7649-271-00-2649-272-00-8649-273-00-3649-274-00-9649-275-00-4649-276-00-X649-277-00-5649-278-00-0649-279-00-6649-280-00-1649-281-00-7649-282-00-2649-283-00-8649-284-00-3649-285-00-9649-286-00-4649-287-00-X649-288-00-5649-289-00-0649-290-00-6649-291-00-1649-292-00-7649-293-00-2649-294-00-8649-295-00-3649-296-00-9649-297-00-4649-298-00-X649-299-00-5649-300-00-9649-301-00-4649-302-00-X649-303-00-5649-304-00-0649-305-00-6649-306-00-1649-307-00-7649-308-00-2649-309-00-8649-310-00-3649-311-00-9649-312-00-4649-313-00-X649-314-00-5649-316-00-6649-317-00-1649-318-00-7649-319-00-2649-320-00-8649-321-00-3649-322-00-9649-323-00-4649-324-00-X649-325-00-5649-326-00-0649-327-00-6649-328-00-1649-329-00-7649-330-00-2649-331-00-8649-332-00-3649-333-00-9649-334-00-4649-335-00-X649-336-00-5649-337-00-0649-338-00-6649-339-00-1649-340-00-7649-341-00-2649-342-00-8649-343-00-3649-344-00-9649-345-00-4649-346-00-X649-347-00-5649-348-00-0649-349-00-6649-350-00-1649-351-00-7649-352-00-2649-353-00-8649-354-00-3649-355-00-9649-356-00-4649-357-00-X649-358-00-5649-359-00-0649-360-00-6649-361-00-1649-362-00-7649-363-00-2649-364-00-8649-365-00-3649-366-00-9649-367-00-4649-368-00-X649-369-00-5649-370-00-0649-371-00-6649-372-00-1649-373-00-7649-374-00-2649-375-00-8649-376-00-3649-377-00-9649-378-00-4649-379-00-X649-380-00-5649-381-00-0649-382-00-6649-383-00-1649-384-00-7649-385-00-2649-386-00-8649-387-00-3649-388-00-9649-389-00-4649-390-00-X649-391-00-5649-392-00-0649-393-00-6649-394-00-1649-395-00-7649-396-00-2649-397-00-8649-398-00-3649-399-00-9649-400-00-2649-401-00-8649-402-00-3649-403-00-9649-404-00-4649-405-00-X649-406-00-5649-407-00-0649-408-00-6649-409-00-1649-410-00-7649-411-00-2649-412-00-8649-413-00-3649-414-00-9649-415-00-4649-416-00-X649-417-00-5649-418-00-0649-419-00-6649-420-00-1649-421-00-7649-422-00-2649-423-00-8649-424-00-3649-425-00-9649-426-00-4649-427-00-X649-428-00-5649-429-00-0649-430-00-6649-431-00-1649-432-00-7649-433-00-2649-434-00-8ANNEX IV A 'PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTSGENERAL INTRODUCTION: PART BA. EXPLANATORY NOTEFor the purposes of the General Introduction, the following numbering applies:B.15. Gene mutation-Saccharomyces cerevisiaeB.16. Mitotic recombination-Saccharomyces cerevisiaeB.17. In vitro mammalian cell gene mutation testB.18. DNA damage and repair-unscheduled DNA synthesis-mammalian cells in vitroB.19. Sister chromatid exchange assay in vitroB.20. Sex-linked recessive lethal test in Drosophila melanogasterB.21. In vitro mammalian cell transformation testsB.22. Rodent dominant lethal testB.23. In vivo mammalian germ-cell cytogeneticsB.24. Mouse spot testB.25. Mouse heritable translocationB.26. Sub-chronic oral toxicity test: 90-day repeated oral dose using rodent speciesB.27. Sub-chronic oral toxicity test: 90-day repeated oral dose using non-rodent speciesB.28. Sub-chronic dermal toxicity study: 90-day repeated dermal dose study using rodent speciesB.29. Sub-chronic inhalation toxicity study: 90-day repeated inhalation dose study using rodent speciesB.30. Chronic toxicity testB.31. Teratogenicity test - rodent and non-rodentB.32. Carcinogenicity testB.33. Combined chronic toxicity/carcinogenicity testB.34. One-generation reproduction toxicity testB.35. Two-generation reproduction toxicity testB.36. ToxicokineticsB. GENERAL DEFINITIONS FOR TERMS USED IN THE TEST METHODS IN THIS ANNEX(i) Acute toxicity comprises the adverse effects occurring within a given time (usually 14 days), after administration of a single dose of a substance.(ii) Evident toxicity is a general term describing clear signs of toxicity following administration of test substance. These should be sufficient for hazard assessment and should be such that an increase in the dose administered can be expected to result in the development of severe toxic signs and probable mortality.(iii) Dose is the amount of test substance administered. Dose is expressed as weight (grams or milligrams) or as weight of test substance per unit weight of test animal (e.g. milligrams per kilogram body weight), or as constant dietary concentrations (parts per million or milligrams per kilogram of food).(iv) Discriminating dose is the highest out of the four fixed dose levels which can be administered without causing compound-related mortality (including humane kills).(v) Dosage is a general term comprising of dose, its frequency and the duration of the dosing.(vi) LD50 (median lethal dose) is a statistically derived single dose of a substance that can be expected to cause death in 50 % of dosed animals. The LD50 value is expressed in terms of weight of test substance per unit weight of test animal (milligrams per kilogram).(vii) LC50 (median lethal concentration) is a statistically derived concentration of a substance that can be expected to cause death during exposure or within a fixed time after exposure in 50 % of animals exposed for a specified time.The LC50 value is expressed as weight of test substance per standard volume of air (milligrams per litre).(viii) NOAEL is the abbreviation for no observed adverse effect level and is the highest dose or exposure level where no adverse treatment-related findings are observed.(ix) Repeated dose/Sub-chronic toxicity comprises the adverse effects occurring in experimental animals as a result of repeated daily dosing with, or exposure to, a chemical for a short part of their expected life-span.(x) Maximum Tolerated Dose (MTD) is the highest dose level eliciting signs of toxicity in animals without having major effects on survival relative to the test in which it is used.(xi) Skin irritation is the production of inflammatory changes in the skin following the application of a test substance.(xii) Eye irritation is the production of changes in the eye following the application of a test substance to the anterior surface of the eye.(xiii) Skin sensitisation (allergic contact dermatitis) is an immunologically mediated cutaneous reaction to a substance.(xiv) Dermal corrosion is the production of irreversible tissue damage in the skin following the application of a test substance for the duration period of 3 minutes up to 4 hours.(xv) Toxicokinetics is the study of the absorption, distribution, metabolism and excretion of test substances.(xvi) Absorption is the process(es) by which an administered substance enters the body.(xvii) Excretion is the process(es) by which the administered substance and/or its metabolites are removed from the body.(xviii) Distribution is the process(es) by which the absorbed substance and/or its metabolites partition within the body.(xvv) Metabolism is the process(es) by which the administered substances are structurally changed in the body by either enzymatic or non enzymatic reactions.B.I Acute - repeated dose / subchronic and chronic toxicityThe acute toxic effects and organ or system toxicity of a substance may be evaluated using a variety of toxicity tests (Methods B.1-B.5) from which, following a single dose, a preliminary indication of toxicity may be obtained.Dependent on the toxicity of the substance, a limit test approach to a full LD50 may be considered, although no limit test is specified in inhalation studies, because it has not been possible to define a single inhalation exposure limit value.Consideration should be given to methods which use as few animals as possible and minimise animal suffering, for example the fixed dose method (Method B.1 bis) and acute toxic class (Method B.1 tris). In level 1 testing, a study in a second species may complement the conclusions drawn from the first study. In this case, a standard test method may be used or the method may be adapted for a smaller number of animals.The repeated dose toxicity test (Methods B.7, B.8 and B.9) includes assessment of toxic effects arising from repeated exposure. The need for careful clinical observations of the animals is stressed, so as to obtain as much information as possible. These tests should help to identify the target organs of toxicity and the toxic and non-toxic doses. Further in-depth investigation of these aspects may be required in long term studies (Methods B.26 - B.30 and B.33).B.II Mutagenicity - GenotoxicityMutagenicity refers to the induction of permanent transmissible changes in the amount or structure of the genetic material of cells or organisms. These changes, "mutations", may involve a single gene or gene segments, a block of genes, or whole chromosomes. Effects on whole chromosomes may be structural and/or numerical.The mutagenic activity of a substance is assessed by in vitro assays for gene (point) mutations in bacteria (Method B.13/14) and/or for structural chromosome aberrations in mammalian cells, (Method B.10).Acceptable are also in vivo procedures, e.g. the micronucleus test (Method B.12) or the metaphase analysis of bone marrow cells, (Method B.11). However, in the absence of any contraindication the in vitro methods are strongly preferred.Additional studies to investigate mutagenicity further or to pre-screen for carcinogenicity may be required for higher production volumes and/or to conduct or follow-up a risk assessment, and these can be used for a number of purposes: to confirm results obtained in the base set; to investigate end-points not studied in the base set; to initiate or extend in vivo studies.For these purposes, methods B.15 to B.25 include both in vivo and in vitro eukaryotic systems and an extended range of biological end-points. These tests provide information on point mutations and other end-points in organisms more complex than the bacteria used for the base set.As a general principle, when a programme of further mutagenicity studies is considered, it should be designed so as to provide relevant additional information on the mutagenic and/or carcinogenic potential of that substance.The actual studies which may be appropriate in a specific instance will depend on numerous factors, including the chemical and physical characteristics of the substance, the results of the initial bacterial and cytogenetic assays, the metabolic profile of the substance, the results of other toxicity studies, and the known uses of the substance. A rigid schedule for selection of tests is therefore inappropriate in view of the variety of factors which may require consideration.Some general principles for the testing strategy are laid down by Dir. 93/67/EEC, but clear testing strategies may be found in the technical guidance document for Risk Assessment, which nevertheless is flexible and can be adapted as appropriate to specific circumstances.Methods for further investigation are however grouped below, on the basis of their principal genetic end-point:Studies to investigate gene (point) mutations(a) Forward or reverse mutation studies using eukaryotic micro-organisms (Saccharomyces cerevisiae) (Method B.15)(b) In vitro studies to investigate forward mutation in mammalian cells, (Method B.17)(c) The sex-linked recessive lethal assay in Drosophila melanogaster, (Method B.20)(d) In vivo somatic cell mutation assay, the mouse spot test, (Method B.24)Studies to investigate chromosome aberrations(a) In vivo cityogenetic studies in mammals; In vivo metaphase analysis of bone marrow cells should be considered if it has not been included in the initial assessment (Method B.11). In addition, in vivo germ cell cytogenetics may be investigated, (Method B.23)(b) In vitro citogenetic studies in mammalian cells, if this has not been included in the initial assessment, (Method B.10)(c) Dominant lethal studies in rodents, (Method B.22)(d) Mouse heritable translocation test, (Method B.25)Genotoxic effects - effects on DNAGenotoxicity, identified as potentially harmful effects on genetic material not necessarily associated with mutagenicity, may be indicated by induced damage to DNA without direct evidence of mutation. The following methods using eukaryotic micro-organisms or mammalian cells may be appropriate for such investigation:(a) Mitotic recombination in saccharomyces cerevisiae, (Methods B.16)(b) DNA damage and repair - unscheduled DNA synthesis - mammalian cells - in vitro, (Method B.18)(c) Sister chromatid exchange in mammalian cells - in vitro, (Method B.19)Alternative methods for investigating carcinogenic potentialMammalian cell-transformation assays are available which measure the ability of a substance to induce morphological and behavioural changes in cell cultures, which are thought to be associated with malignant transformation - in vivo, (Method B.21). A number of different cell types and criteria for transformation may be used.Risk assessment for heritable effects in mammalsThere are methods available to measure heritable effects in whole mammals produced by gene (point) mutations, e. g. the mouse specific locus test, to measure germ-cell mutation in the first generation, (not included in this Annex), or for chromosome aberrations, e. g. the mouse heritable translocation test, (Method B.25). Such methods may be used when estimating the possible genetic risk of a substance to man. However, in view of the complexities involved in these tests and the very large number of animals necessary, particularly for the specific locus test, a strong justification is needed before undertaking these studies.B.III CarcinogenicityChemicals may be described as genotoxic or non-genotoxic carcinogens, dependent on the presumed mechanism of action.Pre-screening information for genotoxic carcinogenic potential of a substance may be obtained from the mutagenicity/genotoxicity studies. Additional information may be obtained from the repeated dose, subchronic or chronic toxicity tests. The repeated dose toxicity test, Method B.7 and longer repeated dose studies include assessment on histopathological changes observed in repeated dose toxicity tests, e. g. hyperplasia in certain tissues which could be of concern. These studies and toxicokinetic information may help to identify chemicals with carcinogenic potential, which may require further in-depth investigation of this aspect, in a carcinogenicity test (Method B.32) or often in a combined chronic toxicity/carcinogenicity study (Method B.33)B.IV Reproductive ToxicityReproductive toxicity may be detected in different ways e. g. impairment of male and female reproductive functions or capacity, identified as "effects on fertility", or induction of non-inheritable harmful effects on the progreny, identified as "development toxicity" where teratogenicity and effects during lactation are also included.For teratogenicity studies, as part of the developmental toxicity testing, the test method (Method B.31), is primarily directed to administration by the oral route. Alternatively, other routes may be used depending on the physical properties of the test substance or likely route of human exposure. In such cases, the test method should be suitably adapted taking into consideration the appropriate elements of the 28-day test methods.Where a three-generation reproduction (fertility) test is required, the described method for the two-generation reproduction test (Method B.35), can be extended to cover a third generation.B.V NeurotoxicityNeurotoxicity may be detected in different ways e. g. functional changes and/or structural and biochemical changes in the central or peripheral nervous system. A preliminary indication of neurotoxicity may be obtained from acute toxicity tests. The repeated dose toxicity test, Method B.7, includes assessment of neurotoxicological effects, and the need for careful clinical observations of the animals is stressed, so as to obtain as much information as possible. The method should help to identify chemicals with neurotoxic potential, which may require further in-depth investigation of this aspect. Additionally, it is important to consider the potential of substances to cause specific neurotoxic effects that may not be detected in other toxicity studies. For example, certain organophosphorous substances have been observed to cause delayed neurotoxicity and can be evaluated in methods B.37 and B.38, following single or repeated-dose exposure.B.VI ImmunotoxicityImmunotoxicity may be detected in different ways e. g. immunosupression and/or enhancement of the responsiveness of the immune system resulting in either hypersensitivity or induced autoimmunity. The repeated dose toxicity test, Method B.7, includes assessment of immunotoxic effects. The method should help to identify chemicals with immunotoxic potential, which may require further in-depth investigation of this aspect.B.VII ToxicokineticsToxicokinetic studies help in the interpretation and evaluation of toxicity data. These studies are intended to elucidate particular aspects of the toxicity of the chemical under test and the results may assist in the design of further toxicity studies. It is not envisaged that in every case all parameters will need to be determined. Only in rare cases will the whole sequence of toxicokinetic studies (absorption, excretion, distribution and metabolism) be necessary. For certain compounds, changes in this sequence may be advisable or a single-dose study may be sufficient (Method B.36).Information on chemical structure (SAR) and physico-chemical properties may also provide an indication of the absorption characteristics by the intended route of administration and the metabolic and tissue distribution possibilities. There may also be information on toxicokinetic parameters from preceding toxicity and toxicokinetic studies.C. CHARACTERISATION OF THE TEST SUBSTANCEThe composition of the test substance, including major impurities, and its relevant physico-chemical properties including stability, should be known prior to the initiation of any toxicity study.The physico-chemical properties of the test substance provide important information for the selection of the route of administration, the design of each particular study and the handling and storage of the test substance.The development of an analytical method for qualitative and quantitative determination of the test substance (including major impurities when possible) in the dosing medium and the biological material should precede the initiation of the study.All information relating to the identification, the physico-chemical properties, the purity, and behaviour of the test substance should be included in the test report.D. ANIMAL CAREStringent control of environmental conditions and proper animal care techniques are essential in toxicity testing.(i) Housing conditionsThe environmental conditions in the experimental animal rooms or enclosures should be appropriate to the test species. For rats, mice and guinea pigs, suitable conditions are a room temperature of 22° C ± 3° C with a relative humidity of 30 to 70 %; for rabbits the temperature should be 20 ± 3° C with a relative humidity of 30 to 70 %.Some experimental techniques are particularly sensitive to temperature effects and, in these cases, details of appropriate conditions are included in the description of the test method. In all investigations of toxic effects, the temperature and humidity should be monitored, recorded, and included in the final report of the study.Lighting should be artificial, the sequence being 12 hours light, 12 hours dark. Details of the lighting pattern should be recorded and included in the final report of the study.Unless otherwise specified in the method, animals may be housed individually, or be caged in small groups of the same sex; for group caging, no more than five animals should be housed per cage.In reports of animal experiments, it is important to indicate the type of caging used and the number of animals housed in each cage both during exposure to the chemical and any subsequent observation period.(ii) Feeding conditionsDiets should meet all the nutritional requirements of the species under test. Where test substances are administered to animals in their diet the nutritional value may be reduced by interaction between the substance and a dietary constituent. The possibility of such a reaction should be considered when interpreting the results of tests. Conventional laboratory diets may be used with an unlimited supply of drinking water. The choice of the diet may be influenced by the need to ensure a suitable admixture of a test substance when administered by this method.Dietary contaminants which are known to influence the toxicity should not be present in interfering concentrations.E. ANIMAL WELFAREWhen elaborating the test methods due consideration was given to animal welfare. Some examples are briefly given below, but this list is not exhaustive. The exact wording and/or conditions should be read in the text of the methods:- For the determination of acute oral toxicity, two alternative methods, the "Fixed Dose Procedure" and the "Acute Toxic Class method" should be considered. The "Fixed Dose Procedure" does not utilise death as specific endpoint and it uses fewer animals. The "Acute Toxic Class method" uses on average 70 % less animals than Method B.1 for Acute Oral toxicity. Both these alternative methods result in less pain and distress than the classical methodology.- The number of animals used is reduced to the scientifically acceptable minimum: only 5 animals of the same sex are tested per dose level for methods B.1 and B.3; only 10 animals (and only 5 for the negative control group) are used for the determination of the skin sensitisation by the guinea pig maximisation test (method B.6); the number of animals needed for the positive control when testing mutagenicity in vivo is also lowered (methods B.11 and B.12)- Pain and distress of animals during the tests are minimised: animals showing severe and enduring signs of distress and pain may need to be humanely killed; dosing test substances in a way known to cause marked pain and distress due to corrosive or irritating properties need not to be carried out (methods B.1, B.2 and B.3).- Testing with irrelevantly high doses is avoided by the introduction of limit tests, not only in the acute toxicity tests (methods B.1, B.2 and B.3) but also in the in vivo tests for mutagenicity (methods B.11 and B.12).- A strategy of testing for irritancy now allows the non-performance of a test, or its reduction to a single animal study, when sufficient scientific evidence can be provided.Such scientific evidence can be based on the physico-chemical properties of the substance, the results of other tests already performed, or the results of well validated in vitro tests. For example, if an acute toxicity study by the dermal route has been conducted at the limit test dose with the substance (method B.3), and no skin irritation was observed, further testing for skin irritation (method B.4) may be unnecessary; materials which have demonstrated definite corrosion or severe skin irritancy in a dermal irritation study (method B.4) should not be further tested for eye irritancy (method B.5).F. ALTERNATIVE TESTINGA scientific objective for the European Union is the development and validation of alternative techniques which can provide the same level of information as current animal tests, but which use fewer animals, cause less suffering or avoid the use of animals completely.Such methods, as they become available, must be considered wherever possible for hazard characterisation and consequent classification and labelling for intrinsic hazards.G. EVALUATION AND INTERPRETATIONWhen tests are evaluated and interpreted, limitations in the extent to which the results of animal and in vitro studies can be extrapolated directly to man must be considered and therefore, evidence of adverse effects in humans, where available, may be used for confirmation of testing results.These results, can be used for the classification and labelling of the new and the existing chemicals for human health effects, on the basis of their intrinsic properties, identified and quantified by these methods. Corresponding Annex VI criteria for classification and labelling relate also to the end-points of the testing protocols included in these testing methods.These results can also be used for risk assessment studies, for new and existing chemicals, and appropriate testing strategies for these purposes are indicated in the corresponding guidance documents.H. LITERATURE REFERENCESMost of these methods are developed within the framework of the OECD programme for Testing Guidelines, and should be performed in conformity with the principles of Good Laboratory Practice, in order to ensure as wide as possible "mutual acceptance of data".Additional information may be found in the references found in the OECD guidelines and the relevant literature published elsewhere.`ANNEX IV B 'B.1 tris ACUTE TOXICITY (ORAL) - ACUTE TOXIC CLASS METHOD1. METHOD1.1. IntroductionThe acute toxic class method provides information both for hazard assessment and for hazard classification purposes.The method uses three fixed doses, adequately separated to enable a compound to be ranked, based on the results of the study. Besides, the procedure described in this test method allows for the selection of three additional fixed doses, which could either be used as alternative options at given decision points or as option for further testing. The use of (any of the) additional doses may be considered in case a further refinement may be desirable or necessary.The method uses defined starting doses and is not intended to allow the calculation of a precise LD50, but does allow for the determination of a range of exposure where lethality is expected, since death of a proportion of the animals is still the major end-point of this test. The results of the test should allow for classification according to Annex VI criteria. Due to the sequential nature of the approach, the duration of the test could be longer than the procedure described in the B.1. The main advantage of this method is that it requires a smaller number of animals than both the acute toxicity (oral) (B.1) and the alternative Fixed Dose Method (B.1bis).See also General Introduction Part B.1.2. DefinitionsSee General Introduction Part B.1.3. Principle of the test methodThe substance is administered orally to a group of experimental animals at one of the defined doses. The substance is tested using a stepwise procedure, each step using three animals of one sex. It is not necessary to perform a preliminary sighting study. Absence or presence of substance related mortality of the animals dosed at one step will determine the next step, i.e.:- no further testing is needed- the next step will be performed with the same dose, but with animals of the other sex- the next step will be performed at the next higher or the next lower dose level1.4. Description of the test method1.4.1. PreparationsHealthy young adult animals are randomly selected, marked to permit individual identification, and kept in their cages for at least 5 days prior to the start of the test, to allow for acclimatisation to the laboratory conditions. The animals may be group-caged by sex and dose, but the number of animals per cage must not interfere with clear observations of each animal.The test substance is administered in a single dose to the animals by gavage using a stomach tube or a suitable intubation cannula.Where necessary, the test substance is dissolved or suspended in a suitable vehicle. It is recommended that, wherever possible, the use of an aqueous solution/suspension be considered first, followed by consideration of a solution/emulsion in oil (e.g. corn oil) and then by possible solution in other vehicles. For non-aqueous vehicles the toxic characteristics of the vehicle should be known, and if not known should be determined before the test.Animals should be fasted prior to dosing (e.g. overnight for the rat or 3-4 hours for the mouse); water should not be withheld.1.4.2. Test conditions1.4.2.1. Test animalsUnless there are contraindications, rat is the preferred rodent species. The females should be nulliparous and non-pregnant.At the commencement of the study, the weight variation of animals should be minimal and not exceed ± 20 per cent of the mean weight for each sex.1.4.2.2. Number and sexThree animals of one sex are used for each step. Either sex can be used in the initial step.1.4.2.3. Dose levelsThe dose level to be used as the starting dose is selected from one of three fixed levels i.e. 25, 200 and 2 000 mg/kg body weight. The starting dose level should be that which is most likely to produce mortality in at least some of the dosed animals. One of the flow charts of the procedures described in Annex 1 may be used depending on the starting dose.For selecting the sex and the starting dose, all the available information should be used, including information on structure activity relationships. When the information suggests that mortality is unlikely at the highest dose level (2 000 mg/kg body weight), then a limit test should be conducted. When there is no information on a substance to be tested, for animal welfare reasons it is recommended to use the starting dose of 200 mg/kg body weight.Occasionally, it may be desirable to achieve a refinement of information further than would be possible after conducting the test with the three fixed dose levels of 25, 200 and 2 000 mg/kg body weight. In these cases further testing at additional fixed dose levels of 5, 50 or 500 mg/kg body weight may be considered.Doses that are known to cause marked pain and distress, due to corrosive or severely irritant actions, need not be administered.The time interval between treatment groups is determined by the onset, duration, and severity of toxic signs. Treatment of animals of the other sex, or at the next dose, should be delayed until one is confident of survival of the previously dosed animals.1.4.2.4. Limit testA limit test at one dose level of 2 000 mg/kg body weight may be carried out with three animals of each sex. If substance related mortality is produced, further testing at 200 mg/kg (or 500 mg/kg) body weight may need to be carried out.1.4.2.5. Observation periodThe animals should normally be observed for 14 days, except where animals need to be removed from the study and humanely killed for animal welfare reasons or are found dead. However, the duration of observation should not be fixed rigidly. It should be determined by the toxic reactions, time of onset and length of recovery period, and may thus be extended when considered necessary. The times at which signs of toxicity appear and disappear are important, especially if there is a tendency for toxic signs to be delayed. All observations are systematically recorded with individual records being maintained for each animal.1.4.3. ProcedureFollowing the period of fasting the animals should be weighed prior to test substance administration. After the substance has been administered, food may be withheld for a further 3-4 hours. Where a dose is administered in fractions over a period, it may be necessary to provide the animals with food and water, depending on the length of the period.The maximum volume of liquid that can be administered at one time depends on the size of the test animal. In rodents, the volume should not normally exceed 1 ml/100 g body weight; however, in the case of aqueous solutions 2 ml/100 g body weight can be considered. Variability in test volume should be minimised by adjusting the concentration to ensure a constant volume at all dose levels. If a single dose is not possible, the dose may be given in smaller fractions over a period not exceeding 24 hours.Details of the test procedure are described in Annex 1.1.4.3.1. General observationsCareful clinical observations should be made at least twice on the day of dosing, or more frequently when indicated by the response of the animals to the treatment, and at least once daily thereafter. Animals found in a moribund condition and animals showing severe pain and enduring signs of severe distress should be humanely killed. Animals killed for humane reasons are considered in the same way as animals that died on test.When animals are killed for humane reasons or found dead, the time of death should be recorded as precisely as possible. Additional observations will be necessary if the animals continue to display signs of toxicity. Observations should include changes in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems, and somatomotor activity and behaviour pattern. Attention should be directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.All observations are systematically recorded with individual records being maintained for each animal.1.4.3.2. Body weightAll animals should be weighed shortly before the test substance is administered, and at least weekly thereafter. Weight changes should be calculated and recorded. At the end of the test surviving animals are weighed before being humanely killed.1.4.3.3. Gross necropsyAll test animals, including those which die during the test or are removed from the study, should be subjected to gross necropsy. All gross pathological changes should be recorded for each animal. Microscopic examination of organs showing evidence of gross pathology, in animals surviving 24 or more hours, may also be considered because it may yield useful information.2. DATAIndividual animal data should be provided. Additionally, all data should be summarised in tabular form showing for each test group the number of animals used, the number of animals displaying signs of toxicity, the number of animals found dead during the test or killed for humane reasons, time of death of individual animals, a description and the time course of toxic effects and reversibility, and necropsy findings.General guidance on the interpretation of the results for classification is given in Annex 2.3. REPORTINGTest reportThe test report shall, if possible, include the following information:Test animals:- species/strain;- microbiological status of the animals, when known;- number, age and sex of animals;- source, housing conditions, diet, etc.;- individual weights of animals at the start of the test, in weekly intervals thereafter and at the end of the test.Test conditions:- justification for choice of vehicle, if other than water;- details of the administration of the test substance including dosing volumes and time of dosing;- details of food and water quality (including type/source, water source);- the rationale for the selection of the starting dose.Results:- tabulation of response data by sex and dose level for each animal (i.e. animals showing signs of toxicity including mortality, nature, severity and duration of effects);- Time course of onset of signs of toxicity and whether these were reversible for each animal;- necropsy findings and any histopathological findings for each animal, if available.Discussion of results.Conclusions.4. REFERENCESThis method is analogous to OECD TG 423.ANNEX 1TEST PROCEDURE1. As indicated in point 1.4.2.3, the starting dose should be the one which is likely to produce mortality in at least some of the dosed animals. Information that could be used to select the starting dose include:- data on physical chemical properties;- structure-activity relationship;- all data from other toxicity tests; and- anticipated use of the test substance.2. For each starting dose, the respective testing schemes, as included in this annex, outline the procedure to be followed. Depending on the number of humanely killed or dead animals the test procedure follows the indicated arrows.3. When at a starting dose of 25 or 200 mg/kg body weight only one animal of the second sex dies, this would normally lead to no further testing. However, when no toxic signs are observed in the other five animals, during autopsy consideration should be given to the possibility that mortality may not have been substance related. In such a case, the test should be continued with dosing at the next higher level.4. When at a dose of 2 000 mg/kg body weight, one animal per sex dies, the LD50 value is expected to exceed 2 000 mg/kg body weight. However, because this is a borderline result, the response of the remaining two animals per sex should be carefully considered and the occurrence of distinct, marked toxic signs in these animals may well lead to classification corresponding to an LD50 value of 2 000 mg/kg body weight or less, or would justify further testing at this same level.5. The procedure allows for testing at three additional fixed doses (option 2). This option could either be used to select an alternative dose at a given decision point, or for further testing after having completed the actual test (option 1). The option 1, test procedure is indicated with bold arrows, whereas for the option 2 test procedure, thin arrows are used.(a) Test procedure with a starting dose of 25 mg/kg body weight>REFERENCE TO A FILM>(b) Test procedure with a starting dose of 200 mg/kg body weight>REFERENCE TO A FILM>(c) Test procedure with a starting dose of 2 000 mg/kg body weight>REFERENCE TO A FILM>ANNEX 2INTERPRETATION OF RESULTS BASED ON OPTION 1 TESTINGThe grey boxes below the "no further testing" box in the schemes of this annex, represent cut off values for classification. Following the test procedure as outlined in option 1, the appropriate arrow should be followed further downwards, until it reaches the grey box of concern.(a) Interpretation of results based on option 1 testingStarting dose: 25 mg/kg body weight>REFERENCE TO A FILM>(b) Interpretation of results based on option 1 testingStarting dose: 200 mg/kg body weight>REFERENCE TO A FILM>(c) Interpretation of results based on option 1 testingStarting dose: 2 000 mg/kg body weight>REFERENCE TO A FILM>ANNEX IV C 'B.6 SKIN SENSITISATION1. METHOD1.1. IntroductionRemarks:The sensitivity and ability of tests to detect potential human skin sensitisers are considered important in a classification system for toxicity relevant to public health.There is no single test method which will adequately identify all substances with a potential for sensitising human skin and which is relevant for all substances.Factors such as the physical characteristics of a substance, including its ability to penetrate the skin, must be considered in the selection of a test.Two types of tests using guinea-pigs have been developed: the adjuvant-type tests, in which an allergic state is potentiated by dissolving or suspending the test substance in Freunds Complete Adjuvant (FCA), and the non-adjuvant tests.Adjuvant-type tests are likely to be more accurate in predicting a probable skin sensitising effect of a substance in humans than those methods not employing Freunds Complete Adjuvant and are thus the preferred methods.The Guinea-Pig Maximisation Test (GPMT) is a widely used adjuvant-type test. Although several other methods can be used to detect the potential of a substance to provoke skin sensitisation reaction, the GPMT is considered to be the preferred adjuvant technique.With many chemical classes, non-adjuvant tests (the preferred one being the Buehler test) are considered to be less sensitive.In certain cases there may be good reasons for choosing the Buehler test involving topical application rather than the intradermal injection used in the Guinea-Pig Maximisation Test. Scientific justification should be given when the Buehler test is used.The Guinea-Pig Maximisation Test (GPMT) and the Buehler test are described in this method. Other methods may be used provided that they are well-validated and scientific justification is given.If a positive result is seen in a recognised screening test, a test substance may be designated as a potential sensitiser, and it may not be necessary to conduct a further guinea pig test. However, if a negative result is seen in such a test, a guinea pig test must be conducted using the procedure described in this test method.See also General Introduction Part B.1.2. DefinitionsSkin sensitisation: (allergic contact dermatitis) is an immunologically mediated cutaneous reaction to a substance. In the human, the responses may be characterised by pruritis, erythema, oedema, papules, vesicles, bullae or a combination of these. In other species the reactions may differ and only erythema and oedema may be seen.Induction exposure: an experimental exposure of a subject to a test substance with the intention of inducing a hypersensitive state.Induction period: a period of at least one week following an induction exposure during which a hypersensitive state may be developed.Challenge exposure: an experimental exposure of a previously treated subject to a test substance following an induction period, to determine if the subject reacts in a hypersensitive manner.1.3. Reference substancesThe sensitivity and reliability of the experimental technique used should be assessed every six months by use of substances which are known to have mild-to-moderate skin sensitisation properties.In a properly conducted test, a response of at least 30 % in an adjuvant test and at least 15 % in a non-adjuvant test should be expected for mild/moderate sensitisers.The following substances are preferred:>TABLE>There may be circumstances where, given adequate justification other control substances meeting the above criteria may be used.1.4. Principle of the test methodThe test animals are initially exposed to the test substance by intradermal injections and/or epidermal application (induction exposure). Following a rest period of 10 to 14 days (induction period), during which an immune response may develop, the animals are exposed to a challenge dose. The extent and degree of skin reaction to the challenge exposure in the test animals is compared with that demonstrated by control animals which undergo sham treatment during induction and receive the challenge exposure.1.5. Description of the test methodsIf removal of the test substance is considered necessary, this should be achieved using water or an appropriate solvent without altering the existing response or the integrity of the epidermis.1.5.1. Guinea-Pig Maximisation Test (GPMT)1.5.1.1. PreparationsHealthy young adult albino guinea-pigs are acclimatised to the laboratory conditions for at least 5 days prior to the test. Before the test, animals are randomised and assigned to the treatment groups. Removal of hair is by clipping, shaving or possibly by chemical depilation, depending on the test method used. Care should be taken to avoid abrading the skin. The animals are weighed before the test commences and at the end of the test.1.5.1.2. Test conditions1.5.1.2.1. Test animalsCommonly used laboratory strains of albino guinea-pigs are used.1.5.1.2.2. Number and sexMale and/or female animals can be used. If females are used, they should be nulliparous and non-pregnant.A minimum of 10 animals is used in the treatment group and at least 5 animals in the control group. When fewer than 20 test and 10 control guinea pigs have been used, and it is not possible to conclude that the test substance is a sensitiser, testing in additional animals to give a total of at least 20 test and 10 control animals is strongly recommended.1.5.1.2.3. Dose levelsThe concentration of the test substance used for each induction exposure should be well-tolerated systemically and should be the highest to cause mild-to-moderate skin irritation. The concentration used for the challenge exposure should be the highest non-irritant dose. If necessary, the appropriate concentrations can be determined from a pilot study using two or three animals. Consideration should be given to the use of FCA-treated animals for this purpose.1.5.1.3. Procedure1.5.1.3.1. InductionDay 0-treated groupThree pairs of intradermal injections of 0.1 ml volume are given in the shoulder region which is cleared of hair so that one of each pair lies on each side of the midline.Injection 1: a 1:1 mixture (v/v) FCA/water or physiological salineInjection 2: the test substance in an appropriate vehicle at the selected concentrationInjection 3: the test substance at the selected concentration formulated in a 1:1 mixture (v/v) FCA/water or physiological salineIn injection 3, water soluble substances are dissolved in the aqueous phase prior to mixing with FCA. Liposoluble or insoluble substances are suspended in FCA prior to combining with the aqueous phase. The final concentration of test substance shall be equal to that used in injection 2.Injections 1 and 2 are given close to each other and nearest the head, while 3 is given towards the caudal part of the test area.Day 0-control groupThree pairs of intradermal injections of 0.1 ml volume are given in the same sites as in the treated animals.Injection 1: a 1:1 mixture (v/v) FCA/water or physiological salineInjection 2: the undiluted vehicleInjection 3: a 50 % w/v formulation of the vehicle in a 1:1 mixture (v/v) FCA/water or physiological saline.Day 5-7-treated and control groupsApproximately twenty-four hours before the topical induction application, if the substance is not a skin irritant, the test area, after close-clipping and/or shaving is treated with 0.5 ml of 10 % sodium lauryl sulphate in vaseline, in order to create a local irritation.Day 6-8-treated groupThe test area is again cleared of hair. A filter paper (2 × 4 cm) is fully-loaded with test substance in a suitable vehicle and applied to the test area and held in contact by an occlusive dressing for 48 hours. The choice of the vehicle should be justified. Solids are finely pulverised and incorporated in a suitable vehicle. Liquids can be applied undiluted, if appropriate.Day 6-8-control groupThe test area is again cleared of hair. The vehicle only is applied in a similar manner to the test area and held in contact by an occlusive dressing for 48 hours.1.5.1.3.2. ChallengeDay 20-22-treated and control groupsThe flanks of treated and control animals are cleared of hair. A patch or chamber loaded with the test substance is applied to one flank of the animals and, when relevant, a patch or chamber loaded with the vehicle only may also be applied to the other flank. The patches are held in contact by an occlusive dressing for 24 hours.1.5.1.3.3. Observation and Grading: treated and control groups- approximately 21 hours after removing the patch the challenge area is cleaned and closely-clipped and/or shaved and depilated if necessary;- approximately 3 hours later (approximately 48 hours from the start of the challenge application) the skin reaction is observed and recorded according to the grades shown in appendix;- approximately 24 hours after this observation a second observation (72 hours) is made and once again recorded.Blind reading of test and control animals is encouraged.If it is necessary to clarify the results obtained in the first challenge, a second challenge (i.e. a rechallenge), where appropriate with a new control group, should be considered approximately one week after the first one. A rechallenge may also be performed on the original control group.All skin reactions and any unusual findings, including systemic reactions, resulting from induction and challenge procedures should be observed and recorded according to the grading scale of Magnusson/Kligman (See appendix). Other procedures, e.g. histopathological examination, the measurement of skin fold thickness, may be carried out to clarify doubtful reactions.1.5.2. Buehler test1.5.2.1. PreparationsHealthy young adult albino guinea-pigs are acclimatised to the laboratory condition for at least 5 days prior to the test. Before the test, animals are randomised and assigned to the treatment groups. Removal of hair is by clipping, shaving or possibly by chemical depilation, depending on the test method used. Care should be taken to avoid abrading the skin. The animals are weighed before the test commences and at the end of the test.1.5.2.2. Test conditions1.5.2.2.1. Test animalsCommonly used laboratory strains of albino guinea-pigs are used.1.5.2.2.2. Number and sexMale and/or female animals can be used. If females are used, they should be nulliparous and non-pregnant.A minimum of 20 animals is used in the treatment group and at least 10 animals in the control group.1.5.2.2.3. Dose levelsThe concentration of test substance used for each induction exposure should be the highest possible to produce a mild but not excessive irritation. The concentration used for the challenge exposure should be the highest non-irritating dose. If necessary, the appropriate concentrations can be determined from a pilot study using two or three animals.For water soluble test materials, it is appropriate to use water or a dilute non-irritating solution of surfactant as the vehicle. For other test materials 80 % ethanol/water is preferred for induction and acetone for challenge.1.5.2.3. Procedure1.5.2.3.1. InductionDay 0-treated groupOne flank is cleared of hair (closely-clipped). The test patch system should be fully loaded with test substance in a suitable vehicle (the choice of the vehicle should be justified; liquid test substances can be applied undiluted, if appropriate).The test patch system is applied to the test area and held in contact with the skin by an occlusive patch or chamber and a suitable dressing for 6 hours.The test patch system must be occlusive. A cotton pad is appropriate and can be circular or square, but should approximate 4-6 cm². Restraint using an appropriate restrainer is preferred to assure occlusion. If wrapping is used, additional exposures may be required.Day 0-control groupOne flank is cleared of hair (closely-clipped). The vehicle only is applied in a similar manner to that used for the treated group. The test patch system is held in contact with the skin by an occlusive patch or chamber and a suitable dressing for 6 hours. If it can be demonstrated that a sham control group is not necessary, a naive control group may be used.Day 6-8 and 13-15-treated and control groupThe same application as on day 0 is carried out on the same test area (cleared of hair if necessary) of the same flank on day 6-8, and again on day 13-15.1.5.2.3.2. ChallengeDay 27-29-treated and control groupThe untreated flank of treated and control animals is cleared of hair (closely-clipped). An occlusive patch or chamber containing the appropriate amount of test substance is applied, at the maximum non-irritant concentration, to the posterior untreated flank of treated and control animals.When relevant, an occlusive patch or chamber with vehicle only is also applied to the anterior untreated flank of both treated and control animals. The patches or chambers are held in contact by a suitable dressing for 6 hours.1.5.2.3.3. Observation and grading- approximately 21 hours after removing the patch the challenge area is cleared of hair;- approximately three hours later (approximately 30 hours after application of the challenge patch) the skin reactions are observed and recorded according to the grades shown in the appendix.- approximately 24 hours after the 30 hour observation (approximately 54 hours after application of the challenge patch) skin reactions are again observed and recorded.Blind reading of the test and control animals is encouraged.If it is necessary to clarify the results obtained in the first challenge, a second challenge (i.e. a rechallenge), where appropriate with a new control group, should be considered approximately one week after the first one. A rechallenge may also be performed on the original control group.All skin reactions and any unusual findings, including systemic reactions, resulting from induction and challenge procedures should be observed and recorded according to the Magnusson/Kligman grading scale (See appendix). Other procedures, e.g. histopathological examination, the measurement of skin fold thickness, may be carried out to clarify doubtful reactions.2. DATA (GPMT AND BUEHLER)Data should be summarised in tabular form showing for each animal the skin reactions at each observation.3. REPORTING (GPMT AND BUEHLER)If a screening assay is performed before the guinea pig test the description or reference of the test (e.g. Local Lymph Node Assay (LLNA), Mouse Ear Swelling Test (MEST)), including details of the procedure, must be given together with results obtained with the test and reference substances.Test report (GMPT and Buehler test)The test report shall, if possible, include the following information:Test animals:- strain of guinea-pig used;- number, age and sex of animals;- source, housing conditions, diet, etc.,- individual weights of animals at the start of the test.Test conditions:- technique of patch site preparation;- detail of patch materials used and patching technique;- result of pilot study with conclusion on induction and challenge concentrations to be used in the test;- details of test substance preparation, application and removal;- justification for choice of vehicle;- vehicle and test substance concentrations used for induction and challenge exposures and the total amount of substance applied for induction and challenge.Results:- a summary of the results of the latest sensitivity and reliability check (see 1.3) including information on substance, concentration and vehicle used;- on each animal including grading system;- narrative description of the nature and degree effects observed;- any histopathological findings.Discussion of results.Conclusions.4. REFERENCESThis method is analogous to OECD TG 406.Appendix>TABLE>`ANNEX IV D 'B.7 REPEATED DOSE (28 DAYS) TOXICITY (ORAL)1. METHOD1.1. IntroductionSee General Introduction Part B.1.2. DefinitionsSee General Introduction Part B.1.3. Principle of the test methodThe test substance is orally administered daily in graduated doses to several groups of experimental animals, one dose level per group for a period of 28 days. During the period of administration the animals are observed closely, each day for signs of toxicity. Animals which die or are killed during the test are necropsied and at the conclusion of the test surviving animals are killed and necropsied.This method places more emphasis on neurological effects as a specific endpoint, and the need for careful clinical observations of the animals, so as to obtain as much information as possible, is stressed. The method should identify chemicals with neurotoxic potential, which may warrant further in-depth investigation of this aspect. In addition, the method may give an indication of immunological effects and reproductive organ toxicity.1.4. Description of the test method1.4.1. PreparationsHealthy young adult animals are randomly assigned to the control and treatment groups. Cages should be arranged in such a way that possible effects due to cage placement are minimized. The animals are identified uniquely and kept in their cages for at least five days prior to the start of the study to allow for acclimatisation to the laboratory conditions.The test substance is administered by gavage or via the diet or drinking water. The method of oral administration is dependent on the purpose of the study, and the physical/chemical properties of the substance.Where necessary, the test substance is dissolved or suspended in a suitable vehicle. It is recommended that, wherever possible, the use of an aqueous solution/suspension be considered first, followed by consideration of a solution/emulsion in oil (e.g. corn oil) and then by possible solution in other vehicles. For vehicles other than water the toxic characteristics of the vehicle must be known. The stability of the test substance in the vehicle should be determined.1.4.2. Test conditions1.4.2.1. Test animalsThe preferred rodent species is the rat, although other rodent species may be used. Commonly used laboratory strains of young healthy adult animals should be employed. The females should be nulliparous and non-pregnant. Dosing should begin as soon as possible after weaning and, in any case, before the animals are nine weeks old.At the commencement of the study the weight variation of animals used should be minimal and not exceed ± 20 % of the mean weight of each sex.Where a repeated dose oral study is conducted as a preliminary to a long term study, preferably animals from the same strain and source should be used in both studies.1.4.2.2. Number and sexAt least 10 animals (five female and five male) should be used at each dose level. If interim kills are planned, the number should be increased by the number of animals scheduled to be killed before the completion of the study.In addition, a satellite group of 10 animals (five animals per sex) may be treated with the high dose level for 28 days and observed for reversibility, persistence, or delayed occurrence of toxic effects for 14 days post-treatment. A satellite group of 10 control animals (five animals per sex) is also used.1.4.2.3. Dose levelsGenerally, at least three test groups and a control group should be used. Except for treatment with the test substance, animals in the control group should be handled in an identical manner to the test group subjects. If a vehicle is used in administering the test substance, the control group should receive the vehicle in the highest volume used.If from assessment of other data, no effects would be expected at a dose of 1 000 mg/kg bw/d, a limit test may be performed. If there are no suitable data available, a range finding study may be performed to aid the determination of the doses to be used.Dose levels should be selected taking into account any existing toxicity and (toxico-) kinetic data available for the test substance or related materials. The highest dose level should be chosen with the aim of inducing toxic effects but not death or severe suffering. Thereafter, a descending sequence of dose levels should be selected with a view to demonstrating any dosage related response and no-observed-adverse effects at the lowest dose level (NOAEL). Two to four fold intervals are frequently optimal for setting the descending dose levels and addition of a fourth test group is often preferable to using very large intervals (e.g. more than a factor of 10) between dosages.For substances administered via the diet or drinking water it is important to ensure that the quantities of the test substance involved do not interfere with normal nutrition or water balance. When the test substance is administered in the diet either a constant dietary concentration (ppm) or a constant dose level in terms of the animals' body weight may be used; the alternative used must be specified. For a substance administered by gavage, the dose should be given at similar times each day, and adjusted as necessary to maintain a constant dose level in terms of animal body weight.Where a repeated dose study is used as a preliminary to a long term study, a similar diet should be used in both studies.1.4.2.4. Limit testIf a test at one dose level of at least 1 000 mg/kg body weight/day or, for dietary or drinking water administration, an equivalent percentage in the diet or drinking water (based upon body weight determinations), using the procedures described for this study, produces no observable toxic effects and if toxicity would not be expected based upon data from structurally related substances, then a full study using three dose levels may not be considered necessary. The limit test applies except when human exposure indicates the need for a higher dose level to be used.1.4.2.5. Observation periodThe observation period should be 28 days. Animals in a satellite group scheduled for follow-up observations should be kept for at least a further 14 days without treatment to detect delayed occurrence, or persistence of, or recovery from toxic effects.1.4.3. ProcedureThe animals are dosed with the test substance daily seven days each week for a period of 28 days; use of a five-day per week dosing regime needs to be justified. When the test substance is administered by gavage, this should be done in a single dose to the animals using a stomach tube or a suitable intubation cannula. The maximum volume of liquid that can be administered at one time depends on the size of the test animal. The volume should not exceed 1 ml/100 g body weight, except in the case of aqueous solutions where 2 ml/100 g body weight may be used. Except for irritating or corrosive substances which will normally reveal exacerbated effects with higher concentrations, variability in test volume should be minimised by adjusting the concentration to ensure a constant volume at all dose levels.1.4.3.1. General observationsGeneral clinical observations should be made at least once a day, preferably at the same time(s) each day and considering the peak period of anticipated effects after dosing. The health condition of the animals should be recorded. At least twice daily, all animals are observed for morbidity and mortality. Moribund animals and animals in severe distress or pain should be removed when noticed, humanely killed and necropsied.Once before the first exposure (to allow for within-subject comparisons), and at least once a week thereafter, detailed clinical observations should be made in all animals. These observations should be made outside the home cage in a standard arena and preferably at the same time, each time. They should be carefully recorded, preferably using scoring systems, explicitly defined by the testing laboratory. Effort should be made to ensure that variations in the test conditions are minimal and that observations are preferably conducted by observers unaware of the treatment. Signs noted should include but not be limited to, changes in skin, fur, eyes, mucous membranes, occurrence of secretions and excretions and autonomic activity (e.g. lacrimation, piloerection, pupil size, unusual respiratory pattern). Changes in gait, posture and response to handling as well as the presence of clonic or tonic movements, stereotypes (e.g. excessive grooming, repetitive circling) or bizarre behaviour (e.g. self-mutilation, walking backwards) should also be recorded.In the fourth exposure week sensory reactivity to stimuli of different types (e.g. auditory, visual and proprioceptive stimuli), assessment of grip strength and motor activity assessment should be conducted. Further details of the procedures that could be followed are given in the literature (see General Introduction Part B).Functional observations conducted in the fourth exposure week may be omitted when the study is conducted as a preliminary study to a subsequent subchronic (90-day) study. In that case, the functional observations should be included in this follow-up study. On the other hand, the availability of data on functional observations from the repeated dose study may enhance the ability to select dose levels for a subsequent subchronic study.Exceptionally, functional observations may also be omitted for groups that otherwise reveal signs of toxicity to an extent that would significantly interfere with the functional test performance.1.4.3.2. Body weight and food/water consumptionAll animals should be weighed at least once a week. Measurements of food and water consumption should be made at least weekly. If the test substance is administered via the drinking water, water consumption should also be measured at least weekly.1.4.3.3. HaematologyThe following haematological examinations should be made at the end of the test period: haematocrit, haemoglobin concentration, erythrocyte count, total an differential leucocyte count, platelet count and a measure of blood clotting time/potential.Blood samples should be taken from a named site just prior to or as part of the procedure for killing the animals, and stored under appropriate conditions.1.4.3.4. Clinical biochemistryClinical biochemistry determinations to investigate major toxic effects in tissues and, specifically, effects on kidney and liver, should be performed on blood samples obtained of all animals just prior to or as part of the procedure for killing the animals (apart from those found moribund and/or intercurrently killed). Overnight fasting of the animals prior to blood sampling is recommended (1). Investigations of plasma or serum shall include sodium, potassium, glucose, total cholesterol, urea, creatinine, total protein and albumin, at least two enzymes indicative of hepatocellular effects (such as alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma glutamyl transpeptidase, and sorbitol dehydrogenase). Measurements of additional enzymes (of hepatic or other origin) and bile acids may provide useful information under certain circumstances(1) For a number of measurements in serum and plasma, most notably for glucose, overnight fasting would be preferable. The major reason for this preference is that the increased variability which would inevitably result from non-fasting, would tend to mask more subtle effects and make interpretation difficult. On the other hand, however, overnight fasting may interfere with the general metabolism of the animals and, particularly in feeding studies, may disturb the daily exposure to the test substance. If overnight fasting is adopted, clinical biochemical determinations should be performed after the conduct of functional observations in week 4 of the study.Optionally, the following urine analysis determinations could be performed during the last week of the study using timed urine volume collection; appearance, volume, osmolality or specific gravity, pH, protein, glucose and blood/blood cells.In addition, studies to investigate serum markers of general tissue damage should be considered. Other determinations that should be carried out if the known properties of the test substance may, or are suspected to, affect related metabolic profiles include calcium, phosphate, fasting triglycerides, specific hormones, methaemoglobin and cholinesterase. These need to be identified for substances in certain classes or on a case-by-case basis.Overall, there is a need for a flexible approach, depending on the species and the observed and/or expected effect with a given substance.If historical baseline data are inadequate, consideration should be given to determination of haematological and clinical biochemistry variables before dosing commences.1.4.3.5. Gross necropsyAll animals in the study shall be subjected to a full, detailed gross necropsy which includes careful examination of the external surface of the body, all orifices, and the cranial, thoracic and abdominal cavities and their contents. The liver, kidneys, adrenals, testes, epididymides, thymus, spleen, brain and heart of all animals should be trimmed of any adherent tissue, as appropriate, and their wet weight taken as soon as possible after dissection to avoid drying.The following tissues should be preserved in the most appropriate fixation medium for both the type of tissue and the intended subsequent histopathological examination: all gross lesions, brain (representative regions including cerebrum, cerebellum and pons), spinal cord, stomach, small and large intestines (including Peyer's patches), liver, kidneys, adrenals, spleen, heart, thymus, thyroid, trachea and lungs (preserved by inflation with fixative and then immersion), gonads, accessory sex organs (e.g. uterus, prostate), urinary bladder, lymph nodes (preferably one lymph node covering the route of administration and another one distant from the route of administration to cover systemic effects), peripheral nerve (sciatic or tibial) preferably in close proximity to the muscle, and a section of bone marrow (or, alternatively, a fresh mounted bone marrow aspirate). The clinical and other findings may suggest the need to examine additional tissues. Also any organs considered likely to be target organs based on the known properties of the test substance should be preserved.1.4.3.6. Histopathological examinationFull histopathology should be carried out on the preserved organs and tissues of all animals in the control and high dose groups. These examinations should be extended to animals of all other dosage groups, if treatment-related changes are observed in the high dose group.All gross lesions shall be examined.When a satellite group is used, histopathology should be performed on tissues and organs identified as showing effects in the treated groups.2. DATAIndividual data should be provided. Additionally, all data should be summarised in tabular form showing for each test group the number of animals at the start of the test, the number of animals found dead during the test or killed for humane reasons and the time of any death or humane kill, the number showing signs of toxicity, a description of the signs of toxicity observed, including time of onset, duration, and severity of any toxic effects, the number of animals showing lesions, the type of lesions and the percentage of animals displaying each type of lesion.When possible, numerical results should be evaluated by an appropriate and generally acceptable statistical method. The statistical methods should be selected during the design of the study.3. REPORTINGTest reportThe test report shall, if possible, include the following information:Test animals:- species/strain used;- number, age and sex of animals;- source, housing conditions, diet, etc.;- individual weights of animals at the start of the test in weekly intervals thereafter and at the end of the testTest conditions:- justification for choice of vehicle, if other than water;- rationale for dose level selection;- details of test substance formulation/diet preparation, achieved concentration, stability and homogeneity of the preparation;- details of the administration of the test substance;- conversion from diet/drinking water test substance concentration (ppm) to the actual dose (mg/kg body weight/day), if applicable;- details of food and water qualityResults:- body weight/body weight changes;- food consumption, and water consumption, if applicable;- toxic response data by sex and dose level, including signs of toxicity;- nature, severity and duration of clinic observations (whether reversible or not);- sensory activity, grip strength and motor activity assessments;- haematological tests with relevant base-line values;- clinical biochemistry tests with relevant base-line values;- body weight at killing and organ weight data;- necropsy findings;- a detailed description of all histopathological findings- absorption data if available;- statistical treatment of results, where appropriate.Discussion of results.Conclusions.4. REFERENCESThis method is analogous to OECD TG 407.`ANNEX IV E 'B.37 DELAYED NEUROTOXICITY OF ORGANOPHOSPHORUS SUBSTANCES FOLLOWING ACUTE EXPOSURE1. METHOD1.1. IntroductionIn the assessment and evaluation of the toxic effects of substances, it is important to consider the potential of certain classes of substances to cause specific types of neurotoxicity that might not be detected in other toxicity studies. Certain organophosphorus substances have been observed to cause delayed neurotoxicity and should be considered as candidates for evaluation.In vitro screening tests could be employed to identify those substances which may cause delayed polyneuropathy; however, negative findings from in vitro studies do not provide evidence that the test substance is not a neurotoxicant.See General Introduction Part B.1.2. DefinitionsOrganophosphorus substances include uncharged organophosphorus esters, thioesters or anhydrides of organophosphoric, organophosphonic or organophosphoramidic acids or of related phosphorothioic, phosphonothioic or phosphorothioamidic acids, or other substances that may cause the delayed neurotoxicity sometimes seen in this class of substances.Delayed neurotoxicity is a syndrome associated with prolonged delayed onset of ataxia, distal axonopathies in spinal cord and peripheral nerve, and inhibition and aging of neuropathy target esterase (NTE) in neural tissue.1.3. Reference substancesA reference substance may be tested with a positive control group as a means of demonstrating that under the laboratory test conditions, the response of the tested species has not changed significantly.An example of a widely used neurotoxicant is tri-o-tolyl phosphate (CAS 78-30-8, EINECS 201-103-5, CAS nomenclature: phosphoric acid, tris(2-methylphenyl)ester), also known as tris-o-cresylphosphate.1.4. Principle of the test methodThe test substance is administered orally in a single dose to domestic hens which have been protected from acute cholinergic effects, when appropriate. The animals are observed for 21 days for behavioural abnormalities, ataxia, and paralysis. Biochemical measurements, in particular neuropathy target esterase inhibition (NTE), are undertaken on hens randomly selected from each group, normally 24 and 48 hours after dosing. Twenty-one days after exposure, the remainder of the hens are killed and histopathological examination of selected neural tissues is undertaken.1.5. Description of the test method1.5.1. PreparationsHealthy young adult hens free from interfering viral diseases and medication and without abnormalities of gait should be randomized and assigned to treatment and control groups and acclimatized to the laboratory conditions for at least 5 days prior to the start of the study.Cages or enclosures which are large enough to permit free mobility of the hens, and easy observation of gait should be used.Dosing with the test substance should normally be by the oral route using gavage, gelatine capsules, or a comparable method. Liquids may be given undiluted or dissolved in an appropriate vehicle such as corn oil; solids should be dissolved if possible since large doses of solids in gelatine capsules may not be absorbed efficiently. For non-aqueous vehicles the toxic characteristics of the vehicle should be known, and if not known should be determined before the test.1.5.2. Test conditions1.5.2.1. Test animalsThe young adult domestic laying hen (Gallus gallus domesticus), aged 8 to 12 months, is recommended. Standard size breeds and strains should be employed and the hens normally should have been reared under conditions which permitted free mobility.1.5.2.2. Number and sexIn addition to the treatment group, both a vehicle control group and a positive control group should be used. The vehicle control group should be treated in a manner identical to the treatment group, except that administration of the test substance is omitted.Sufficient number of hens should be utilized in each group of birds so that at least six birds can be killed for biochemical determination (three at each of two time points) and six can survive the 21 day observation period for pathology.The positive control group may be run concurrently or be a recent historical control group. It should contain at least six hens, treated with a known delayed neurotoxicant, three hens for biochemistry and three hens for pathology. Periodic updating of historical data is recommended. New positive control data should be developed when some essential element (e.g. strain, feed, housing conditions) of the conduct of the test has been changed by the performing laboratory.1.5.2.3. Dose levelsA preliminary study using an appropriate number of hens and dose levels groups should be performed to establish the level to be used in the main study. Some lethality is typically necessary in this preliminary study to define an adequate main study dose. However, to prevent death due to acute cholinergic effects, atropine or another protective agent, known to not interfere with delayed neurotoxic responses, may be used. A variety of test methods may be used to estimate the maximum non-lethal dose of test substances (See method B.1bis). Historical data in the hen or other toxicological information may also be helpful in dose selection.The dose level of the test substance in the main study should be as high as possible taking into account the results of the preliminary dose selection study and the upper limit dose of 2,000 mg/kg body weight. Any mortality which might occur should not interfere with the survival of sufficient animals for biochemistry (six) and histology (six) at 21 days. Atropine or another protective agent, known to not interfere with delayed neurotoxic responses, should be used to prevent death due to acute cholinergic effects.1.5.2.4. Limit testIf a test at a dose level of at least 2,000 mg/kg body weight/day, using the procedures described for this study, produces no observable toxic effects and if toxicity would not be expected based upon data from structurally related substances, then a study using a higher dose may not be considered necessary. The limit test applies except when human exposure indicates the need for a higher dose level to be used.1.5.2.5. Observation periodObservation period should be 21 days.1.5.3. ProcedureAfter administration of a protective agent to prevent death due to acute cholinergic effect, the test substance is administered in a single dose.1.5.3.1. General observationObservations should start immediately after exposure. All hens should be carefully observed several times during the first 2 days and thereafter at least once daily for a period of 21 days or until scheduled kill. All signs of toxicity should be recorded, including the time of onset, type, severity and duration of behavioural abnormalities. Ataxia should be measured on an ordinal grading scale consisting of at least four levels, and paralysis should be noted. At least twice a week the hens selected for pathology should be taken outside the cages and subjected to a period of forced motor activity, such as ladder climbing, in order to facilitate the observation of minimal toxic effects. Moribund animals and animals in severe distress or pain should be removed when noticed, humanely killed and necropsied.1.5.3.2. Body weightAll hens should be weighed just prior to administration of the test substance and at least once a week thereafter.1.5.3.3. BiochemistrySix hens randomly selected from each of the treatment and vehicle control groups, and three hens from the positive control group (when this group is run concurrently), should be killed within a few days after dosing, and the brain and lumbar spinal cord prepared and assayed for neuropathy target esterase inhibition activity. In addition, it may also be useful to prepare and assay sciatic nerve tissue for neuropathy target esterase inhibition activity. Normally, three birds of the control and each treatment group are killed after 24 hours and three at 48 hours, whereas the three hens of the positive controls should be killed at 24 hours. If observation of clinical signs of intoxication (this can often be assessed by observation of the time of onset of cholinergic signs) indicates that the toxic agent may be disposed of very slowly then it may be preferable to sample tissue from three birds at each of two times between 24 and as late as 72 hours after dosing.Analyses of acetylcholinesterase (AChE) may also be performed on these samples, if deemed appropriate. However, spontaneous reactivation of AChE may occur in vivo, and so lead to underestimation of the potency of the substance as an AChE inhibitor.1.5.3.4. Gross necropsyGross necropsy of all animals (scheduled killed and killed when moribund) should include observation of the appearance of the brain and spinal cord.1.5.3.5. Histopathological examinationNeural tissue from animals surviving the observation period and not used for biochemical studies should be subjected to microscopic examination. Tissues should be fixed in situ, using perfusion techniques. Sections should include cerebellum (mid-longitudinal level), medulla oblongata, spinal cord, and peripheral nerves. The spinal cord sections should be taken from the upper cervical segment, the mid-thoracic and the lumbo-sacral regions. Sections of the distal region of the tibial nerve and its branches to the gastrocnemial muscle and of the sciatic nerve should be taken. Sections should be stained with appropriate myelin and axon-specific stains.2. DATANegative results on the endpoints selected in this method (biochemistry, histopathology and behavioural observation) would not normally require further testing for delayed neurotoxicity. Equivocal or inconclusive results for these endpoints may require further evaluation.Individual data should be provided. Additionally, all data should be summarized in tabular form, showing for each test group the number of animals at the start of the test, the number of animals showing lesions, behavioural or biochemical effects, the types and severity of these lesions or effects, and the percentage of animals displaying each type and severity of lesion or effect.The findings of this study should be evaluated in terms of the incidence, severity, and correlation of behavioural, biochemical and histopathological effects and any other observed effects in the treated and control groups.Numerical results should be evaluated by appropriate and generally acceptable statistical methods. The statistical methods used should be selected during the design of the study.3. REPORTINGTest reportThe test report shall, if possible, include the following information:Test animals:- strain used;- number and age of animals;- source, housing conditions, etc.;- individual weights of animals at the start of the test.Test conditions:- details of test substance preparation, stability and homogeneity; where appropriate;- justification for choice of vehicle;- details of the administration of the test substance;- details of food and water quality;- rationale for dose selection;- specification of doses administered, including details of the vehicle, volume and physical form of the material administered;- identity and details of the administration of any protective agent.Results:- body weight data;- toxic response data by group, including mortality;- nature, severity and duration of clinic observations (whether reversible or not);- a detailed description of biochemical methods and findings;- necropsy findings;- a detailed description of all histopathological findings;- statistical treatment of results, where appropriate.Discussion of results.Conclusions.4. REFERENCESThis method is analogous to OECD TG 418.B.38 DELAYED NEUROTOXICITY OF ORGANOPHOSPHORUS SUBSTANCES 28 DAY REPEATED DOSE STUDY1. METHOD1.1. IntroductionIn the assessment and evaluation of the toxic effects of substances, it is important to consider the potential of certain classes of substances to cause specific types of neurotoxicity that might not be detected in other toxicity studies. Certain organophosphorus substances have been observed to cause delayed neurotoxicity and should be considered as candidates for evaluation.In vitro screening tests could be employed to identify those substances which may cause delayed polyneuropathy; however, negative findings from in vitro studies do not provide evidence that the test substance is not a neurotoxicant.This 28-day delayed neurotoxicity test provides information on possible health hazards likely to arise from repeated exposures over a limited period of time. It will provide information on dose response and can provide an estimate of a no-observed-adverse effect level which can be of use for establishing safety criteria for exposure.See also General Introduction Part B.1.2. DefinitionsOrganophosphorus substances include uncharged organophosphorus esters, thioesters or anhydrides of organophosphoric, organophosphonic or organophosphoramidic acids or of related phosphorothioic, phosphonothioic or phosphorothioamidic acids or other substances that may cause the delayed neurotoxicity sometimes seen in this class of substances.Delayed neurotoxicity is a syndrome associated with prolonged delayed onset of ataxia, distal axonopathies in spinal cord and peripheral nerve, and inhibition and ageing of neuropathy target esterase (NTE) in neural tissue.1.3. Principle of the test methodDaily doses of the test substance are administered orally to domestic hens for 28 days. The animals are observed at least daily for behavioural abnormalities, ataxia and paralysis until 14 days after the last dose: Biochemical measurements, in particular neuropathy target esterase inhibition (NTE), are undertaken, on hens randomly selected from each group, normally 24 and 48 hours after the last dose. Two weeks after the last dose, the remainder of the hens are killed and histopathological examination of selected neural tissues is undertaken.1.4. Description of the test method1.4.1. PreparationsHealthy young adult hens free from interfering viral diseases and medication, and without abnormalities of gait should be randomized and assigned to treatment and control groups and acclimatized to the laboratory conditions for at least 5 days prior to the start of the study.Cages or enclosures which are large enough to permit free mobility of the hens and easy observation of gait should be used.Oral dosing each day, 7 days per week, should be carried out, preferably by gavage or administration of gelatine capsules. Liquids may be given undiluted or dissolved in an appropriate vehicle such as corn oil; solids should be dissolved if possible since large doses of solids in gelatine capsules may not be absorbed efficiently. For non-aqueous vehicles the toxic characteristics of the vehicle should be known, and if not known should be determined before the test.1.4.2. Test conditions1.4.2.1. Test animalsThe young adult domestic laying hen (Gallus gallus domesticus), aged 8 to 12 months, is recommended. Standard size, breeds and strains should be employed and the hens normally should have been reared under conditions with permitted free mobility.1.4.2.2. Number and sexGenerally at least three treatment groups and a vehicle control group should be used. The vehicle control group should be treated in a manner identical to the treatment group, except that administration of the test substance is omitted.Sufficient number of hens should be utilized in each group of birds so that at least six birds can be killed for biochemical determinations (three at each of two timepoints) and six birds can survive the 14-day post-treatment observation period for pathology.1.4.2.3. Dose levelsDose levels should be selected taking into account three results from an acute test on delayed neurotoxicity and any other existing toxicity or kinetic data available for the test compound. The highest dose level should be chosen with the aim of inducing toxic effects, preferably delayed neurotoxicity, but not death nor obvious suffering. Thereafter, a descending sequence of dose levels should be selected with a view to demonstrate any dose-related response and no-observed-adverse effects at the lowest dose level.1.4.2.4. Limit testIf a test at a dose level of at least 1000 mg/kg body weight/day, using the procedures described for this study, produces no observable toxic effects and if toxicity would not be expected based upon data from structurally related substances, then a study using a higher dose may not be considered necessary. The limit test applies except when expected human exposure indicates the need for a higher dose level to be used.1.4.2.5. Observation periodAll the animals should be observed at least daily during the exposure period and 14 days after, unless scheduled necropsy.1.4.3. ProcedureAnimals are dosed with the test substance on seven days per week for a period of 28 days1.4.3.1. General observationsObservations should start immediately after treatment begins. All hens should be carefully observed at least once daily on each of the 28 days of treatment, and for 14 days after dosing or until scheduled kill. All signs of toxicity should be recorded including their time of onset, type, severity and duration. Observations should include, but not be limited to, behavioural abnormalities. Ataxia should be measured on an ordinal grading scale consisting of at least four levels, and paralysis should be noted. At least twice a week the hens should be taken outside the cages and subjected to a period of forced motor activity, such as ladder climbing, in order to facilitate the observation of minimal toxic effects. Moribund animals in severe distress or pain should be removed when noticed, humanely killed and necropsied.1.4.3.2. Body weightAll hens should be weighed just prior to the first administration of the test substance and at least once a week thereafter.1.4.3.3. BiochemistrySix hens randomly selected from each of the treatment and vehicle control groups should be killed within a few days after the last dose, and the brain and lumbar spinal cord prepared and assayed for neuropathy target esterase (NTE) inhibition activity. In addition, it may also be useful to prepare and assay sciatic nerve tissue for neuropathy target esterase (NTE) inhibition activity. Normally, three birds of the control and each treatment group are killed after 24 hours and three at 48 hours after the last dose. If data from the acute study or other studies (e.g. toxicokinetics) indicate that other times of killing after final dosing are preferable then these times should be used and the rationale documented.Analyses of acetylcholinesterase (AChE) may also be performed on these samples, if deemed appropriate. However, spontaneous reactivation of AChE may occur in vivo, and so lead to underestimation of the potency of the substance as an AChE inhibitor.1.4.3.4. Gross necropsyGross necropsy of all animals (scheduled killed and killed when moribund) should include observation of the appearance of the brain and spinal cord.1.4.3.5. Histopathological examinationNeural tissue from animals surviving the observation period and not used for biochemical studies should be subjected to microscopic examination. Tissues should be fixed in situ, using perfusion techniques. Sections should include cerebellum (mid longitudinal level), medulla oblongata, spinal cord and peripheral nerves. The spinal cord sections should be taken from the upper cervical segment, the mid-thoracic and the lumbo-sacral regions. Sections of the distal region of the tibial nerve and its branches to the gastrocnemial muscle and of the sciatic nerve should be taken. Sections should be stained with appropriate myelin and axon-specific stains. Initially, microscopic examination should be carried out on the preserved tissues of all animals in the control and high dose group. When there is evidence of effects in the high dose group, microscopic examination should also be carried out in hens from the intermediate and low dose groups.2. DATANegative results on the endpoints selected in this method (biochemistry, histopathology and behavioural observation) would not normally require further testing for delayed neurotoxicity. Equivocal or inconclusive results for these endpoints may require further evaluation.Individual data should be provided. Additionally, all data should be summarized in tabular form, showing for each test group the number of animals at the start of the test, the number of animals showing lesions, behavioural or biochemical effects, the types and severity of these lesions or effects, and the percentage of animals displaying each type and severity of lesion or effect.The findings of this study should be evaluated in terms of the incidence, severity, and correlation of behavioural, biochemical and histopathological effects and any other observed effects in each of the treated and control groups.Numerical results should be evaluated by appropriate and generally acceptable statistical methods. The statistical methods should be selected during the design of the study.3. REPORTINGTest reportThe test report shall, if possible, include the following information:Test animals:- strain used;- number and age of animals;- source, housing conditions, etc.;- individual weights of animals at the start of the test.Test conditions:- details of test substance preparation, stability and homogeneity, where appropriate;- justification for choice of vehicle;- details of the administration of the test substance;- details of food and water quality;- rationale for dose selection;- specification of doses administered, including details of the vehicle, volume and physical form of the material administered;- rationale for choosing other times for biochemical determination, if other than 24 and 48 h.Results:- body weight data;- toxic response data by dose level, including mortality;- no-observed adverse effect level;- nature, severity and duration of clinic observations (whether reversible or not);- a detailed description of biochemical methods and findings;- necropsy findings;- a detailed description of all histopathological findings;- statistical treatment of results, where appropriate.Discussion of results.Conclusions.4. REFERENCESThis method is analogous to OECD TG 419`ANNEX V A. Sections 8 and 9 of the 'Contents` of the Annex are modified as follows:'8. SPECIAL CASES: substances8.1. Mobile gas containers8.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)8.3. Metals in massive form8.4. Substances classified with R659. SPECIAL CASES: preparations9.1. Gaseous preparations (gas mixtures)9.2. Gas containers intended for preparations containing stenched propane, butane or liquefied petroleum gas (LPG)9.3. Alloys, preparations containing polymers, preparations containing elastomers9.4. Preparations classified with R659.5. Organic peroxides`B. The following text is inserted in section 3.2.3 after the criteria for R20 'Harmful by inhalation`:'R65 Harmful: may cause lung damage if swallowedLiquid substances and preparations presenting an aspiration hazard in humans because of their low viscosity:(a) For substances and preparations containing aliphatic, alicyclic and aromatic hydrocarbons in a total concentration equal to or greater than 10 % and having either- a flow time of less than 30 sec. in a 3 mm ISO cup according to EN 535, or- a kinematic viscosity measured by a calibrated glass capillary viscometer in accordance with ISO 3104/3105 of less than 7 × 10-6 m²/sec at 40 °C, or- a kinematic viscosity derived from measurements of rotational viscometry in accordance with ISO 3219 of less than 7 × 10-6 m²/sec at 40 °C.Note that substances and preparations meeting these criteria need not be classified if they have a mean surface tension greater than 25mN/m at 40 °C.(b) For other substances and preparations, not subject to the above criteria, based on practical experience in humans.`C. The text of section 3.2.6.3 is replaced by the following text:'3.2.6.3. Respiratory system irritationThe following risk phrase shall be assigned in accordance with the criteria given:R37 Irritating to respiratory systemSubstances and preparations which cause serious irritation to the respiratory system based on:- practical observation in humans- positive results from appropriate animal testsComments regarding the use of R37In interpreting practical observations in humans, care should be taken to distinguish between effects which lead to classification with R48 (see section 3.2.4) from those leading to classification with R37. Conditions normally leading to classification with R37 are reversible and usually limited to the upper airways.Positive results from appropriate animal tests may include data obtained in a general toxicity test, including histopathological data from the respiratory system. Data from the measurement of experimental bradypnea may also be used to assess airway irritation.`D. The text of section 3.2.7 Sensitisation is replaced by the following text:'3.2.7. Sensitisation3.2.7.1. Sensitisation by inhalationSubstances and preparations shall be classified as sensitising and assigned the symbol "Xn", the indication of danger "Harmful", and the risk phrase R42 in accordance with the criteria given below:R42 May cause sensitisation by inhalation- if there is evidence that the substance or preparation can induce specific respiratory hypersensitivity- where there are positive results from appropriate animal tests- if the substance is an isocyanate, unless there is evidence that the substance does not cause respiratory hypersensitivityComments regarding the use of R42Human evidenceEvidence that the substance can induce specific respiratory hypersensitivity will normally be based on human experience. In this context hypersensitivity is normally seen as asthma, but other hyerpsensitivity reactions such as rhinitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.When considering the evidence from human exposure, it is necessary for a decision on classification to take into account in addition to the evidence from the cases:- the size of the population exposed- the extent of exposureThe evidence referred to above could be- clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:- a chemical structure related to substances known to cause respiratory hypersensitivity- in vivo immunological test (e.g. skin prick test)- in vitro immunological test (e.g. serological analysis)- studies that may indicate other specific but non-immunological mechanisms of action, e.g. repeated low-level irritation, pharmacologically mediated effects- data from a positive bronchial challenge test with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reactionClinical history should include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history should also include a note of other allergic or airway disorders from childhood, and smoking history.The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognized that in practice many of the examinations listed above will already have been carried out.Substances that elicit symptoms of asthma by irritation only in people with bronchial hyperreactivity should not be assigned R42.Animal studiesData from tests which may be indicative of the potential of a substance to cause sensitisation by inhalation in humans may include:- IgE measurements (e.g. in mice)- specific pulmonary responses in guinea pigs3.2.7.2. Sensitisation by skin contactSubstances and preparations shall be classified as sensitising and assigned the symbol "Xi", the indication of danger "Irritant", and the risk phrase R43 in accordance with the criteria given below:R43 May cause sensitisation by skin contact- if practical experience shows the substance or preparation to be capable of inducing sensitisation by skin contact in a substantial number of persons- where there are positive results from an appropriate animal testComments regarding the use of R43Human evidenceThe following evidence (practical experience) is sufficient to classify a substance with R43:- Positive data from appropriate patch testing, normally in more than one dermatological clinic, or- Epidemiological studies showing allergic contact dermaitis caused by the substance. Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small, or- Positive data from experimental studies in man (see also 3.1.1).The following is sufficient to classify a substance with R43 when there is supportive evidence:- Isolated episodes of allergic contact dermatitis, or- Epidemiological studies where chance, bias or confounders have not been ruled out fully with reasonable confidence.Supportive evidence may include:- data from animal tests performed according to existing guidelines, with a result that does not meet the criteria given in the section on animal studies but is sufficiently close to the limit to be considered significant, or- data from non-standard methods, or- appropriate structure-activity relationships.Animal studiesPositive results from appropriate animal tests are:In the case of the adjuvant type test method for skin sensitization detailed in Annex V or in the case of other adjuvant-type test methods, a response of at least 30 % of the animals is considered as positive. For any other test method a response of at least 15 % of the animals is considered positive.3.2.7.3. Immunological contact urticariaSome substances which meet the criteria for R42 may in addition cause immunological contact urticaria. In these cases, information concerning contact urticaria should be included by the use of appropriate S-phrases, usually S24 and S36/37, and in the Safety Data Sheet.For substances which produce signs of immunological contact urticaria which do not fulfil the criteria for R42, consideration should be given to classification with R43.There is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence which will be similar to that for skin sensitisation (R43).3.2.7.4. Note that if the symbol "Xn" and the indication of danger "Harmful" are assigned, the symbol "Xi" and indication of danger "Irritant" are optional.`E. The text of the criteria for S62 in section 6 is replaced by the following:'S62 If swallowed, do not induce vomiting: seek medical advice immediately and show this container or label- Applicability:- substances and preparations classified as harmful with R65 in accordance with the criteria in section 3.2.3,- not applicable to substances or preparations which are placed on the market in aerosol containers (or in containers fitted with a sealed spray attachment), see sections 8 and 9.- Criteria for use:- obligatory for substances and preparations mentioned above if sold to, or likely to be used by, the general public,- recommended for the substances and preparations mentioned above when used in industry.`F. The following section is inserted in Section 8:'8.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)These substances are classified in Annex I. Although classified in accordance with Article 2, they do not present a danger to human health when they are placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion.These cylinders or cartridges must be labelled with the appropriate symbol and the R- and S-phrases concerning flammability. No information concerning the effects on human health is required on the label. However, the information concerning effects on human health which should have appeared on the label shall be transmitted to the professional user by the person responsible for placing the substance on the market in the format foreseen in Article 27 of the Directive. For the consumer, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety as foreseen in Article 1 paragraph 3 of Directive 91/155/EEC, as modified by Directive 93/112/EEC.`G. The heading to 'Section 8.2 Metals in massive form` is replaced by:'8.3. Metals in massive form`H. The following section is inserted in Section 8:'8.4. Substances classified with R65Substances classified as harmful on the basis of an aspiration hazard need not be labelled as harmful with R56 when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.`I. The text of Section 9.1.3 is replaced by the following text:'9.1.3. LabellingFor mobile gas containers the requirements concerning labelling are considered to be satisfied when they are in agreement with Article 8 (5) (b) of Directive 88/379/EEC.However, by way of derogation from Articles 8 (1) and (2), for gas containers with a water capacity of less than or equal to 150 litres, the format and dimensions of the label can follow the prescriptions of the ISO Standard 7225. In this case, the label can bear the generic name or industrial/commercial name of the preparation provided that the dangerous component substances of the preparation are shown on the body of the gas container in a clear and indelible way.The information specified in Article 7 may be provided on a durable information disc or label held captive on the containers.`J. The following section is inserted in Section 9:'9.2. Gas containers intended for preparations containing stenched propane, butane or liquefied petroleum gas (LPG)Propane, butane and liquefied petroleum gas are classified in Annex I. Although preparations containing these substances are classified in accordance with Article 3 of Directive 88/379/EEC, they do not present a danger to human health when they are placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope on EN 417 as fuel gases which are only released for combustion.These cylinders and cartridges must be labelled with the appropriate symbol and the R- and S-phrases concerning flammability. No information concerning the effects on human health is required on the label. However, the information concerning effects on human health which should have appeared on the label shall be transmitted to the professional user by the person responsible for placing the substance on the market in the format foreseen in Article 10 of Directive 88/379/EEC. For the consumer, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety as foreseen in Article 1 paragraph 3 of Directive 91/155/EEC.`K. The heading of 'Section 9.2 Alloys, preparations containing polymers, preparations containing elastomers` is replaced by:'9.3. Alloys, preparations containing polymers, preparations containing elastomers`.L. The following section is added to Section 9:'9.4. Preparations classified with R65Preparations classified as harmful on the basis of an aspiration hazard need not be labelled as harmful with R65 when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.`M. The heading of 'Section 9.4 Organic peroxides` is replaced by:'9.5. Organic peroxides`